CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
G
A2M
alpha-2-macroglobulin
increases expression multiple interactions
EXP
Selenium results in increased expression of A2M mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein]
CTD
PMID:18997278 PMID:21144892
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
AAMP
angio associated migratory cell protein
increases expression
EXP
Selenium results in increased expression of AAMP mRNA
CTD
PMID:19244175
NCBI chr 2:218,264,129...218,270,137
Ensembl chr 2:218,264,129...218,270,178
G
AASS
aminoadipate-semialdehyde synthase
decreases expression multiple interactions
EXP
Selenium results in decreased expression of AASS mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA
CTD
PMID:19244175
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
G
AATF
apoptosis antagonizing transcription factor
increases expression
EXP
Selenium results in increased expression of AATF mRNA
CTD
PMID:19244175
NCBI chr17:36,948,954...37,056,871
Ensembl chr17:36,948,925...37,056,871
G
ABCA7
ATP binding cassette subfamily A member 7
increases expression
EXP
Selenium results in increased expression of ABCA7 mRNA
CTD
PMID:19244175
NCBI chr19:1,040,107...1,065,572
Ensembl chr19:1,039,997...1,065,572
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]
CTD
PMID:11444866 PMID:36464106
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCF3
ATP binding cassette subfamily F member 3
increases expression
EXP
Selenium results in increased expression of ABCF3 mRNA
CTD
PMID:19244175
NCBI chr 3:184,186,199...184,194,005
Ensembl chr 3:184,186,095...184,194,012
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]
CTD
PMID:36464106
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ABCG5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]
CTD
PMID:36464106
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABHD17A
abhydrolase domain containing 17A, depalmitoylase
increases expression
EXP
Selenium results in increased expression of ABHD17A mRNA
CTD
PMID:19244175
NCBI chr19:1,876,810...1,885,496
Ensembl chr19:1,876,810...1,885,496
G
ABHD2
abhydrolase domain containing 2, acylglycerol lipase
increases expression
EXP
Selenium results in increased expression of ABHD2 mRNA
CTD
PMID:19244175
NCBI chr15:89,040,998...89,202,355
Ensembl chr15:89,087,459...89,202,355
G
ABR
ABR activator of RhoGEF and GTPase
increases expression
EXP
Selenium results in increased expression of ABR mRNA
CTD
PMID:19244175
NCBI chr17:1,003,519...1,229,722
Ensembl chr17:1,003,519...1,229,738
G
ACAA2
acetyl-CoA acyltransferase 2
increases expression
EXP
Selenium results in increased expression of ACAA2 mRNA
CTD
PMID:19244175
NCBI chr18:49,782,164...49,813,533
Ensembl chr18:49,782,164...49,813,953
G
ACADS
acyl-CoA dehydrogenase short chain
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Selenium results in increased expression of ACADS mRNA
CTD
PMID:19244175
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
G
ACHE
acetylcholinesterase (Yt blood group)
multiple interactions
ISO
[Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium co-treated with Zinc] results in increased activity of ACHE protein; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in increased activity of ACHE protein; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in decreased activity of ACHE protein]
CTD
PMID:20688495 PMID:37415728
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ACIN1
apoptotic chromatin condensation inducer 1
increases expression
EXP
Selenium results in increased expression of ACIN1 mRNA
CTD
PMID:19244175
NCBI chr14:23,058,564...23,095,614
Ensembl chr14:23,058,564...23,095,614
G
ACO2
aconitase 2
increases expression
EXP
Selenium results in increased expression of ACO2 mRNA
CTD
PMID:19244175
NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273
G
ACOT2
acyl-CoA thioesterase 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Selenium results in increased expression of ACOT2 mRNA
CTD
PMID:19244175
NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658
G
ACP1
acid phosphatase 1
decreases expression
EXP
Selenium results in decreased expression of ACP1 mRNA
CTD
PMID:19244175
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
G
ACSL4
acyl-CoA synthetase long chain family member 4
multiple interactions
ISO
[2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] inhibits the reaction [Aflatoxin B1 results in increased expression of ACSL4 protein]; [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in decreased expression of ACSL4 protein
CTD
PMID:34116104
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
G
ACTB
actin beta
increases expression
EXP
Selenium results in increased expression of ACTB mRNA
CTD
PMID:19244175
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
G
ACTG1
actin gamma 1
increases expression
EXP
Selenium results in increased expression of ACTG1 mRNA
CTD
PMID:19244175
NCBI chr17:81,509,971...81,512,799
Ensembl chr17:81,509,413...81,523,847
G
ACTN1
actinin alpha 1
increases expression
EXP
Selenium results in increased expression of ACTN1 mRNA
CTD
PMID:19244175
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
G
ACTN4
actinin alpha 4
increases expression
EXP
Selenium results in increased expression of ACTN4 mRNA
CTD
PMID:19244175
NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589
G
ACTR1A
actin related protein 1A
increases expression
EXP
Selenium results in increased expression of ACTR1A mRNA
CTD
PMID:19244175
NCBI chr10:102,479,229...102,502,712
Ensembl chr10:102,461,881...102,502,712
G
ACTR1B
actin related protein 1B
increases expression
EXP
Selenium results in increased expression of ACTR1B mRNA
CTD
PMID:19244175
NCBI chr 2:97,655,939...97,664,044
Ensembl chr 2:97,655,939...97,664,044
G
ACY1
aminoacylase 1
increases expression
EXP
Selenium results in increased expression of ACY1 mRNA
CTD
PMID:19244175
NCBI chr 3:51,983,535...51,989,197
Ensembl chr 3:51,983,340...51,989,197
G
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif 5
decreases expression
EXP
Selenium results in decreased expression of ADAMTS5 mRNA
CTD
PMID:19244175
NCBI chr21:26,917,922...26,967,088
Ensembl chr21:26,917,922...26,967,088
G
ADAP1
ArfGAP with dual PH domains 1
increases expression
EXP
Selenium results in increased expression of ADAP1 mRNA
CTD
PMID:19244175
NCBI chr 7:897,900...955,407
Ensembl chr 7:897,900...955,407
G
ADCY2
adenylate cyclase 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA Selenium results in decreased expression of ADCY2 mRNA
CTD
PMID:19244175
NCBI chr 5:7,396,138...7,830,081
Ensembl chr 5:7,396,138...7,830,081
G
ADCY6
adenylate cyclase 6
increases expression
EXP
Selenium results in increased expression of ADCY6 mRNA
CTD
PMID:19244175
NCBI chr12:48,766,194...48,789,974
Ensembl chr12:48,766,194...48,789,089
G
ADD1
adducin 1
increases expression
EXP
Selenium results in increased expression of ADD1 mRNA
CTD
PMID:19244175
NCBI chr 4:2,843,844...2,930,062
Ensembl chr 4:2,843,844...2,930,076
G
ADD3
adducin 3
decreases expression
EXP
Selenium results in decreased expression of ADD3 mRNA
CTD
PMID:19244175
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
G
ADGRB1
adhesion G protein-coupled receptor B1
increases expression
EXP
Selenium results in increased expression of ADGRB1 mRNA
CTD
PMID:19244175
NCBI chr 8:142,449,649...142,545,007
Ensembl chr 8:142,449,430...142,545,009
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
decreases expression
EXP
Selenium results in decreased expression of ADH1B mRNA
CTD
PMID:19244175
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
ADISSP
adipose secreted signaling protein
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA
CTD
PMID:19244175
NCBI chr20:3,753,508...3,768,388
Ensembl chr20:3,753,508...3,767,781
G
ADORA2A
adenosine A2a receptor
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of ADORA2A mRNA
CTD
PMID:21481475
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADRA2C
adrenoceptor alpha 2C
increases expression
EXP
Selenium results in increased expression of ADRA2C mRNA
CTD
PMID:19244175
NCBI chr 4:3,766,385...3,768,526
Ensembl chr 4:3,766,348...3,768,526
G
ADRM1
ADRM1 26S proteasome ubiquitin receptor
increases expression
EXP
Selenium results in increased expression of ADRM1 mRNA
CTD
PMID:19244175
NCBI chr20:62,302,896...62,308,862
Ensembl chr20:62,302,093...62,308,862
G
AEBP2
AE binding protein 2
decreases methylation
EXP
Selenium results in decreased methylation of AEBP2 gene
CTD
PMID:21606628
NCBI chr12:19,404,072...19,522,227
Ensembl chr12:19,404,045...19,720,801
G
AGPAT2
1-acylglycerol-3-phosphate O-acyltransferase 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA Selenium results in increased expression of AGPAT2 mRNA
CTD
PMID:19244175
NCBI chr 9:136,673,143...136,687,457
Ensembl chr 9:136,673,143...136,687,457
G
AGRN
agrin
increases expression
EXP
Selenium results in increased expression of AGRN mRNA
CTD
PMID:19244175
NCBI chr 1:1,020,120...1,056,116
Ensembl chr 1:1,020,120...1,056,118
G
AIMP1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Selenium results in decreased expression of AIMP1 mRNA
CTD
PMID:19244175
NCBI chr 4:106,315,544...106,349,456
Ensembl chr 4:106,315,544...106,349,456
G
AIP
aryl hydrocarbon receptor interacting protein
increases expression
EXP
Selenium results in increased expression of AIP mRNA
CTD
PMID:19244175
NCBI chr11:67,483,026...67,491,103
Ensembl chr11:67,468,174...67,491,154
G
AK1
adenylate kinase 1
increases expression
EXP
Selenium results in increased expression of AK1 mRNA
CTD
PMID:19244175
NCBI chr 9:127,866,480...127,879,621
Ensembl chr 9:127,866,486...127,877,675
G
AK2
adenylate kinase 2
increases expression
EXP
Selenium results in increased expression of AK2 mRNA
CTD
PMID:19244175
NCBI chr 1:33,007,940...33,036,883
Ensembl chr 1:33,007,986...33,080,996
G
AK3
adenylate kinase 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA
CTD
PMID:19244175
NCBI chr 9:4,709,556...4,742,043
Ensembl chr 9:4,709,556...4,742,043
G
AKAP13
A-kinase anchoring protein 13
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA
CTD
PMID:19244175
NCBI chr15:85,380,603...85,749,358
Ensembl chr15:85,380,571...85,749,358
G
AKT1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation increases expression decreases phosphorylation
EXP ISO
[Selenium results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] Selenium results in increased phosphorylation of AKT1 protein Selenium inhibits the reaction [arsenite results in decreased expression of and results in decreased phosphorylation of AKT1 protein]; Selenium inhibits the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein] Selenium inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein] Selenium results in increased expression of AKT1 mRNA
CTD
PMID:17339365 PMID:17997286 PMID:19244175 PMID:29324385 PMID:38013145
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALAD
aminolevulinate dehydratase
multiple interactions
ISO
Selenium inhibits the reaction [Arsenic results in decreased activity of ALAD protein]
CTD
PMID:20587388
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
ALAS1
5'-aminolevulinate synthase 1
increases expression
EXP
Selenium results in increased expression of ALAS1 mRNA
CTD
PMID:19244175
NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
G
ALB
albumin
multiple interactions
ISO
Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]
CTD
PMID:24485406
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALCAM
activated leukocyte cell adhesion molecule
decreases expression
EXP
Selenium results in decreased expression of ALCAM mRNA
CTD
PMID:19244175
NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900
G
ALDH1B1
aldehyde dehydrogenase 1 family member B1
increases expression
ISO
Selenium deficiency results in increased expression of ALDH1B1 mRNA
CTD
PMID:16170372
NCBI chr 9:38,392,702...38,398,661
Ensembl chr 9:38,392,702...38,398,661
G
ALDH1L1
aldehyde dehydrogenase 1 family member L1
affects expression
ISO
Selenium affects the expression of ALDH1L1 protein
CTD
PMID:19351701
NCBI chr 3:126,103,570...126,197,945
Ensembl chr 3:126,103,562...126,197,994
G
ALDH4A1
aldehyde dehydrogenase 4 family member A1
increases expression
EXP
Selenium results in increased expression of ALDH4A1 mRNA
CTD
PMID:19244175
NCBI chr 1:18,871,430...18,902,555
Ensembl chr 1:18,871,430...18,902,724
G
ALDOA
aldolase, fructose-bisphosphate A
increases expression
EXP
Selenium results in increased expression of ALDOA mRNA
CTD
PMID:19244175
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ALG3
ALG3 alpha-1,3- mannosyltransferase
increases expression
EXP
Selenium results in increased expression of ALG3 mRNA
CTD
PMID:19244175
NCBI chr 3:184,242,301...184,249,525
Ensembl chr 3:184,242,301...184,249,548
G
ALG9
ALG9 alpha-1,2-mannosyltransferase
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA
CTD
PMID:19244175
NCBI chr11:111,768,025...111,871,581
Ensembl chr11:111,782,195...111,871,581
G
ALOX15
arachidonate 15-lipoxygenase
increases expression multiple interactions
ISO
Selenium deficiency results in increased expression of ALOX15 mRNA Selenomethionine inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]
CTD
PMID:11444866 PMID:34970773
NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
G
ALOX5
arachidonate 5-lipoxygenase
multiple interactions
ISO
[Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein
CTD
PMID:22223226
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ALS2CL
ALS2 C-terminal like
increases expression
EXP
Selenium results in increased expression of ALS2CL mRNA
CTD
PMID:19244175
NCBI chr 3:46,668,995...46,693,679
Ensembl chr 3:46,668,995...46,693,704
G
AMPD3
adenosine monophosphate deaminase 3
decreases expression
EXP
Selenium results in decreased expression of AMPD3 mRNA
CTD
PMID:19244175
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
AMY2A
amylase alpha 2A
decreases expression
EXP
Selenium results in decreased expression of AMY2A mRNA
CTD
PMID:19244175
NCBI chr 1:103,616,651...103,625,780
Ensembl chr 1:103,617,427...103,625,780
G
ANAPC15
anaphase promoting complex subunit 15
increases expression
EXP
Selenium results in increased expression of ANAPC15 mRNA
CTD
PMID:19244175
NCBI chr11:72,106,372...72,112,780
Ensembl chr11:72,106,378...72,112,780
G
ANAPC2
anaphase promoting complex subunit 2
increases expression
EXP
Selenium results in increased expression of ANAPC2 mRNA
CTD
PMID:19244175
NCBI chr 9:137,174,784...137,188,560
Ensembl chr 9:137,174,784...137,188,560
G
ANGPT1
angiopoietin 1
decreases expression
EXP
Selenium results in decreased expression of ANGPT1 mRNA
CTD
PMID:19244175
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
G
ANK3
ankyrin 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA
CTD
PMID:19244175
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
ANKRA2
ankyrin repeat family A member 2
decreases expression
EXP
Selenium results in decreased expression of ANKRA2 mRNA
CTD
PMID:19244175
NCBI chr 5:73,552,190...73,565,639
Ensembl chr 5:73,552,190...73,565,667
G
ANP32B
acidic nuclear phosphoprotein 32 family member B
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA
CTD
PMID:19244175
NCBI chr 9:97,983,341...98,015,943
Ensembl chr 9:97,983,341...98,015,943
G
ANPEP
alanyl aminopeptidase, membrane
increases expression
EXP
Selenium results in increased expression of ANPEP mRNA
CTD
PMID:19244175
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
G
AOX1
aldehyde oxidase 1
multiple interactions decreases expression
ISO
Selenium deficiency results in decreased expression of and results in decreased activity of AOX1 protein Selenium deficiency results in decreased expression of AOX1 mRNA
CTD
PMID:19182374
NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
G
AOX3P
aldehyde oxidase 3, pseudogene
increases expression
ISO
Selenium deficiency results in increased expression of AOX3 mRNA; Selenium results in increased expression of AOX3 mRNA
CTD
PMID:16170372
NCBI chr 2:200,695,723...200,738,781
Ensembl chr 2:200,678,233...200,732,539
G
AP1B1
adaptor related protein complex 1 subunit beta 1
increases expression
EXP
Selenium results in increased expression of AP1B1 mRNA
CTD
PMID:19244175
NCBI chr22:29,327,680...29,388,570
Ensembl chr22:29,327,680...29,388,583
G
AP1M2
adaptor related protein complex 1 subunit mu 2
increases expression
EXP
Selenium results in increased expression of AP1M2 mRNA
CTD
PMID:19244175
NCBI chr19:10,572,671...10,587,312
Ensembl chr19:10,572,671...10,587,315
G
AP2A2
adaptor related protein complex 2 subunit alpha 2
increases expression
EXP
Selenium results in increased expression of AP2A2 mRNA
CTD
PMID:19244175
NCBI chr11:925,870...1,012,240
Ensembl chr11:924,881...1,012,245
G
AP2M1
adaptor related protein complex 2 subunit mu 1
increases expression
EXP
Selenium results in increased expression of AP2M1 mRNA
CTD
PMID:19244175
NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214
G
AP2S1
adaptor related protein complex 2 subunit sigma 1
increases expression
EXP
Selenium results in increased expression of AP2S1 mRNA
CTD
PMID:19244175
NCBI chr19:46,838,167...46,850,846
Ensembl chr19:46,838,136...46,850,846
G
APC
APC regulator of WNT signaling pathway
decreases expression
EXP
Selenium results in decreased expression of APC mRNA
CTD
PMID:19244175
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
G
APEH
acylaminoacyl-peptide hydrolase
increases expression
EXP
Selenium results in increased expression of APEH mRNA
CTD
PMID:19244175
NCBI chr 3:49,673,117...49,683,971
Ensembl chr 3:49,674,014...49,683,971
G
APLP2
amyloid beta precursor like protein 2
increases expression
EXP
Selenium results in increased expression of APLP2 mRNA
CTD
PMID:19244175
NCBI chr11:130,069,894...130,144,805
Ensembl chr11:130,068,147...130,144,811
G
APOB
apolipoprotein B
multiple interactions decreases expression
ISO
Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] Selenium results in decreased expression of APOB protein
CTD
PMID:16271152 PMID:16581047
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOE
apolipoprotein E
increases expression affects expression
EXP ISO
Selenium results in increased expression of APOE mRNA Selenium affects the expression of APOE protein
CTD
PMID:17996733 PMID:19244175
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOL1
apolipoprotein L1
increases expression
EXP
Selenium results in increased expression of APOL1 mRNA
CTD
PMID:19244175
NCBI chr22:36,253,133...36,267,525
Ensembl chr22:36,253,071...36,267,530
G
APOL3
apolipoprotein L3
increases expression
EXP
Selenium results in increased expression of APOL3 mRNA
CTD
PMID:19244175
NCBI chr22:36,140,323...36,166,177
Ensembl chr22:36,140,329...36,166,177
G
APP
amyloid beta precursor protein
decreases expression
EXP
Selenium results in decreased expression of APP mRNA
CTD
PMID:19244175
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
APPBP2
amyloid beta precursor protein binding protein 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA
CTD
PMID:19244175
NCBI chr17:60,443,158...60,526,242
Ensembl chr17:60,443,158...60,526,242
G
AQP3
aquaporin 3 (Gill blood group)
increases expression multiple interactions
EXP
Selenium results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA
CTD
PMID:19244175
NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
G
AR
androgen receptor
multiple interactions decreases localization decreases expression
EXP
Selenium results in decreased expression of and results in decreased activity of AR protein Selenium results in decreased localization of AR protein Selenium results in decreased expression of AR mRNA
CTD
PMID:14729601 PMID:16648561
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARAF
A-Raf proto-oncogene, serine/threonine kinase
increases expression multiple interactions
EXP
Selenium results in increased expression of ARAF mRNA [Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA
CTD
PMID:19244175
NCBI chr X:47,561,205...47,571,908
Ensembl chr X:47,561,205...47,571,908
G
ARF5
ADP ribosylation factor 5
increases expression
EXP
Selenium results in increased expression of ARF5 mRNA
CTD
PMID:19244175
NCBI chr 7:127,588,411...127,591,700
Ensembl chr 7:127,588,386...127,591,700
G
ARFGAP2
ADP ribosylation factor GTPase activating protein 2
increases expression
EXP
Selenium results in increased expression of ARFGAP2 mRNA
CTD
PMID:19244175
NCBI chr11:47,164,301...47,176,879
Ensembl chr11:47,164,299...47,177,125
G
ARFIP2
ADP ribosylation factor interacting protein 2
increases expression
EXP
Selenium results in increased expression of ARFIP2 mRNA
CTD
PMID:19244175
NCBI chr11:6,476,519...6,481,331
Ensembl chr11:6,474,683...6,481,479
G
ARFRP1
ADP ribosylation factor related protein 1
increases expression
EXP
Selenium results in increased expression of ARFRP1 mRNA
CTD
PMID:19244175
NCBI chr20:63,698,647...63,707,976
Ensembl chr20:63,698,642...63,708,025
G
ARG1
arginase 1
multiple interactions
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]
CTD
PMID:21775527
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARG2
arginase 2
decreases expression
EXP
Selenium results in decreased expression of ARG2 mRNA
CTD
PMID:19244175
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGDIA
Rho GDP dissociation inhibitor alpha
increases expression
EXP
Selenium results in increased expression of ARHGDIA mRNA
CTD
PMID:19244175
NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,721...81,871,378
G
ARIH1
ariadne RBR E3 ubiquitin protein ligase 1
decreases expression
EXP
Selenium results in decreased expression of ARIH1 mRNA
CTD
PMID:19244175
NCBI chr15:72,474,330...72,602,987
Ensembl chr15:72,474,330...72,602,987
G
ARL5A
ADP ribosylation factor like GTPase 5A
decreases expression
EXP
Selenium results in decreased expression of ARL5A mRNA
CTD
PMID:19244175
NCBI chr 2:151,798,797...151,828,421
Ensembl chr 2:151,788,984...151,828,492
G
ARL6IP4
ADP ribosylation factor like GTPase 6 interacting protein 4
increases expression
EXP
Selenium results in increased expression of ARL6IP4 mRNA
CTD
PMID:19244175
NCBI chr12:122,980,233...122,982,909
Ensembl chr12:122,980,060...122,982,913
G
ARPC1A
actin related protein 2/3 complex subunit 1A
increases expression
EXP
Selenium results in increased expression of ARPC1A mRNA
CTD
PMID:19244175
NCBI chr 7:99,325,898...99,366,262
Ensembl chr 7:99,325,898...99,366,262
G
ARPC1B
actin related protein 2/3 complex subunit 1B
increases expression
EXP
Selenium results in increased expression of ARPC1B mRNA
CTD
PMID:19244175
NCBI chr 7:99,374,259...99,394,816
Ensembl chr 7:99,374,249...99,394,816
G
ARPC4
actin related protein 2/3 complex subunit 4
increases expression
EXP
Selenium results in increased expression of ARPC4 mRNA
CTD
PMID:19244175
NCBI chr 3:9,792,518...9,807,101
Ensembl chr 3:9,792,495...9,807,101
G
AS3MT
arsenite methyltransferase
multiple interactions
EXP
Selenium inhibits the reaction [AS3MT protein results in increased methylation of Arsenic]
CTD
PMID:19167370
NCBI chr10:102,869,470...102,901,899
Ensembl chr10:102,869,470...102,901,899
G
ASAP3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
increases expression
EXP
Selenium results in increased expression of ASAP3 mRNA
CTD
PMID:19244175
NCBI chr 1:23,428,563...23,484,631
Ensembl chr 1:23,428,563...23,484,637
G
ASB1
ankyrin repeat and SOCS box containing 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Selenium results in increased expression of ASB1 mRNA
CTD
PMID:19244175
NCBI chr 2:238,426,927...238,452,250
Ensembl chr 2:238,426,742...238,452,250
G
ASCC2
activating signal cointegrator 1 complex subunit 2
increases expression
EXP
Selenium results in increased expression of ASCC2 mRNA
CTD
PMID:19244175
NCBI chr22:29,788,611...29,838,274
Ensembl chr22:29,788,609...29,838,304
G
ASL
argininosuccinate lyase
increases expression
EXP
Selenium results in increased expression of ASL mRNA
CTD
PMID:19244175
NCBI chr 7:66,075,819...66,093,576
Ensembl chr 7:66,075,800...66,094,697
G
ASMTL
acetylserotonin O-methyltransferase like
increases expression
EXP
Selenium results in increased expression of ASMTL mRNA
CTD
PMID:19244175
NCBI chr X:1,403,139...1,453,756 NCBI chr Y:1,403,139...1,453,756
Ensembl chr Y:1,403,139...1,453,762 Ensembl chr X:1,403,139...1,453,762
G
ASS1
argininosuccinate synthase 1
increases expression
EXP
Selenium results in increased expression of ASS1 mRNA
CTD
PMID:19244175
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ASXL1
ASXL transcriptional regulator 1
decreases expression
EXP
Selenium results in decreased expression of ASXL1 mRNA
CTD
PMID:19244175
NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319
G
ASXL2
ASXL transcriptional regulator 2
decreases expression
EXP
Selenium results in decreased expression of ASXL2 mRNA
CTD
PMID:19244175
NCBI chr 2:25,733,753...25,878,487
Ensembl chr 2:25,733,753...25,878,487
G
ATF4
activating transcription factor 4
increases expression
EXP
Selenium results in increased expression of ATF4 mRNA
CTD
PMID:19244175
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
G
ATF5
activating transcription factor 5
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Selenium results in increased expression of ATF5 mRNA
CTD
PMID:19244175
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
G
ATG12
autophagy related 12
decreases expression
EXP
Selenium results in decreased expression of ATG12 mRNA
CTD
PMID:19244175
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
G
ATG13
autophagy related 13
increases expression
EXP
Selenium results in increased expression of ATG13 mRNA
CTD
PMID:19244175
NCBI chr11:46,617,553...46,674,518
Ensembl chr11:46,617,527...46,674,818
G
ATG14
autophagy related 14
decreases expression
EXP
Selenium results in decreased expression of ATG14 mRNA
CTD
PMID:19244175
NCBI chr14:55,366,391...55,411,830
Ensembl chr14:55,366,391...55,411,830
G
ATG9A
autophagy related 9A
increases expression
EXP
Selenium results in increased expression of ATG9A mRNA
CTD
PMID:19244175
NCBI chr 2:219,219,380...219,229,636
Ensembl chr 2:219,219,380...219,229,717
G
ATMIN
ATM interactor
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Selenium results in decreased expression of ATMIN mRNA
CTD
PMID:19244175
NCBI chr16:81,035,842...81,047,350
Ensembl chr16:81,035,842...81,047,350
G
ATP10D
ATPase phospholipid transporting 10D (putative)
decreases expression
EXP
Selenium results in decreased expression of ATP10D mRNA
CTD
PMID:19244175
NCBI chr 4:47,485,275...47,593,486
Ensembl chr 4:47,485,275...47,593,486
G
ATP2B4
ATPase plasma membrane Ca2+ transporting 4
increases expression
EXP
Selenium results in increased expression of ATP2B4 mRNA
CTD
PMID:19244175
NCBI chr 1:203,626,832...203,744,081
Ensembl chr 1:203,626,832...203,744,081
G
ATP2C1
ATPase secretory pathway Ca2+ transporting 1
decreases expression
EXP
Selenium results in decreased expression of ATP2C1 mRNA
CTD
PMID:19244175
NCBI chr 3:130,850,595...131,016,712
Ensembl chr 3:130,850,595...131,016,712
G
ATP5ME
ATP synthase membrane subunit e
decreases expression
EXP
Selenium results in decreased expression of ATP5ME mRNA
CTD
PMID:19244175
NCBI chr 4:672,436...674,276
Ensembl chr 4:672,436...674,330
G
ATP5PD
ATP synthase peripheral stalk subunit d
decreases expression
EXP
Selenium results in decreased expression of ATP5PD mRNA
CTD
PMID:19244175
NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
G
ATP5PF
ATP synthase peripheral stalk subunit F6
decreases expression
EXP
Selenium results in decreased expression of ATP5PF mRNA
CTD
PMID:19244175
NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
G
ATP6AP1
ATPase H+ transporting accessory protein 1
increases expression
EXP
Selenium results in increased expression of ATP6AP1 mRNA
CTD
PMID:19244175
NCBI chr X:154,428,677...154,436,516
Ensembl chr X:154,428,633...154,436,516
G
ATP6V0D1
ATPase H+ transporting V0 subunit d1
increases expression
EXP
Selenium results in increased expression of ATP6V0D1 mRNA
CTD
PMID:19244175
NCBI chr16:67,438,019...67,481,157
Ensembl chr16:67,438,014...67,481,181
G
ATP6V0E1
ATPase H+ transporting V0 subunit e1
decreases expression
EXP
Selenium results in decreased expression of ATP6V0E mRNA
CTD
PMID:19244175
NCBI chr 5:172,983,771...173,035,445
Ensembl chr 5:172,983,771...173,035,445
G
ATP6V1C1
ATPase H+ transporting V1 subunit C1
decreases expression
EXP
Selenium results in decreased expression of ATP6V1C1 mRNA
CTD
PMID:19244175
NCBI chr 8:103,021,083...103,073,051
Ensembl chr 8:103,021,063...103,073,051
G
ATRX
ATRX chromatin remodeler
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA Selenium results in decreased expression of ATRX mRNA
CTD
PMID:19244175
NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233
G
ATXN1
ataxin 1
decreases expression
EXP
Selenium results in decreased expression of ATXN1 mRNA
CTD
PMID:19244175
NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491
G
ATXN7
ataxin 7
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Selenium results in decreased expression of ATXN7 mRNA
CTD
PMID:19244175
NCBI chr 3:63,863,144...64,003,462
Ensembl chr 3:63,863,155...64,003,462
G
AVL9
AVL9 cell migration associated
decreases expression
EXP
Selenium results in decreased expression of AVL9 mRNA
CTD
PMID:19244175
NCBI chr 7:32,495,489...32,588,726
Ensembl chr 7:32,495,426...32,588,726
G
AXL
AXL receptor tyrosine kinase
decreases expression
EXP
Selenium results in decreased expression of AXL mRNA
CTD
PMID:19244175
NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766
G
B3GAT3
beta-1,3-glucuronyltransferase 3
increases expression
EXP
Selenium results in increased expression of B3GAT3 mRNA
CTD
PMID:19244175
NCBI chr11:62,615,296...62,621,986
Ensembl chr11:62,615,296...62,622,154
G
BAG1
BAG cochaperone 1
increases expression
EXP
Selenium results in increased expression of BAG1 mRNA
CTD
PMID:19244175
NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720
G
BAG6
BAG cochaperone 6
increases expression
EXP
Selenium results in increased expression of BAG6 mRNA
CTD
PMID:19244175
NCBI chr 6:31,639,028...31,652,661
Ensembl chr 6:31,639,028...31,652,705
G
BAP1
BRCA1 associated protein 1
increases expression
EXP
Selenium results in increased expression of BAP1 mRNA
CTD
PMID:19244175
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
G
BARD1
BRCA1 associated RING domain 1
decreases expression
EXP
Selenium results in decreased expression of BARD1 mRNA
CTD
PMID:19244175
NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
G
BATF
basic leucine zipper ATF-like transcription factor
increases expression
EXP
Selenium results in increased expression of BATF mRNA
CTD
PMID:19244175
NCBI chr14:75,522,469...75,546,992
Ensembl chr14:75,522,455...75,546,993
G
BAX
BCL2 associated X, apoptosis regulator
decreases expression multiple interactions
ISO EXP
Selenium results in decreased expression of BAX protein Selenium inhibits the reaction [arsenite results in increased expression of BAX protein] [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium inhibits the reaction [T-2 Toxin results in increased expression of BAX mRNA]
CTD
PMID:16307838 PMID:17997286 PMID:27920530 PMID:29324385
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BAZ1B
bromodomain adjacent to zinc finger domain 1B
increases expression
EXP
Selenium results in increased expression of BAZ1B mRNA
CTD
PMID:19244175
NCBI chr 7:73,440,406...73,522,293
Ensembl chr 7:73,440,406...73,522,293
G
BBX
BBX high mobility group box domain containing
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Selenium results in decreased expression of BBX mRNA
CTD
PMID:19244175
NCBI chr 3:107,522,962...107,811,339
Ensembl chr 3:107,522,936...107,811,339
G
BCL11A
BCL11 transcription factor A
decreases expression
EXP
Selenium results in decreased expression of BCL11A mRNA
CTD
PMID:19244175
NCBI chr 2:60,450,520...60,553,924
Ensembl chr 2:60,450,520...60,554,467
G
BCL2
BCL2 apoptosis regulator
decreases expression multiple interactions
EXP ISO
Selenium results in decreased expression of BCL2 protein Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]
CTD
PMID:17523932 PMID:27920530 PMID:34612572
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
increases expression multiple interactions
EXP ISO
Selenium results in increased expression of BCL2L1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L11
BCL2 like 11
multiple interactions increases expression
EXP
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] Selenium results in increased expression of BCL2L11 protein
CTD
PMID:17339365
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BCL3
BCL3 transcription coactivator
increases expression
EXP
Selenium results in increased expression of BCL3 mRNA
CTD
PMID:19244175
NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044
G
BCL7B
BAF chromatin remodeling complex subunit BCL7B
increases expression
EXP
Selenium results in increased expression of BCL7B mRNA
CTD
PMID:19244175
NCBI chr 7:73,536,356...73,557,690
Ensembl chr 7:73,536,356...73,557,690
G
BCLAF1
BCL2 associated transcription factor 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of BCLAF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA
CTD
PMID:19244175
NCBI chr 6:136,256,627...136,289,846
Ensembl chr 6:136,256,627...136,289,851
G
BDH2
3-hydroxybutyrate dehydrogenase 2
decreases expression
EXP
Selenium results in decreased expression of BDH2 mRNA
CTD
PMID:19244175
NCBI chr 4:103,077,592...103,099,834
Ensembl chr 4:103,077,592...103,099,870
G
BDNF
brain derived neurotrophic factor
increases expression multiple interactions
ISO
Selenium results in increased expression of BDNF protein Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein]
CTD
PMID:30695686
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BECN1
beclin 1
multiple interactions
ISO
Selenium deficiency inhibits the reaction [T-2 Toxin results in increased expression of BECN1 mRNA]
CTD
PMID:30629952
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BICD1
BICD cargo adaptor 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA Selenium results in decreased expression of BICD1 mRNA
CTD
PMID:19244175
NCBI chr12:32,106,847...32,383,633
Ensembl chr12:32,106,835...32,383,633
G
BICDL1
BICD family like cargo adaptor 1
increases expression
EXP
Selenium results in increased expression of BICDL1 mRNA
CTD
PMID:19244175
NCBI chr12:119,989,236...120,094,495
Ensembl chr12:119,989,236...120,094,494
G
BICRA
BRD4 interacting chromatin remodeling complex associated protein
increases expression
EXP
Selenium results in increased expression of BICRA mRNA
CTD
PMID:19244175
NCBI chr19:47,608,196...47,703,277
Ensembl chr19:47,608,196...47,703,277
G
BID
BH3 interacting domain death agonist
increases cleavage
EXP
Selenium results in increased cleavage of BID protein
CTD
PMID:12432279
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BIN1
bridging integrator 1
increases expression
EXP
Selenium results in increased expression of BIN1 mRNA
CTD
PMID:19244175
NCBI chr 2:127,048,023...127,107,154
Ensembl chr 2:127,048,027...127,107,288
G
BIRC2
baculoviral IAP repeat containing 2
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA
CTD
PMID:11444866
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
G
BIRC5
baculoviral IAP repeat containing 5
affects response to substance multiple interactions
EXP
BIRC5 protein affects the susceptibility to Selenium [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]
CTD
PMID:17876054 PMID:27920530
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BLTP2
bridge-like lipid transfer protein family member 2
increases expression
EXP
Selenium results in increased expression of BLTP2 mRNA
CTD
PMID:19244175
NCBI chr17:28,614,440...28,645,159
Ensembl chr17:28,614,446...28,645,454
G
BLTP3B
bridge-like lipid transfer protein family member 3B
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Selenium results in decreased expression of BLTP3B mRNA
CTD
PMID:19244175
NCBI chr12:100,037,072...100,142,874
Ensembl chr12:100,028,455...100,142,874
G
BLVRB
biliverdin reductase B
increases expression
EXP
Selenium results in increased expression of BLVRB mRNA
CTD
PMID:19244175
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
G
BPTF
bromodomain PHD finger transcription factor
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Selenium results in decreased expression of BPTF mRNA
CTD
PMID:19244175
NCBI chr17:67,825,503...67,984,378
Ensembl chr17:67,825,503...67,984,378
G
BRD2
bromodomain containing 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Selenium results in increased expression of BRD2 mRNA
CTD
PMID:19244175
NCBI chr 6:32,968,594...32,981,505
Ensembl chr 6:32,968,594...32,981,505
G
BRF2
BRF2 RNA polymerase III transcription initiation factor subunit
increases expression
EXP
Selenium results in increased expression of BRF2 mRNA
CTD
PMID:19244175
NCBI chr 8:37,843,268...37,849,861
Ensembl chr 8:37,843,268...37,849,861
G
BRMS1
BRMS1 transcriptional repressor and anoikis regulator
increases expression
EXP
Selenium results in increased expression of BRMS1 mRNA
CTD
PMID:19244175
NCBI chr11:66,337,339...66,345,104
Ensembl chr11:66,337,333...66,345,125
G
BSCL2
BSCL2 lipid droplet biogenesis associated, seipin
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Selenium results in increased expression of BSCL2 mRNA
CTD
PMID:19244175
NCBI chr11:62,690,262...62,709,537
Ensembl chr11:62,689,289...62,709,845
G
BST2
bone marrow stromal cell antigen 2
increases expression
EXP
Selenium results in increased expression of BST2 mRNA
CTD
PMID:19244175
NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630
G
BYSL
bystin like
increases expression
EXP
Selenium results in increased expression of BYSL mRNA
CTD
PMID:19244175
NCBI chr 6:41,908,759...41,933,046
Ensembl chr 6:41,921,499...41,933,046
G
C11orf68
chromosome 11 open reading frame 68
increases expression
EXP
Selenium results in increased expression of C11ORF68 mRNA
CTD
PMID:19244175
NCBI chr11:65,916,810...65,919,062
Ensembl chr11:65,916,810...65,919,062
G
C14orf132
chromosome 14 open reading frame 132
decreases expression
EXP
Selenium results in decreased expression of C14ORF132 mRNA
CTD
PMID:19244175
NCBI chr14:96,039,362...96,093,971
Ensembl chr14:96,039,362...96,093,971
G
C1orf50
chromosome 1 open reading frame 50
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA Selenium results in decreased expression of C1ORF50 mRNA
CTD
PMID:19244175
NCBI chr 1:42,767,249...42,779,491
Ensembl chr 1:42,767,245...42,779,491
G
C1orf54
chromosome 1 open reading frame 54
decreases expression
EXP
Selenium results in decreased expression of C1ORF54 mRNA
CTD
PMID:19244175
NCBI chr 1:150,268,731...150,280,924
Ensembl chr 1:150,268,200...150,280,916
G
C1QB
complement C1q B chain
increases expression
EXP
Selenium results in increased expression of C1QB mRNA
CTD
PMID:19244175
NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
G
C2CD5
C2 calcium dependent domain containing 5
decreases expression
EXP
Selenium results in decreased expression of C2CD5 mRNA
CTD
PMID:19244175
NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,583...22,544,546
G
C2orf42
chromosome 2 open reading frame 42
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Selenium results in decreased expression of C2ORF42 mRNA
CTD
PMID:19244175
NCBI chr 2:70,149,885...70,191,019
Ensembl chr 2:70,149,885...70,248,615
G
C7orf25
chromosome 7 open reading frame 25
decreases expression
EXP
Selenium results in decreased expression of C7ORF25 mRNA
CTD
PMID:19244175
NCBI chr 7:42,909,273...42,912,070
Ensembl chr 7:42,909,273...42,912,305
G
CA3
carbonic anhydrase 3
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA
CTD
PMID:11444866
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CABIN1
calcineurin binding protein 1
increases expression
EXP
Selenium results in increased expression of CABIN1 mRNA
CTD
PMID:19244175
NCBI chr22:24,011,304...24,178,628
Ensembl chr22:24,011,192...24,178,628
G
CALCOCO1
calcium binding and coiled-coil domain 1
increases expression
EXP
Selenium results in increased expression of CALCOCO1 mRNA
CTD
PMID:19244175
NCBI chr12:53,708,517...53,727,452
Ensembl chr12:53,708,517...53,727,745
G
CALD1
caldesmon 1
decreases expression
EXP
Selenium results in decreased expression of CALD1 mRNA
CTD
PMID:19244175
NCBI chr 7:134,745,467...134,970,729
Ensembl chr 7:134,744,252...134,970,729
G
CALHM2
calcium homeostasis modulator family member 2
increases expression
EXP
Selenium results in increased expression of CALHM2 mRNA
CTD
PMID:19244175
NCBI chr10:103,446,786...103,452,370
Ensembl chr10:103,446,786...103,452,402
G
CALM3
calmodulin 3
increases expression
EXP
Selenium results in increased expression of CALM3 mRNA
CTD
PMID:19244175
NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782
G
CALR
calreticulin
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Selenium results in decreased expression of CALR mRNA
CTD
PMID:19244175
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CALU
calumenin
increases expression multiple interactions
EXP
Selenium results in increased expression of CALU mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA
CTD
PMID:19244175
NCBI chr 7:128,739,359...128,773,400
Ensembl chr 7:128,739,292...128,773,400
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
increases expression
EXP
Selenium results in increased expression of CAMK2B mRNA
CTD
PMID:19244175
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
CAP2
cyclase associated actin cytoskeleton regulatory protein 2
decreases expression
EXP
Selenium results in decreased expression of CAP2 mRNA
CTD
PMID:19244175
NCBI chr 6:17,393,595...17,557,780
Ensembl chr 6:17,393,595...17,557,780
G
CAPG
capping actin protein, gelsolin like
increases expression
EXP
Selenium results in increased expression of CAPG mRNA
CTD
PMID:19244175
NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432
G
CAPN1
calpain 1
increases expression
EXP
Selenium results in increased expression of CAPN1 mRNA
CTD
PMID:19244175
NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
G
CAPN7
calpain 7
decreases expression
EXP
Selenium results in decreased expression of CAPN7 mRNA
CTD
PMID:19244175
NCBI chr 3:15,206,246...15,252,916
Ensembl chr 3:15,206,152...15,252,916
G
CAPNS1
calpain small subunit 1
increases expression
EXP
Selenium results in increased expression of CAPNS1 mRNA
CTD
PMID:19244175
NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353
G
CAPZB
capping actin protein of muscle Z-line subunit beta
increases expression
EXP
Selenium results in increased expression of CAPZB mRNA
CTD
PMID:19244175
NCBI chr 1:19,338,775...19,485,539
Ensembl chr 1:19,338,775...19,485,539
G
CASC3
CASC3 exon junction complex subunit
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA
CTD
PMID:19244175
NCBI chr17:40,140,537...40,172,171
Ensembl chr17:40,140,318...40,172,171
G
CASP12
caspase 12 (gene/pseudogene)
multiple interactions
ISO
Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP12 protein]
CTD
PMID:34612572
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
decreases activity multiple interactions increases activity
ISO EXP
Selenium results in decreased activity of CASP3 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CASP3 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Selenium deficiency promotes the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [arsenite results in increased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein] Selenium results in increased activity of CASP3 protein
CTD
PMID:15318939 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:30629952 PMID:34612572 More...
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
multiple interactions increases activity decreases expression
EXP
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] Selenium results in increased activity of CASP8 protein Selenium results in decreased expression of CASP8 mRNA
CTD
PMID:12432279 PMID:17970047 PMID:19244175 PMID:27920530
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
multiple interactions decreases activity
EXP ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]]; [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [arsenite results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] Selenium results in decreased activity of CASP9 protein
CTD
PMID:17339365 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:34612572 More...
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
multiple interactions increases activity decreases expression increases expression
EXP ISO
Arsenic promotes the reaction [Selenium results in increased expression of CAT protein]; Fluorides promotes the reaction [Selenium results in increased activity of CAT protein]; Selenium inhibits the reaction [Fluorides results in decreased activity of CAT protein] Selenium deficiency results in decreased expression of CAT mRNA [[Sodium Selenite results in increased abundance of Selenium] which co-treated with Ascorbic Acid] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased activity of CAT protein; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; Selenium affects the reaction [Clofibrate results in increased activity of CAT protein]; Selenium affects the reaction [Mercury results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in increased activity of CAT protein]; Selenium inhibits the reaction [Chromium results in increased activity of CAT protein]; Selenium inhibits the reaction [cyfluthrin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Enrofloxacin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Selenium inhibits the reaction [nickel sulfate results in increased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in increased activity of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]]
CTD
PMID:3456598 PMID:8250967 PMID:11260395 PMID:17512462 PMID:19652462 PMID:19913299 PMID:20143455 PMID:20478284 PMID:20494564 PMID:20580087 PMID:21628957 PMID:23595963 PMID:24485406 PMID:27083143 PMID:27941167 PMID:30526071 PMID:34612572 PMID:37415728 More...
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAVIN1
caveolae associated protein 1
increases expression
EXP
Selenium results in increased expression of CAVIN1 mRNA
CTD
PMID:19244175
NCBI chr17:42,402,449...42,423,256
Ensembl chr17:42,402,449...42,423,256
G
CBLB
Cbl proto-oncogene B
decreases expression
EXP
Selenium results in decreased expression of CBLB mRNA
CTD
PMID:19244175
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CBX5
chromobox 5
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Selenium results in decreased expression of CBX5 mRNA
CTD
PMID:19244175
NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133
G
CBX7
chromobox 7
increases expression
EXP
Selenium results in increased expression of CBX7 mRNA
CTD
PMID:19244175
NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680
G
CCDC85B
coiled-coil domain containing 85B
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Selenium results in increased expression of DIPA mRNA
CTD
PMID:19244175
NCBI chr11:65,890,673...65,891,635
Ensembl chr11:65,890,673...65,891,635
G
CCHCR1
coiled-coil alpha-helical rod protein 1
increases expression
EXP
Selenium results in increased expression of CCHCR1 mRNA
CTD
PMID:19244175
NCBI chr 6:31,142,439...31,158,197
Ensembl chr 6:31,142,439...31,158,238
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA]
CTD
PMID:16143069 PMID:21481475
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL3L1
C-C motif chemokine ligand 3 like 1
increases expression
EXP
Selenium results in increased expression of CCL3L1 mRNA
CTD
PMID:17293063
Ensembl chr17:36,194,869...36,196,758
G
CCNB1
cyclin B1
decreases expression
EXP
Selenium deficiency results in decreased expression of CCNB1 mRNA
CTD
PMID:11925459
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNC
cyclin C
decreases expression
EXP
Selenium deficiency results in decreased expression of CCNC mRNA
CTD
PMID:11925459
NCBI chr 6:99,542,387...99,568,814
Ensembl chr 6:99,542,387...99,568,825
G
CCND1
cyclin D1
increases expression multiple interactions
EXP ISO
Selenium results in increased expression of CCND1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCND2
cyclin D2
decreases expression
EXP
Selenium deficiency results in decreased expression of CCND2 mRNA
CTD
PMID:11925459
NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
G
CCPG1
cell cycle progression 1
decreases expression
EXP
Selenium results in decreased expression of CPR8 mRNA
CTD
PMID:19244175
NCBI chr15:55,355,239...55,408,359
Ensembl chr15:55,340,032...55,408,510
G
CCR3
C-C motif chemokine receptor 3
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CCR3 mRNA
CTD
PMID:21481475
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCSER2
coiled-coil serine rich protein 2
decreases expression
EXP
Selenium results in decreased expression of CCSER2 mRNA
CTD
PMID:19244175
NCBI chr10:84,328,589...84,518,517
Ensembl chr10:84,328,586...84,518,521
G
CD14
CD14 molecule
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CD14 mRNA
CTD
PMID:21481475
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD2BP2
CD2 cytoplasmic tail binding protein 2
increases expression
EXP
Selenium results in increased expression of CD2BP2 mRNA
CTD
PMID:19244175
NCBI chr16:30,350,773...30,355,308
Ensembl chr16:30,350,773...30,355,308
G
CD44
CD44 molecule (IN blood group)
multiple interactions increases expression
EXP
Selenium inhibits the reaction [T-2 Toxin results in decreased expression of CD44 protein] Selenium results in increased expression of CD44 mRNA; Selenium results in increased expression of CD44 protein
CTD
PMID:18196609
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD74
CD74 molecule
increases expression
EXP
Selenium results in increased expression of CD74 mRNA
CTD
PMID:19244175
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
G
CD99
CD99 molecule (Xg blood group)
increases expression
EXP
Selenium results in increased expression of CD99 mRNA
CTD
PMID:19244175
NCBI chr X:2,691,295...2,741,309 NCBI chr Y:2,691,295...2,741,309
Ensembl chr Y:2,691,187...2,741,309 Ensembl chr X:2,691,187...2,741,309
G
CDC14B
cell division cycle 14B
decreases expression
EXP
Selenium results in decreased expression of CDC14B mRNA
CTD
PMID:19244175
NCBI chr 9:96,490,939...96,619,843
Ensembl chr 9:96,490,241...96,619,843
G
CDC16
cell division cycle 16
decreases expression
EXP
Selenium results in decreased expression of CDC16 mRNA
CTD
PMID:19244175
NCBI chr13:114,234,897...114,272,723
Ensembl chr13:114,234,887...114,272,723
G
CDC23
cell division cycle 23
decreases expression
EXP
Selenium results in decreased expression of CDC23 mRNA
CTD
PMID:19244175
NCBI chr 5:138,187,650...138,213,323
Ensembl chr 5:138,187,650...138,213,343
G
CDC42BPA
CDC42 binding protein kinase alpha
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Selenium results in decreased expression of CDC42BPA mRNA
CTD
PMID:19244175
NCBI chr 1:226,989,858...227,318,492
Ensembl chr 1:226,989,865...227,318,492
G
CDC42EP4
CDC42 effector protein 4
increases expression
EXP
Selenium results in increased expression of CDC42EP4 mRNA
CTD
PMID:19244175
NCBI chr17:73,283,624...73,312,001
Ensembl chr17:73,283,624...73,312,005
G
CDC73
cell division cycle 73
decreases expression
EXP
Selenium results in decreased expression of CDC73 mRNA
CTD
PMID:19244175
NCBI chr 1:193,122,031...193,254,815
Ensembl chr 1:193,121,983...193,254,815
G
CDH11
cadherin 11
decreases expression
EXP
Selenium results in decreased expression of CDH11 mRNA
CTD
PMID:19244175
NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
G
CDH3
cadherin 3
increases expression
EXP
Selenium results in increased expression of CDH3 mRNA
CTD
PMID:19244175
NCBI chr16:68,645,310...68,733,771
Ensembl chr16:68,636,189...68,727,468
G
CDK1
cyclin dependent kinase 1
decreases expression
EXP
Selenium deficiency results in decreased expression of CDK1 mRNA
CTD
PMID:11925459
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK10
cyclin dependent kinase 10
increases expression multiple interactions
EXP
Selenium results in increased expression of CDK10 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA
CTD
PMID:19244175
NCBI chr16:89,686,689...89,696,354
Ensembl chr16:89,680,737...89,696,354
G
CDK2
cyclin dependent kinase 2
decreases expression
EXP
Selenium deficiency results in decreased expression of CDK2 mRNA
CTD
PMID:11925459
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDK2AP2
cyclin dependent kinase 2 associated protein 2
increases expression
EXP
Selenium results in increased expression of CDK2AP2 mRNA
CTD
PMID:19244175
NCBI chr11:67,506,497...67,508,162
Ensembl chr11:67,506,497...67,508,649
G
CDK4
cyclin dependent kinase 4
decreases expression increases expression
EXP
Selenium deficiency results in decreased expression of CDK4 mRNA Selenium results in increased expression of CDK4 mRNA
CTD
PMID:11925459 PMID:19244175
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
CDKN1C
cyclin dependent kinase inhibitor 1C
decreases expression
EXP
Selenium results in decreased expression of CDKN1C mRNA
CTD
PMID:19244175
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CDS1
CDP-diacylglycerol synthase 1
decreases expression
EXP
Selenium results in decreased expression of CDS1 mRNA
CTD
PMID:19244175
NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334
G
CEBPA
CCAAT enhancer binding protein alpha
increases expression
ISO
Selenium results in increased expression of CEBPA mRNA
CTD
PMID:28810182
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CEL
carboxyl ester lipase
increases expression
EXP
Selenium results in increased expression of CEL mRNA
CTD
PMID:19244175
NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
G
CELF2
CUGBP Elav-like family member 2
decreases expression
EXP
Selenium results in decreased expression of CELF2 mRNA
CTD
PMID:19244175
NCBI chr10:10,462,550...11,336,675
Ensembl chr10:10,798,397...11,336,675
G
CEP170
centrosomal protein 170
decreases expression
EXP
Selenium results in decreased expression of CEP170 mRNA
CTD
PMID:19244175
NCBI chr 1:243,124,428...243,255,785
Ensembl chr 1:243,124,428...243,255,348
G
CEP290
centrosomal protein 290
decreases expression
EXP
Selenium results in decreased expression of CEP290 mRNA
CTD
PMID:19244175
NCBI chr12:88,049,016...88,142,088
Ensembl chr12:88,049,016...88,142,099
G
CEP350
centrosomal protein 350
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Selenium results in decreased expression of CEP350 mRNA
CTD
PMID:19244175
NCBI chr 1:179,954,810...180,114,875
Ensembl chr 1:179,954,674...180,114,880
G
CEP57
centrosomal protein 57
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Selenium results in decreased expression of CEP57 mRNA
CTD
PMID:19244175
NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693
G
CERT1
ceramide transporter 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Selenium results in decreased expression of CERT1 mRNA
CTD
PMID:19244175
NCBI chr 5:75,368,486...75,511,981
Ensembl chr 5:75,356,345...75,512,138
G
CES1
carboxylesterase 1
increases expression
EXP
Selenium results in increased expression of CES1 mRNA
CTD
PMID:19244175
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CFH
complement factor H
decreases expression
EXP
Selenium results in decreased expression of CFH mRNA
CTD
PMID:19244175
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
G
CFLAR
CASP8 and FADD like apoptosis regulator
multiple interactions
EXP
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA]; Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA]
CTD
PMID:27920530
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CHD1
chromodomain helicase DNA binding protein 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of CHD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA
CTD
PMID:19244175
NCBI chr 5:98,853,985...98,929,007
Ensembl chr 5:98,853,985...98,929,007
G
CHD3
chromodomain helicase DNA binding protein 3
increases expression
EXP
Selenium results in increased expression of CHD3 mRNA
CTD
PMID:19244175
NCBI chr17:7,884,796...7,912,755
Ensembl chr17:7,884,796...7,912,760
G
CHD4
chromodomain helicase DNA binding protein 4
increases expression
EXP
Selenium results in increased expression of CHD4 mRNA
CTD
PMID:19244175
NCBI chr12:6,570,082...6,607,379
Ensembl chr12:6,570,082...6,614,524
G
CHD9
chromodomain helicase DNA binding protein 9
decreases expression
EXP
Selenium results in decreased expression of CHD9 mRNA
CTD
PMID:19244175
NCBI chr16:53,054,991...53,327,497
Ensembl chr16:53,054,991...53,329,150
G
CHKA
choline kinase alpha
increases expression
EXP
Selenium results in increased expression of CHKA mRNA
CTD
PMID:19244175
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
G
CHMP1A
charged multivesicular body protein 1A
increases expression
EXP
Selenium results in increased expression of CHMP1A mRNA
CTD
PMID:19244175
NCBI chr16:89,644,435...89,657,708
Ensembl chr16:89,640,816...89,657,738
G
CHMP2A
charged multivesicular body protein 2A
increases expression
EXP
Selenium results in increased expression of CHMP2A mRNA
CTD
PMID:19244175
NCBI chr19:58,551,566...58,555,105
Ensembl chr19:58,551,452...58,555,105
G
CHN2
chimerin 2
increases expression
EXP
Selenium results in increased expression of CHN2 mRNA
CTD
PMID:19244175
NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,328
G
CHORDC1
cysteine and histidine rich domain containing 1
decreases expression
EXP
Selenium results in decreased expression of CHORDC1 mRNA
CTD
PMID:19244175
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
G
CHPF
chondroitin polymerizing factor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA Selenium results in increased expression of CHPF mRNA
CTD
PMID:19244175
NCBI chr 2:219,538,954...219,543,809
Ensembl chr 2:219,538,954...219,543,809
G
CHRNA4
cholinergic receptor nicotinic alpha 4 subunit
increases expression
EXP
Selenium results in increased expression of CHRNA4 mRNA
CTD
PMID:19244175
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
G
CHRNE
cholinergic receptor nicotinic epsilon subunit
increases expression
EXP
Selenium results in increased expression of CHRNE mRNA
CTD
PMID:19244175
NCBI chr17:4,897,771...4,908,677
Ensembl chr17:4,897,771...4,934,438
G
CHST3
carbohydrate sulfotransferase 3
increases expression
EXP
Selenium results in increased expression of CHST3 mRNA
CTD
PMID:19244175
NCBI chr10:71,964,395...72,013,558
Ensembl chr10:71,964,395...72,013,558
G
CHST6
carbohydrate sulfotransferase 6
increases expression
EXP
Selenium results in increased expression of CHST6 mRNA
CTD
PMID:19244175
NCBI chr16:75,472,042...75,495,441
Ensembl chr16:75,472,052...75,495,445
G
CIZ1
CDKN1A interacting zinc finger protein 1
increases expression
EXP
Selenium results in increased expression of CIZ1 mRNA
CTD
PMID:19244175
NCBI chr 9:128,166,065...128,204,222
Ensembl chr 9:128,161,251...128,204,383
G
CKAP2
cytoskeleton associated protein 2
decreases expression
EXP
Selenium results in decreased expression of CKAP2 mRNA
CTD
PMID:19244175
NCBI chr13:52,455,478...52,476,627
Ensembl chr13:52,455,429...52,476,628
G
CKB
creatine kinase B
increases expression
EXP
Selenium results in increased expression of CKB mRNA
CTD
PMID:19244175
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CKS2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
Selenium results in decreased expression of CKS2 mRNA
CTD
PMID:19244175
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLCC1
chloride channel CLIC like 1
decreases expression
EXP
Selenium results in decreased expression of CLCC1 mRNA
CTD
PMID:19244175
NCBI chr 1:108,929,505...108,963,484
Ensembl chr 1:108,881,885...108,963,527
G
CLCN3
chloride voltage-gated channel 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Selenium results in decreased expression of CLCN3 mRNA
CTD
PMID:19244175
NCBI chr 4:169,620,578...169,723,673
Ensembl chr 4:169,612,633...169,723,673
G
CLDN4
claudin 4
increases expression
EXP
Selenium results in increased expression of CLDN4 mRNA
CTD
PMID:19244175
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
G
CLDN5
claudin 5
multiple interactions
EXP
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; Selenium results in increased expression of and results in increased localization of CLDN5 protein
CTD
PMID:16514648
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLEC3B
C-type lectin domain family 3 member B
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Selenium results in increased expression of TNA mRNA
CTD
PMID:19244175
NCBI chr 3:45,026,303...45,036,071
Ensembl chr 3:45,001,548...45,036,071
G
CLN3
CLN3 lysosomal/endosomal transmembrane protein, battenin
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Selenium results in increased expression of CLN3 mRNA
CTD
PMID:19244175
NCBI chr16:28,466,653...28,492,082
Ensembl chr16:28,474,111...28,495,575
G
CLPTM1
CLPTM1 regulator of GABA type A receptor forward trafficking
increases expression
EXP
Selenium results in increased expression of CLPTM1 mRNA
CTD
PMID:19244175
NCBI chr19:44,954,585...44,993,341
Ensembl chr19:44,954,585...44,993,341
G
CLTB
clathrin light chain B
increases expression
EXP
Selenium results in increased expression of CLTB mRNA
CTD
PMID:19244175
NCBI chr 5:176,392,455...176,416,569
Ensembl chr 5:176,392,501...176,416,539
G
CLU
clusterin
increases expression
EXP
Selenium results in increased expression of CLU mRNA
CTD
PMID:19244175
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CMC2
C-X9-C motif containing 2
decreases expression
EXP
Selenium results in decreased expression of CMC2 mRNA
CTD
PMID:19244175
NCBI chr16:80,966,448...81,006,885
Ensembl chr16:80,966,448...81,020,270
G
CNIH1
cornichon family member 1
decreases expression
EXP
Selenium results in decreased expression of CNIH1 mRNA
CTD
PMID:19244175
NCBI chr14:54,423,561...54,441,374
Ensembl chr14:54,423,561...54,441,391
G
CNIH4
cornichon family member 4
decreases expression
EXP
Selenium results in decreased expression of CNIH4 mRNA
CTD
PMID:19244175
NCBI chr 1:224,356,803...224,379,452
Ensembl chr 1:224,356,858...224,379,459
G
CNN2
calponin 2
increases expression
EXP
Selenium results in increased expression of CNN2 mRNA
CTD
PMID:19244175
NCBI chr19:1,026,608...1,039,065
Ensembl chr19:1,026,586...1,039,068
G
CNN3
calponin 3
increases expression
EXP
Selenium results in increased expression of CNN3 mRNA
CTD
PMID:19244175
NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,223
G
CNOT8
CCR4-NOT transcription complex subunit 8
decreases expression
EXP
Selenium results in decreased expression of CNOT8 mRNA
CTD
PMID:19244175
NCBI chr 5:154,858,249...154,876,792
Ensembl chr 5:154,857,553...154,876,792
G
CNPY2
canopy FGF signaling regulator 2
decreases expression
EXP
Selenium results in decreased expression of CNPY2 mRNA
CTD
PMID:19244175
NCBI chr12:56,309,844...56,316,346
Ensembl chr12:56,309,842...56,316,119
G
CNPY3
canopy FGF signaling regulator 3
increases expression
EXP
Selenium results in increased expression of CNPY3 mRNA
CTD
PMID:19244175
NCBI chr 6:42,928,002...42,939,294
Ensembl chr 6:42,929,480...42,939,294
G
COG4
component of oligomeric golgi complex 4
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA
CTD
PMID:19244175
NCBI chr16:70,480,567...70,523,554
Ensembl chr16:70,480,568...70,523,560
G
COG7
component of oligomeric golgi complex 7
increases expression
EXP
Selenium results in increased expression of COG7 mRNA
CTD
PMID:19244175
NCBI chr16:23,388,493...23,453,189
Ensembl chr16:23,388,493...23,453,189
G
COG8
component of oligomeric golgi complex 8
increases expression
EXP
Selenium results in increased expression of COG8 mRNA
CTD
PMID:19244175
NCBI chr16:69,326,428...69,339,564
Ensembl chr16:69,320,140...69,339,583
G
COL14A1
collagen type XIV alpha 1 chain
decreases expression
EXP
Selenium results in decreased expression of COL14A1 mRNA
CTD
PMID:19244175
NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573
G
COL18A1
collagen type XVIII alpha 1 chain
increases expression
EXP
Selenium results in increased expression of COL18A1 mRNA
CTD
PMID:19244175
NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
G
COL1A1
collagen type I alpha 1 chain
multiple interactions
ISO
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL1A1 protein
CTD
PMID:8435081
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL2A1
collagen type II alpha 1 chain
multiple interactions
ISO
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL2A1 protein
CTD
PMID:8435081
NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,554
G
COL4A3
collagen type IV alpha 3 chain
decreases expression
EXP
Selenium results in decreased expression of COL4A3 mRNA
CTD
PMID:19244175
NCBI chr 2:227,164,624...227,314,792
Ensembl chr 2:227,164,624...227,314,792
G
COL6A2
collagen type VI alpha 2 chain
increases expression
EXP
Selenium results in increased expression of COL6A2 mRNA
CTD
PMID:19244175
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
G
COLEC12
collectin subfamily member 12
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of COLEC12 mRNA
CTD
PMID:21481475
NCBI chr18:316,737...500,701
Ensembl chr18:316,737...500,722
G
COMMD3
COMM domain containing 3
decreases expression
EXP
Selenium results in decreased expression of COMMD3 mRNA
CTD
PMID:19244175
NCBI chr10:22,316,388...22,320,306
Ensembl chr10:22,316,386...22,320,306
G
COMMD4
COMM domain containing 4
increases expression
EXP
Selenium results in increased expression of COMMD4 mRNA
CTD
PMID:19244175
NCBI chr15:75,336,063...75,343,227
Ensembl chr15:75,336,020...75,343,224
G
COPE
COPI coat complex subunit epsilon
increases expression
EXP
Selenium results in increased expression of COPE mRNA
CTD
PMID:19244175
NCBI chr19:18,899,514...18,919,387
Ensembl chr19:18,899,514...18,919,387
G
COPG1
COPI coat complex subunit gamma 1
increases expression
EXP
Selenium results in increased expression of COPG1 mRNA
CTD
PMID:19244175
NCBI chr 3:129,249,606...129,277,773
Ensembl chr 3:129,249,606...129,277,773
G
COPS7A
COP9 signalosome subunit 7A
increases expression
EXP
Selenium results in increased expression of COPS7A mRNA
CTD
PMID:19244175
NCBI chr12:6,724,046...6,731,865
Ensembl chr12:6,724,014...6,731,875
G
COPS8
COP9 signalosome subunit 8
decreases expression
EXP
Selenium results in decreased expression of COPS8 mRNA
CTD
PMID:19244175
NCBI chr 2:237,085,889...237,100,474
Ensembl chr 2:237,085,882...237,100,474
G
COX6A1
cytochrome c oxidase subunit 6A1
decreases expression
EXP
Selenium results in decreased expression of COX6A1 mRNA
CTD
PMID:19244175
NCBI chr12:120,438,113...120,440,730
Ensembl chr12:120,438,090...120,440,737
G
COX7A1
cytochrome c oxidase subunit 7A1
decreases expression
EXP
Selenium results in decreased expression of COX7A1 mRNA
CTD
PMID:19244175
NCBI chr19:36,150,922...36,152,447
Ensembl chr19:36,150,922...36,152,449
G
COX7A2
cytochrome c oxidase subunit 7A2
decreases expression
EXP
Selenium results in decreased expression of COX7A2 mRNA
CTD
PMID:19244175
NCBI chr 6:75,237,675...75,250,298
Ensembl chr 6:75,237,675...75,250,323
G
COX7B
cytochrome c oxidase subunit 7B
decreases expression
EXP
Selenium results in decreased expression of COX7B mRNA
CTD
PMID:19244175
NCBI chr X:77,899,468...77,907,376
Ensembl chr X:77,899,440...77,907,376
G
COX7C
cytochrome c oxidase subunit 7C
decreases expression
EXP
Selenium results in decreased expression of COX7C mRNA
CTD
PMID:19244175
NCBI chr 5:86,617,941...86,620,962
Ensembl chr 5:86,617,928...86,620,962
G
CPA3
carboxypeptidase A3
decreases expression
EXP
Selenium results in decreased expression of CPA3 mRNA
CTD
PMID:19244175
NCBI chr 3:148,865,296...148,897,203
Ensembl chr 3:148,865,296...148,897,203
G
CPD
carboxypeptidase D
decreases expression
EXP
Selenium results in decreased expression of CPD mRNA
CTD
PMID:19244175
NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989
G
CPSF1
cleavage and polyadenylation specific factor 1
increases expression
EXP
Selenium results in increased expression of CPSF1 mRNA
CTD
PMID:19244175
NCBI chr 8:144,393,231...144,409,335
Ensembl chr 8:144,393,229...144,409,335
G
CRABP2
cellular retinoic acid binding protein 2
increases expression
ISO
Selenium deficiency results in increased expression of CRABP2 mRNA
CTD
PMID:11444866
NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816
G
CRAT
carnitine O-acetyltransferase
increases expression
EXP
Selenium results in increased expression of CRAT mRNA
CTD
PMID:19244175
NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,189
G
CRBN
cereblon
decreases expression
EXP
Selenium results in decreased expression of CRBN mRNA
CTD
PMID:19244175
NCBI chr 3:3,149,633...3,179,717
Ensembl chr 3:3,144,628...3,179,727
G
CREB1
cAMP responsive element binding protein 1
multiple interactions decreases expression
EXP ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of CREB1 protein] Selenium results in decreased expression of CREB1 mRNA
CTD
PMID:19244175 PMID:30695686
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREB3
cAMP responsive element binding protein 3
increases expression
EXP
Selenium results in increased expression of CREB3 mRNA
CTD
PMID:19244175
NCBI chr 9:35,732,666...35,736,999
Ensembl chr 9:35,732,598...35,736,999
G
CREBBP
CREB binding protein
decreases expression
EXP
Selenium results in decreased expression of CREBBP mRNA
CTD
PMID:19244175
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
CRELD1
cysteine rich with EGF like domains 1
increases expression
EXP
Selenium results in increased expression of CRELD1 mRNA
CTD
PMID:19244175
NCBI chr 3:9,933,834...9,945,406
Ensembl chr 3:9,933,793...9,945,413
G
CRTC1
CREB regulated transcription coactivator 1
increases expression
EXP
Selenium results in increased expression of CRTC1 mRNA
CTD
PMID:19244175
NCBI chr19:18,683,680...18,782,333
Ensembl chr19:18,683,678...18,782,333
G
CRYBG2
crystallin beta-gamma domain containing 2
increases expression multiple interactions
EXP
Selenium results in increased expression of CRYBG2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA
CTD
PMID:19244175
NCBI chr 1:26,321,865...26,354,130
Ensembl chr 1:26,321,698...26,360,080
G
CSF1
colony stimulating factor 1
increases expression
EXP
Selenium results in increased expression of CSF1 mRNA
CTD
PMID:19244175
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
G
CSK
C-terminal Src kinase
increases expression
EXP
Selenium results in increased expression of CSK mRNA
CTD
PMID:19244175
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
G
CSNK1A1
casein kinase 1 alpha 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Selenium results in decreased expression of CSNK1A1 mRNA
CTD
PMID:19244175
NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471
G
CSNK1E
casein kinase 1 epsilon
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA Selenium results in increased expression of CSNK1E mRNA
CTD
PMID:19244175
NCBI chr22:38,290,691...38,318,084
Ensembl chr22:38,290,691...38,318,084
G
CSNK2A1
casein kinase 2 alpha 1
decreases expression
EXP
Selenium results in decreased expression of CSNK2A1 mRNA
CTD
PMID:19244175
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
G
CSNK2B
casein kinase 2 beta
increases expression
EXP
Selenium results in increased expression of CSNK2B mRNA
CTD
PMID:19244175
NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
G
CSPG4
chondroitin sulfate proteoglycan 4
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA
CTD
PMID:19244175
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
CSPP1
centrosome and spindle pole associated protein 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of CSPP1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA
CTD
PMID:19244175
NCBI chr 8:67,064,368...67,196,614
Ensembl chr 8:67,062,417...67,196,778
G
CST3
cystatin C
increases expression
EXP
Selenium results in increased expression of CST3 mRNA
CTD
PMID:19244175
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CSTA
cystatin A
decreases expression
EXP
Selenium results in decreased expression of CSTA mRNA
CTD
PMID:19244175
NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969
G
CTBP1
C-terminal binding protein 1
increases expression
EXP
Selenium results in increased expression of CTBP1 mRNA
CTD
PMID:19244175
NCBI chr 4:1,211,445...1,250,355
Ensembl chr 4:1,211,445...1,250,333
G
CTBP2
C-terminal binding protein 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Selenium results in decreased expression of CTBP2 mRNA
CTD
PMID:19244175
NCBI chr10:124,984,317...125,162,463
Ensembl chr10:124,984,317...125,161,170
G
CTBS
chitobiase
decreases expression
EXP
Selenium results in decreased expression of CTBS mRNA
CTD
PMID:19244175
NCBI chr 1:84,549,611...84,574,440
Ensembl chr 1:84,549,611...84,574,480
G
CTDNEP1
CTD nuclear envelope phosphatase 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Selenium results in increased expression of CTDNEP1 mRNA
CTD
PMID:19244175
NCBI chr17:7,243,591...7,251,978
Ensembl chr17:7,243,591...7,252,491
G
CTNNA1
catenin alpha 1
increases expression
EXP
Selenium results in increased expression of CTNNA1 mRNA
CTD
PMID:19244175
NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
G
CTNNBL1
catenin beta like 1
increases expression
EXP
Selenium results in increased expression of CTNNBL1 mRNA
CTD
PMID:19244175
NCBI chr20:37,694,030...37,872,118
Ensembl chr20:37,694,030...37,872,129
G
CTSA
cathepsin A
increases expression
EXP
Selenium results in increased expression of CTSA mRNA
CTD
PMID:19244175
NCBI chr20:45,891,335...45,898,820
Ensembl chr20:45,890,144...45,898,949
G
CTSB
cathepsin B
increases expression
EXP
Selenium results in increased expression of CTSB mRNA
CTD
PMID:19244175
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSO
cathepsin O
decreases expression
EXP
Selenium results in decreased expression of CTSO mRNA
CTD
PMID:19244175
NCBI chr 4:155,924,118...155,953,866
Ensembl chr 4:155,921,580...155,953,912
G
CUEDC2
CUE domain containing 2
increases expression
EXP
Selenium results in increased expression of CUEDC2 mRNA
CTD
PMID:19244175
NCBI chr10:102,423,249...102,432,574
Ensembl chr10:102,423,245...102,432,584
G
CUL3
cullin 3
decreases expression
EXP
Selenium results in decreased expression of CUL3 mRNA
CTD
PMID:19244175
NCBI chr 2:224,470,150...224,585,363
Ensembl chr 2:224,470,150...224,585,397
G
CUL4A
cullin 4A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA
CTD
PMID:19244175
NCBI chr13:113,208,193...113,267,108
Ensembl chr13:113,208,193...113,267,108
G
CUL7
cullin 7
increases expression
EXP
Selenium results in increased expression of CUL7 mRNA
CTD
PMID:19244175
NCBI chr 6:43,037,617...43,053,851
Ensembl chr 6:43,037,617...43,053,943
G
CUTC
cutC copper transporter
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Selenium results in decreased expression of CUTC mRNA
CTD
PMID:19244175
NCBI chr10:99,732,234...99,756,134
Ensembl chr10:99,702,558...99,756,134
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression
EXP
Selenium results in increased expression of CXCL1 mRNA
CTD
PMID:17293063
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
EXP
Selenium results in increased expression of CXCL2 mRNA
CTD
PMID:17293063
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Selenium results in increased expression of CXCL8 mRNA
CTD
PMID:17293063
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
decreases expression
EXP
Selenium results in decreased expression of CXCL9 mRNA
CTD
PMID:18997278
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR4
C-X-C motif chemokine receptor 4
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CXCR4 mRNA
CTD
PMID:21481475
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CXXC1
CXXC finger protein 1
increases expression
EXP
Selenium results in increased expression of CXXC1 mRNA
CTD
PMID:19244175
NCBI chr18:50,282,347...50,287,692
Ensembl chr18:50,282,343...50,287,839
G
CYB561D2
cytochrome b561 family member D2
increases expression
EXP
Selenium results in increased expression of CYB561D2 mRNA
CTD
PMID:19244175
NCBI chr 3:50,350,862...50,368,197
Ensembl chr 3:50,350,845...50,358,460
G
CYCS
cytochrome c, somatic
multiple interactions
EXP ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CYCS mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein]
CTD
PMID:27920530 PMID:34612572
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
ISO
Selenium promotes the reaction [Plant Extracts results in increased activity of CYP1A1 protein]
CTD
PMID:19650632
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
ISO
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein]
CTD
PMID:21424224
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]
CTD
PMID:36464106
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
increases expression
ISO
Selenium deficiency results in increased expression of CYP2A5 mRNA
CTD
PMID:16170372
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
increases expression
ISO
Selenium deficiency results in increased expression of CYP2B10 mRNA
CTD
PMID:16170372
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
ISO
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein]
CTD
PMID:21424224
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
decreases expression
EXP
Selenium results in decreased expression of CYP3A4 mRNA
CTD
PMID:19244175
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
decreases expression
EXP
Selenium results in decreased expression of CYP3A5 mRNA
CTD
PMID:19244175
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP4B1
cytochrome P450 family 4 subfamily B member 1
increases expression
ISO
Selenium deficiency results in increased expression of CYP4B1 mRNA
CTD
PMID:11444866
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]
CTD
PMID:30031400 PMID:36464106
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
increases expression
ISO
Selenium deficiency results in increased expression of CYP7B1 mRNA; Selenium results in increased expression of CYP7B1 mRNA
CTD
PMID:16170372
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
increases expression multiple interactions
ISO
Selenium deficiency results in increased expression of CYP8B1 mRNA; Selenium results in increased expression of CYP8B1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]
CTD
PMID:16170372 PMID:36464106
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DAAM1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
Selenium results in decreased expression of DAAM1 mRNA
CTD
PMID:19244175
NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
G
DACT1
dishevelled binding antagonist of beta catenin 1
decreases expression
EXP
Selenium results in decreased expression of DACT1 mRNA
CTD
PMID:19244175
NCBI chr14:58,634,061...58,648,321
Ensembl chr14:58,633,967...58,648,321
G
DAD1
defender against cell death 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA
CTD
PMID:11444866
NCBI chr14:22,564,907...22,589,224
Ensembl chr14:22,564,907...22,589,224
G
DAPK3
death associated protein kinase 3
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Selenium results in increased expression of DAPK3 mRNA
CTD
PMID:19244175
NCBI chr19:3,958,453...3,971,099
Ensembl chr19:3,958,453...3,971,123
G
DCTN1
dynactin subunit 1
increases expression
EXP
Selenium results in increased expression of DCTN1 mRNA
CTD
PMID:19244175
NCBI chr 2:74,361,155...74,391,866
Ensembl chr 2:74,361,154...74,392,087
G
DCXR
dicarbonyl and L-xylulose reductase
increases expression
EXP
Selenium results in increased expression of DCXR mRNA
CTD
PMID:19244175
NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709
G
DDAH2
DDAH family member 2, ADMA-independent
increases expression
EXP
Selenium results in increased expression of DDAH2 mRNA
CTD
PMID:19244175
NCBI chr 6:31,727,040...31,730,263
Ensembl chr 6:31,727,038...31,730,617
G
DDOST
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
increases expression
EXP
Selenium results in increased expression of DDOST mRNA
CTD
PMID:19244175
NCBI chr 1:20,651,777...20,661,369
Ensembl chr 1:20,651,767...20,661,544
G
DDX17
DEAD-box helicase 17
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Selenium results in decreased expression of DDX17 mRNA
CTD
PMID:19244175
NCBI chr22:38,483,438...38,506,311
Ensembl chr22:38,483,438...38,507,660
G
DDX18
DEAD-box helicase 18
decreases expression multiple interactions
EXP
Selenium results in decreased expression of DDX18 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA
CTD
PMID:19244175
NCBI chr 2:117,814,691...117,832,377
Ensembl chr 2:117,814,691...117,832,377
G
DDX24
DEAD-box helicase 24
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Selenium results in decreased expression of DDX24 mRNA
CTD
PMID:19244175
NCBI chr14:94,048,287...94,081,202
Ensembl chr14:94,048,287...94,081,202
G
DDX39B
DExD-box helicase 39B
decreases expression increases expression
EXP
Selenium results in decreased expression of DDX39B mRNA Selenium results in increased expression of DDX39B mRNA
CTD
PMID:19244175
NCBI chr 6:31,530,226...31,542,003
Ensembl chr 6:31,530,219...31,542,448
G
DDX3Y
DEAD-box helicase 3 Y-linked
decreases expression
EXP
Selenium results in decreased expression of DDX3Y mRNA
CTD
PMID:19244175
NCBI chr Y:12,903,999...12,920,478
Ensembl chr Y:12,904,108...12,920,478
G
DDX41
DEAD-box helicase 41
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA Selenium results in increased expression of DDX41 mRNA
CTD
PMID:19244175
NCBI chr 5:177,511,577...177,516,961
Ensembl chr 5:177,511,577...177,516,961
G
DDX49
DEAD-box helicase 49
increases expression
EXP
Selenium results in increased expression of DDX49 mRNA
CTD
PMID:19244175
NCBI chr19:18,919,715...18,928,630
Ensembl chr19:18,919,705...18,929,189
G
DECR2
2,4-dienoyl-CoA reductase 2
increases expression
ISO
Selenium deficiency results in increased expression of DECR2 mRNA
CTD
PMID:16170372
NCBI chr16:401,885...412,482
Ensembl chr16:401,858...412,487
G
DEDD
death effector domain containing
increases expression
EXP
Selenium results in increased expression of DEDD mRNA
CTD
PMID:19244175
NCBI chr 1:161,120,974...161,132,667
Ensembl chr 1:161,120,974...161,132,688
G
DEGS1
delta 4-desaturase, sphingolipid 1
decreases expression
EXP
Selenium results in decreased expression of DEGS1 mRNA
CTD
PMID:19244175
NCBI chr 1:224,183,240...224,193,441
Ensembl chr 1:224,175,756...224,193,441
G
DENND10P1
DENND10 pseudogene 1
decreases expression
EXP
Selenium results in decreased expression of DENND10P1 mRNA
CTD
PMID:19244175
NCBI chr X:130,494,941...130,497,448
Ensembl chr X:130,495,159...130,496,232
G
DENND2B
DENN domain containing 2B
increases expression
EXP
Selenium results in increased expression of DENND2B mRNA
CTD
PMID:19244175
NCBI chr11:8,693,352...8,910,951
Ensembl chr11:8,693,351...8,910,951
G
DERA
deoxyribose-phosphate aldolase
decreases expression
EXP
Selenium results in decreased expression of DERA mRNA
CTD
PMID:19244175
NCBI chr12:15,911,332...16,037,381
Ensembl chr12:15,911,302...16,037,381
G
DES
desmin
increases expression
EXP
Selenium results in increased expression of DES mRNA
CTD
PMID:19244175
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
G
DESI2
desumoylating isopeptidase 2
decreases expression
EXP
Selenium results in decreased expression of DESI2 mRNA
CTD
PMID:19244175
NCBI chr 1:244,653,126...244,709,033
Ensembl chr 1:244,653,103...244,709,033
G
DGCR6
DiGeorge syndrome critical region gene 6
increases expression
EXP
Selenium results in increased expression of DGCR6 mRNA
CTD
PMID:19244175
NCBI chr22:18,906,223...18,912,088
Ensembl chr22:18,906,028...18,914,238
G
DGCR8
DGCR8 microprocessor complex subunit
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA Selenium results in increased expression of DGCR8 mRNA
CTD
PMID:19244175
NCBI chr22:20,080,241...20,111,872
Ensembl chr22:20,080,221...20,111,877
G
DHCR24
24-dehydrocholesterol reductase
increases expression
EXP
Selenium results in increased expression of DHCR24 mRNA
CTD
PMID:19244175
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DHCR7
7-dehydrocholesterol reductase
increases expression
EXP
Selenium results in increased expression of DHCR7 mRNA
CTD
PMID:19244175
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
G
DHPS
deoxyhypusine synthase
increases expression multiple interactions
EXP
Selenium results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA
CTD
PMID:19244175
NCBI chr19:12,672,470...12,681,880
Ensembl chr19:12,675,717...12,681,880
G
DHRS4
dehydrogenase/reductase 4
increases expression
EXP
Selenium results in increased expression of DHRS4 mRNA
CTD
PMID:19244175
NCBI chr14:23,953,770...23,969,279
Ensembl chr14:23,953,734...23,969,279
G
DHRS7B
dehydrogenase/reductase 7B
increases expression
EXP
Selenium results in increased expression of DHRS7B mRNA
CTD
PMID:19244175
NCBI chr17:21,126,964...21,191,420
Ensembl chr17:21,123,364...21,193,265
G
DHX30
DExH-box helicase 30
increases expression
EXP
Selenium results in increased expression of DHX30 mRNA
CTD
PMID:19244175
NCBI chr 3:47,803,138...47,850,193
Ensembl chr 3:47,802,909...47,850,195
G
DICER1
dicer 1, ribonuclease III
decreases expression
EXP
Selenium results in decreased expression of DICER1 mRNA
CTD
PMID:19244175
NCBI chr14:95,086,228...95,158,010
Ensembl chr14:95,086,228...95,158,010
G
DIO1
iodothyronine deiodinase 1
decreases expression increases expression affects expression increases activity multiple interactions
ISO
Selenium deficiency results in decreased expression of DIO1 mRNA Selenium results in increased expression of DIO1 mRNA Selenium deficiency affects the expression of DIO1 mRNA Selenium results in increased activity of DIO1 protein Selenium inhibits the reaction [Iodine results in decreased activity of DIO1 protein]; Selenium inhibits the reaction [Iodine results in decreased expression of DIO1 mRNA]; Selenium inhibits the reaction [potassium iodate results in decreased activity of DIO1 protein]
CTD
PMID:16170372 PMID:16271152 PMID:16874406 PMID:16959840 PMID:17044649 PMID:18095564 More...
NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
G
DIO2
iodothyronine deiodinase 2
multiple interactions increases activity
EXP ISO
Selenium results in increased expression of and results in increased activity of DIO2 protein Selenium results in increased activity of DIO2 protein
CTD
PMID:11425850 PMID:15471965
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
G
DIP2C
disco interacting protein 2 homolog C
decreases expression
EXP
Selenium results in decreased expression of DIP2C mRNA
CTD
PMID:19244175
NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668
G
DLG1
discs large MAGUK scaffold protein 1
decreases expression
EXP
Selenium results in decreased expression of DLG1 mRNA
CTD
PMID:19244175
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
G
DMGDH
dimethylglycine dehydrogenase
affects abundance
EXP
DMGDH gene SNP affects the abundance of Selenium
CTD
PMID:23720494
NCBI chr 5:78,997,564...79,069,674
Ensembl chr 5:78,997,564...79,236,038
G
DMTF1
cyclin D binding myb like transcription factor 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Selenium results in decreased expression of DMTF1 mRNA
CTD
PMID:19244175
NCBI chr 7:87,152,453...87,196,325
Ensembl chr 7:87,152,409...87,196,337
G
DMWD
DM1 locus, WD repeat containing
increases expression
EXP
Selenium results in increased expression of DMWD mRNA
CTD
PMID:19244175
NCBI chr19:45,782,947...45,792,845
Ensembl chr19:45,782,947...45,792,845
G
DMXL2
Dmx like 2
decreases expression
EXP
Selenium results in decreased expression of DMXL2 mRNA
CTD
PMID:19244175
NCBI chr15:51,447,791...51,622,771
Ensembl chr15:51,447,711...51,622,833
G
DNA2
DNA replication helicase/nuclease 2
decreases expression
EXP
Selenium results in decreased expression of DNA2 mRNA
CTD
PMID:19244175
NCBI chr10:68,414,064...68,472,521
Ensembl chr10:68,414,064...68,472,121
G
DNAJA3
DnaJ heat shock protein family (Hsp40) member A3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Selenium results in decreased expression of DNAJA3 mRNA
CTD
PMID:19244175
NCBI chr16:4,425,868...4,456,775
Ensembl chr16:4,425,805...4,456,775
G
DNAJB3
DnaJ heat shock protein family (Hsp40) member B3
multiple interactions decreases expression
ISO
[Selenium co-treated with Selenium] results in decreased expression of DNAJB3 mRNA Selenium deficiency results in decreased expression of DNAJB3 mRNA
CTD
PMID:19367646
NCBI chr 2:233,742,750...233,743,998
Ensembl chr 2:233,743,188...233,743,916 Ensembl chr 2:233,743,188...233,743,916
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
EXP
Selenium results in decreased expression of DNAJB4 mRNA
CTD
PMID:19244175
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DNAJC2
DnaJ heat shock protein family (Hsp40) member C2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA
CTD
PMID:19244175
NCBI chr 7:103,312,289...103,344,767
Ensembl chr 7:103,312,289...103,344,830
G
DNAJC7
DnaJ heat shock protein family (Hsp40) member C7
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA
CTD
PMID:19244175
NCBI chr17:41,976,435...42,017,439
Ensembl chr17:41,976,421...42,021,376
G
DNAJC9
DnaJ heat shock protein family (Hsp40) member C9
decreases expression
EXP
Selenium results in decreased expression of DNAJC9 mRNA
CTD
PMID:19244175
NCBI chr10:73,232,272...73,247,255
Ensembl chr10:73,183,362...73,247,255
G
DNMT1
DNA methyltransferase 1
affects activity
ISO
Selenium affects the activity of DNMT1 protein
CTD
PMID:16632891
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNPEP
aspartyl aminopeptidase
increases expression
EXP
Selenium results in increased expression of DNPEP mRNA
CTD
PMID:19244175
NCBI chr 2:219,372,043...219,400,007
Ensembl chr 2:219,372,043...219,400,022
G
DOHH
deoxyhypusine hydroxylase
increases expression multiple interactions
EXP
Selenium results in increased expression of DOHH mRNA [Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA
CTD
PMID:19244175
NCBI chr19:3,490,824...3,500,674
Ensembl chr19:3,490,821...3,500,674
G
DOLPP1
dolichyldiphosphatase 1
increases expression
EXP
Selenium results in increased expression of DOLPP1 mRNA
CTD
PMID:19244175
NCBI chr 9:129,081,111...129,090,438
Ensembl chr 9:129,081,111...129,090,438
G
DPYD
dihydropyrimidine dehydrogenase
decreases expression
EXP
Selenium results in decreased expression of DPYD mRNA
CTD
PMID:19244175
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DR1
down-regulator of transcription 1
decreases expression
EXP
Selenium results in decreased expression of DR1 mRNA
CTD
PMID:19244175
NCBI chr 1:93,345,907...93,369,493
Ensembl chr 1:93,345,907...93,369,493
G
DRG2
developmentally regulated GTP binding protein 2
increases expression
EXP
Selenium results in increased expression of DRG2 mRNA
CTD
PMID:19244175
NCBI chr17:18,087,948...18,107,969
Ensembl chr17:18,087,892...18,107,970
G
DSC2
desmocollin 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA Selenium results in decreased expression of DSC2 mRNA
CTD
PMID:19244175
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,840...31,102,522
G
DSE
dermatan sulfate epimerase
decreases expression
EXP
Selenium results in decreased expression of DSE mRNA
CTD
PMID:19244175
NCBI chr 6:116,254,171...116,444,861
Ensembl chr 6:116,254,173...116,444,861
G
DUOX1
dual oxidase 1
increases expression
EXP
Selenium results in increased expression of DUOX1 mRNA
CTD
PMID:19244175
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
G
DUSP8
dual specificity phosphatase 8
increases expression
EXP
Selenium results in increased expression of DUSP8 mRNA
CTD
PMID:19244175
NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271
G
DXO
decapping exoribonuclease
increases expression
EXP
Selenium results in increased expression of DXO mRNA
CTD
PMID:19244175
NCBI chr 6:31,969,815...31,972,138
Ensembl chr 6:31,969,810...31,972,290
G
DYM
dymeclin
decreases expression
EXP
Selenium results in decreased expression of DYM mRNA
CTD
PMID:19244175
NCBI chr18:49,036,387...49,460,645
Ensembl chr18:49,036,387...49,461,347
G
DYNC1H1
dynein cytoplasmic 1 heavy chain 1
increases expression
EXP
Selenium results in increased expression of DYNC1H1 mRNA
CTD
PMID:19244175
NCBI chr14:101,964,573...102,056,443
Ensembl chr14:101,964,573...102,056,443
G
DYNLRB1
dynein light chain roadblock-type 1
decreases expression
EXP
Selenium results in decreased expression of DYNLRB1 mRNA
CTD
PMID:19244175
NCBI chr20:34,515,602...34,540,958
Ensembl chr20:34,516,395...34,540,958
G
E2F1
E2F transcription factor 1
increases expression
EXP
Selenium results in increased expression of E2F1 mRNA
CTD
PMID:19244175
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
E2F4
E2F transcription factor 4
increases expression
EXP
Selenium results in increased expression of E2F4 mRNA
CTD
PMID:19244175
NCBI chr16:67,192,155...67,198,918
Ensembl chr16:67,192,155...67,198,918
G
E2F6
E2F transcription factor 6
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Selenium results in decreased expression of E2F6 mRNA
CTD
PMID:19244175
NCBI chr 2:11,444,375...11,466,161
Ensembl chr 2:11,444,375...11,466,177
G
E4F1
E4F transcription factor 1
increases expression
EXP
Selenium results in increased expression of E4F1 mRNA
CTD
PMID:19244175
NCBI chr16:2,223,591...2,235,742
Ensembl chr16:2,223,580...2,235,742
G
ECM2
extracellular matrix protein 2
decreases expression
EXP
Selenium results in decreased expression of ECM2 mRNA
CTD
PMID:19244175
NCBI chr 9:92,493,547...92,559,106
Ensembl chr 9:92,493,554...92,536,655
G
ECSIT
ECSIT signaling integrator
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA Selenium results in increased expression of ECSIT mRNA
CTD
PMID:19244175
NCBI chr19:11,505,929...11,529,134
Ensembl chr19:11,505,929...11,529,172
G
EDF1
endothelial differentiation related factor 1
increases expression
EXP
Selenium results in increased expression of EDF1 mRNA
CTD
PMID:19244175
NCBI chr 9:136,862,119...136,866,308
Ensembl chr 9:136,862,119...136,866,308
G
EDNRA
endothelin receptor type A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Selenium results in decreased expression of EDNRA mRNA
CTD
PMID:19244175
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EEF1A2
eukaryotic translation elongation factor 1 alpha 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA Selenium results in increased expression of EEF1A2 mRNA
CTD
PMID:19244175
NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239
G
EEF1D
eukaryotic translation elongation factor 1 delta
increases expression
EXP
Selenium results in increased expression of EEF1D mRNA
CTD
PMID:19244175
NCBI chr 8:143,579,728...143,597,415
Ensembl chr 8:143,579,697...143,599,541
G
EFCAB14
EF-hand calcium binding domain 14
increases expression
EXP
Selenium results in increased expression of EFCAB14 mRNA
CTD
PMID:19244175
NCBI chr 1:46,675,159...46,719,114
Ensembl chr 1:46,674,659...46,719,146
G
EFEMP2
EGF containing fibulin extracellular matrix protein 2
increases expression
EXP
Selenium results in increased expression of EFEMP2 mRNA
CTD
PMID:19244175
NCBI chr11:65,866,441...65,872,800
Ensembl chr11:65,866,441...65,873,592
G
EFHC1
EF-hand domain containing 1
decreases expression
EXP
Selenium results in decreased expression of EFHC1 mRNA
CTD
PMID:19244175
NCBI chr 6:52,420,342...52,497,198
Ensembl chr 6:52,362,123...52,529,886
G
EFHD2
EF-hand domain family member D2
increases expression
EXP
Selenium results in increased expression of EFHD2 mRNA
CTD
PMID:19244175
NCBI chr 1:15,409,888...15,430,339
Ensembl chr 1:15,409,888...15,430,339
G
EGF
epidermal growth factor
multiple interactions
ISO
Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]; Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides]
CTD
PMID:11158190
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGFR
epidermal growth factor receptor
decreases expression
EXP
Selenium results in decreased expression of EGFR mRNA
CTD
PMID:17390030
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA
CTD
PMID:11444866
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EHBP1
EH domain binding protein 1
decreases expression
EXP
Selenium results in decreased expression of EHBP1 mRNA
CTD
PMID:19244175
NCBI chr 2:62,673,878...63,046,487
Ensembl chr 2:62,673,851...63,046,487
G
EHD2
EH domain containing 2
increases expression
EXP
Selenium results in increased expression of EHD2 mRNA
CTD
PMID:19244175
NCBI chr19:47,713,422...47,743,134
Ensembl chr19:47,713,422...47,743,134
G
EIF1B
eukaryotic translation initiation factor 1B
decreases expression
EXP
Selenium results in decreased expression of EIF1B mRNA
CTD
PMID:19244175
NCBI chr 3:40,309,707...40,312,424
Ensembl chr 3:40,309,707...40,312,424
G
EIF2AK2
eukaryotic translation initiation factor 2 alpha kinase 2
decreases expression
EXP
Selenium results in decreased expression of EIF2AK2 mRNA
CTD
PMID:19244175
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
G
EIF3A
eukaryotic translation initiation factor 3 subunit A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA
CTD
PMID:19244175
NCBI chr10:119,033,670...119,080,817
Ensembl chr10:119,033,670...119,080,817
G
EIF3B
eukaryotic translation initiation factor 3 subunit B
increases expression
EXP
Selenium results in increased expression of EIF3B mRNA
CTD
PMID:19244175
NCBI chr 7:2,354,086...2,380,745
Ensembl chr 7:2,354,086...2,380,745
G
EIF3C
eukaryotic translation initiation factor 3 subunit C
increases expression
EXP
Selenium results in increased expression of EIF3C mRNA
CTD
PMID:19244175
NCBI chr16:28,688,558...28,735,730
Ensembl chr16:28,688,558...28,735,727
G
EIF4G1
eukaryotic translation initiation factor 4 gamma 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Selenium results in increased expression of EIF4G1 mRNA
CTD
PMID:19244175
NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358
G
EIF5A
eukaryotic translation initiation factor 5A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA
CTD
PMID:19244175
NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463
G
EIF5B
eukaryotic translation initiation factor 5B
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Selenium results in decreased expression of IF2 mRNA
CTD
PMID:19244175
NCBI chr 2:99,337,389...99,401,326
Ensembl chr 2:99,337,389...99,401,326
G
EIF6
eukaryotic translation initiation factor 6
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Selenium results in increased expression of EIF6 mRNA
CTD
PMID:19244175
NCBI chr20:35,278,906...35,284,772
Ensembl chr20:35,278,907...35,284,985
G
ELOA
elongin A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA
CTD
PMID:19244175
NCBI chr 1:23,743,471...23,762,059
Ensembl chr 1:23,743,448...23,762,059
G
ELP1
elongator acetyltransferase complex subunit 1
decreases expression
EXP
Selenium results in decreased expression of ELP1 mRNA
CTD
PMID:19244175
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
G
EMC9
ER membrane protein complex subunit 9
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA
CTD
PMID:19244175
NCBI chr14:24,138,965...24,141,591
Ensembl chr14:24,138,959...24,141,591
G
EMILIN1
elastin microfibril interfacer 1
increases expression
EXP
Selenium results in increased expression of EMILIN1 mRNA
CTD
PMID:19244175
NCBI chr 2:27,078,615...27,086,403
Ensembl chr 2:27,078,615...27,086,403
G
EML2
EMAP like 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Selenium results in increased expression of EML2 mRNA
CTD
PMID:19244175
NCBI chr19:45,609,400...45,645,629
Ensembl chr19:45,606,994...45,645,602
G
EMP2
epithelial membrane protein 2
increases expression
EXP
Selenium results in increased expression of EMP2 mRNA
CTD
PMID:19244175
NCBI chr16:10,528,422...10,580,598
Ensembl chr16:10,528,422...10,580,632
G
EMP3
epithelial membrane protein 3 (MAM blood group)
increases expression
EXP
Selenium results in increased expression of EMP3 mRNA
CTD
PMID:19244175
NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,509...48,330,553
G
EMSY
EMSY transcriptional repressor, BRCA2 interacting
decreases expression
EXP
Selenium results in decreased expression of EMSY mRNA
CTD
PMID:19244175
NCBI chr11:76,445,018...76,553,031
Ensembl chr11:76,444,923...76,553,031
G
ENDOG
endonuclease G
increases expression
EXP
Selenium results in increased expression of ENDOG mRNA
CTD
PMID:19244175
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
G
ENG
endoglin
increases expression
EXP
Selenium results in increased expression of ENG mRNA
CTD
PMID:19244175
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,815,013...127,854,658
G
ENO2
enolase 2
increases expression
EXP
Selenium results in increased expression of ENO2 mRNA
CTD
PMID:19244175
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
ENPP1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
ISO
Selenium results in decreased expression of ENPP1 mRNA
CTD
PMID:28810182
NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155
G
EOLA1
endothelium and lymphocyte associated ASCH domain 1
decreases expression
EXP
Selenium results in decreased expression of EOLA1 mRNA
CTD
PMID:19244175
NCBI chr X:149,540,601...149,555,345
Ensembl chr X:149,540,355...149,550,510
G
EPB41L4B
erythrocyte membrane protein band 4.1 like 4B
decreases expression
EXP
Selenium results in decreased expression of EPB41L4B mRNA
CTD
PMID:19244175
NCBI chr 9:109,171,974...109,321,059
Ensembl chr 9:109,171,974...109,321,059
G
EPHB6
EPH receptor B6
increases expression
EXP
Selenium results in increased expression of EPHB6 mRNA
CTD
PMID:19244175
NCBI chr 7:142,855,076...142,871,093
Ensembl chr 7:142,855,061...142,871,094
G
EPHX2
epoxide hydrolase 2
increases expression
EXP
Selenium results in increased expression of EPHX2 mRNA
CTD
PMID:19244175
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPN2
epsin 2
increases expression
EXP
Selenium results in increased expression of EPN2 mRNA
CTD
PMID:19244175
NCBI chr17:19,237,366...19,336,715
Ensembl chr17:19,215,615...19,336,715
G
ERBB2
erb-b2 receptor tyrosine kinase 2
increases expression multiple interactions
EXP
Selenium results in increased expression of ERBB2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA
CTD
PMID:19244175
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
increases expression
EXP
Selenium results in increased expression of ERCC1 mRNA
CTD
PMID:19244175
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
G
ERGIC3
ERGIC and golgi 3
increases expression
EXP
Selenium results in increased expression of ERGIC3 mRNA
CTD
PMID:19244175
NCBI chr20:35,542,078...35,557,634
Ensembl chr20:35,542,038...35,557,634
G
ESR1
estrogen receptor 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of ESR1 mRNA]
CTD
PMID:30526071
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ESRP2
epithelial splicing regulatory protein 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA
CTD
PMID:19244175
NCBI chr16:68,229,033...68,236,127
Ensembl chr16:68,229,033...68,238,102
G
ESS2
ess-2 splicing factor homolog
increases expression
EXP
Selenium results in increased expression of ESS2 mRNA
CTD
PMID:19244175
NCBI chr22:19,130,279...19,144,651
Ensembl chr22:19,130,279...19,144,684
G
EVC
EvC ciliary complex subunit 1
increases expression
EXP
Selenium results in increased expression of EVC mRNA
CTD
PMID:19244175
NCBI chr 4:5,711,201...5,829,057
Ensembl chr 4:5,711,201...5,814,305
G
EVI5
ecotropic viral integration site 5
decreases expression
EXP
Selenium results in decreased expression of EVI5 mRNA
CTD
PMID:19244175
NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,404
G
EWSR1
EWS RNA binding protein 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Selenium results in increased expression of EWSR1 mRNA
CTD
PMID:19244175
NCBI chr22:29,268,268...29,300,521
Ensembl chr22:29,268,009...29,300,525
G
EXOC3
exocyst complex component 3
increases expression
EXP
Selenium results in increased expression of SEC6 mRNA
CTD
PMID:19244175
NCBI chr 5:443,176...467,290
Ensembl chr 5:443,175...471,937
G
EXOSC4
exosome component 4
increases expression
EXP
Selenium results in increased expression of EXOSC4 mRNA
CTD
PMID:19244175
NCBI chr 8:144,064,056...144,080,648
Ensembl chr 8:144,078,648...144,080,648
G
EXOSC8
exosome component 8
decreases expression
EXP
Selenium results in decreased expression of EXOSC8 mRNA
CTD
PMID:19244175
NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881
G
EXT1
exostosin glycosyltransferase 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA
CTD
PMID:19244175
NCBI chr 8:117,794,490...118,111,826
Ensembl chr 8:117,794,490...118,111,826
G
EXT2
exostosin glycosyltransferase 2
decreases expression
EXP
Selenium results in decreased expression of EXT2 mRNA
CTD
PMID:19244175
NCBI chr11:44,095,678...44,251,962
Ensembl chr11:44,095,648...44,251,962
G
EYA2
EYA transcriptional coactivator and phosphatase 2
increases expression
EXP
Selenium results in increased expression of EYA2 mRNA
CTD
PMID:19244175
NCBI chr20:46,894,843...47,188,844
Ensembl chr20:46,894,624...47,188,844
G
EZR
ezrin
decreases expression multiple interactions
EXP
Selenium results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA
CTD
PMID:19244175
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
G
F11R
F11 receptor
increases expression
EXP
Selenium results in increased expression of F11R mRNA
CTD
PMID:19244175
NCBI chr 1:160,995,211...161,021,152
Ensembl chr 1:160,995,211...161,021,175
G
F2R
coagulation factor II thrombin receptor
decreases expression multiple interactions
EXP
Selenium results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA
CTD
PMID:19244175
NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770
G
FAAH
fatty acid amide hydrolase
increases expression
EXP
Selenium results in increased expression of FAAH mRNA
CTD
PMID:19244175
NCBI chr 1:46,394,317...46,413,845
Ensembl chr 1:46,394,317...46,413,848
G
FADD
Fas associated via death domain
multiple interactions increases expression
EXP
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FADD mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of FADD mRNA] Selenium results in increased expression of FADD protein
CTD
PMID:17970047 PMID:27920530
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
FADS3
fatty acid desaturase 3
increases expression
EXP
Selenium results in increased expression of FADS3 mRNA
CTD
PMID:19244175
NCBI chr11:61,873,526...61,892,224
Ensembl chr11:61,873,519...61,892,051
G
FAM107A
family with sequence similarity 107 member A
increases expression
EXP
Selenium results in increased expression of FAM107A mRNA
CTD
PMID:19244175
NCBI chr 3:58,564,117...58,627,610
Ensembl chr 3:58,564,117...58,627,610
G
FAM111A
FAM111 trypsin like peptidase A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA Selenium results in decreased expression of FAM111A mRNA
CTD
PMID:19244175
NCBI chr11:59,142,856...59,155,039
Ensembl chr11:59,142,748...59,155,039
G
FAM149A
family with sequence similarity 149 member A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Selenium results in decreased expression of FAM149A mRNA
CTD
PMID:19244175
NCBI chr 4:186,104,704...186,175,337
Ensembl chr 4:186,104,419...186,175,337
G
FAM32A
family with sequence similarity 32 member A
increases expression
EXP
Selenium results in increased expression of FAM32A mRNA
CTD
PMID:19244175
NCBI chr19:16,185,410...16,192,046
Ensembl chr19:16,185,380...16,192,046
G
FAM3A
FAM3 metabolism regulating signaling molecule A
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA Selenium results in increased expression of FAM3A mRNA
CTD
PMID:19244175
NCBI chr X:154,506,171...154,516,232
Ensembl chr X:154,506,159...154,516,242
G
FAM50A
family with sequence similarity 50 member A
increases expression
EXP
Selenium results in increased expression of FAM50A mRNA
CTD
PMID:19244175
NCBI chr X:154,444,141...154,450,654
Ensembl chr X:154,444,141...154,450,654
G
FAM53B
family with sequence similarity 53 member B
increases expression
EXP
Selenium results in increased expression of FAM53B mRNA
CTD
PMID:19244175
NCBI chr10:124,619,292...124,744,378
Ensembl chr10:124,619,292...124,744,378
G
FAN1
FANCD2 and FANCI associated nuclease 1
decreases expression
EXP
Selenium results in decreased expression of FAN1 mRNA
CTD
PMID:19244175
NCBI chr15:30,903,852...30,943,108
Ensembl chr15:30,890,559...30,943,108
G
FARP1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
increases expression
EXP
Selenium results in increased expression of FARP1 mRNA
CTD
PMID:19244175
NCBI chr13:98,142,589...98,455,176
Ensembl chr13:98,142,562...98,455,176
G
FARSA
phenylalanyl-tRNA synthetase subunit alpha
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Selenium results in increased expression of FARSA mRNA
CTD
PMID:19244175
NCBI chr19:12,922,479...12,933,711
Ensembl chr19:12,922,479...12,934,037
G
FAS
Fas cell surface death receptor
multiple interactions
EXP
[Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of FAS mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of FAS mRNA]
CTD
PMID:17970047 PMID:27920530
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
multiple interactions
EXP
[Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA]
CTD
PMID:27920530
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FASN
fatty acid synthase
increases expression multiple interactions
ISO EXP
Selenium results in increased expression of FASN mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]
CTD
PMID:19022953 PMID:19244175 PMID:36464106
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FAT4
FAT atypical cadherin 4
decreases expression
EXP
Selenium results in decreased expression of FAT4 mRNA
CTD
PMID:19244175
NCBI chr 4:125,314,955...125,492,932
Ensembl chr 4:125,314,918...125,492,932
G
FAXDC2
fatty acid hydroxylase domain containing 2
decreases expression
EXP
Selenium results in decreased expression of FAXDC2 mRNA
CTD
PMID:19244175
NCBI chr 5:154,818,492...154,850,603
Ensembl chr 5:154,818,492...154,859,252
G
FBLN1
fibulin 1
increases expression
EXP
Selenium results in increased expression of FBLN1 mRNA
CTD
PMID:19244175
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBLN5
fibulin 5
increases expression
EXP
Selenium results in increased expression of FBLN5 mRNA
CTD
PMID:19244175
NCBI chr14:91,869,411...91,947,694
Ensembl chr14:91,869,411...91,947,987
G
FBP1
fructose-bisphosphatase 1
increases expression
ISO
Selenium results in increased expression of FBP1 mRNA
CTD
PMID:28810182
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
G
FBXL5
F-box and leucine rich repeat protein 5
decreases expression
EXP
Selenium results in decreased expression of FBXL5 mRNA
CTD
PMID:19244175
NCBI chr 4:15,604,381...15,681,569
Ensembl chr 4:15,604,381...15,681,679
G
FBXL8
F-box and leucine rich repeat protein 8
increases expression
EXP
Selenium results in increased expression of FBXL8 mRNA
CTD
PMID:19244175
NCBI chr16:67,159,957...67,164,174
Ensembl chr16:67,159,932...67,164,570
G
FBXO11
F-box protein 11
decreases expression
EXP
Selenium results in decreased expression of FBXO11 mRNA
CTD
PMID:19244175
NCBI chr 2:47,806,920...47,906,498
Ensembl chr 2:47,789,316...47,906,498
G
FBXO17
F-box protein 17
increases expression
EXP
Selenium results in increased expression of FBXO17 mRNA
CTD
PMID:19244175
NCBI chr19:38,941,401...38,975,742
Ensembl chr19:38,941,401...38,975,742
G
FBXO2
F-box protein 2
increases expression
EXP
Selenium results in increased expression of FBXO2 mRNA
CTD
PMID:19244175
NCBI chr 1:11,648,387...11,654,429
Ensembl chr 1:11,637,018...11,655,785
G
FBXO28
F-box protein 28
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA Selenium results in decreased expression of FBXO28 mRNA
CTD
PMID:19244175
NCBI chr 1:224,114,111...224,162,047
Ensembl chr 1:224,114,111...224,162,047
G
FCGRT
Fc gamma receptor and transporter
increases expression
EXP
Selenium results in increased expression of FCGRT mRNA
CTD
PMID:19244175
NCBI chr19:49,512,661...49,526,428
Ensembl chr19:49,506,816...49,526,428
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
increases expression
ISO
Selenium deficiency results in increased expression of FDFT1 mRNA
CTD
PMID:16170372
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
G
FECH
ferrochelatase
decreases expression
EXP
Selenium results in decreased expression of FECH mRNA
CTD
PMID:19244175
NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732
G
FERMT1
FERM domain containing kindlin 1
decreases expression
EXP
Selenium results in decreased expression of FERMT1 mRNA
CTD
PMID:19244175
NCBI chr20:6,074,845...6,123,030
Ensembl chr20:6,074,845...6,123,214
G
FFAR2
free fatty acid receptor 2
increases expression
EXP
Selenium results in increased expression of FFAR2 mRNA
CTD
PMID:17293063
NCBI chr19:35,448,257...35,451,767
Ensembl chr19:35,443,907...35,451,767
G
FGG
fibrinogen gamma chain
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA
CTD
PMID:11444866
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
G
FHOD3
formin homology 2 domain containing 3
decreases expression
EXP
Selenium results in decreased expression of FHOD3 mRNA
CTD
PMID:19244175
NCBI chr18:36,297,713...36,780,220
Ensembl chr18:36,297,713...36,780,220
G
FIG4
FIG4 phosphoinositide 5-phosphatase
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Selenium results in decreased expression of FIG4 mRNA
CTD
PMID:19244175
NCBI chr 6:109,691,296...109,825,426
Ensembl chr 6:109,690,609...109,878,098
G
FIS1
fission, mitochondrial 1
increases expression
EXP
Selenium results in increased expression of FIS1 mRNA
CTD
PMID:19244175
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
FKBP1A
FKBP prolyl isomerase 1A
increases expression multiple interactions
EXP
Selenium results in increased expression of FKBP1A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA
CTD
PMID:19244175
NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
G
FKBP3
FKBP prolyl isomerase 3
decreases expression
EXP
Selenium results in decreased expression of FKBP3 mRNA
CTD
PMID:19244175
NCBI chr14:45,115,599...45,134,481
Ensembl chr14:45,115,599...45,135,319
G
FLII
FLII actin remodeling protein
increases expression
EXP
Selenium results in increased expression of FLII mRNA
CTD
PMID:19244175
NCBI chr17:18,244,815...18,259,022
Ensembl chr17:18,244,815...18,258,738
G
FLNA
filamin A
increases expression
EXP
Selenium results in increased expression of FLNA mRNA
CTD
PMID:19244175
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634
G
FLOT1
flotillin 1
increases expression
EXP
Selenium results in increased expression of FLOT1 mRNA
CTD
PMID:19244175
NCBI chr 6:30,727,709...30,742,687
Ensembl chr 6:30,727,709...30,742,732
G
FLOT2
flotillin 2
increases expression
EXP
Selenium results in increased expression of FLOT2 mRNA
CTD
PMID:19244175
NCBI chr17:28,879,339...28,897,733
Ensembl chr17:28,879,335...28,897,733
G
FLRT3
fibronectin leucine rich transmembrane protein 3
decreases expression
EXP
Selenium results in decreased expression of FLRT3 mRNA
CTD
PMID:19244175
NCBI chr20:14,322,985...14,337,612
Ensembl chr20:14,322,985...14,337,614
G
FMO5
flavin containing dimethylaniline monoxygenase 5
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA
CTD
PMID:19244175
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
G
FOLH1
folate hydrolase 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Selenium results in decreased expression of FOLH1 mRNA
CTD
PMID:19244175
NCBI chr11:49,145,092...49,208,602
Ensembl chr11:49,145,092...49,208,638
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
Selenium results in increased expression of FOS mRNA; Selenium results in increased expression of FOS protein [Selenium co-treated with Iodine] results in increased expression of FOS mRNA; [Selenium co-treated with Iodine] results in increased expression of FOS protein
CTD
PMID:12475444 PMID:12666833
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOXF2
forkhead box F2
decreases expression
EXP
Selenium results in decreased expression of FOXF2 mRNA
CTD
PMID:19244175
NCBI chr 6:1,389,576...1,395,603
Ensembl chr 6:1,389,576...1,395,603
G
FOXO1
forkhead box O1
multiple interactions
ISO
Selenium inhibits the reaction [arsenite results in decreased phosphorylation of FOXO1 protein]
CTD
PMID:29324385
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
FOXO3
forkhead box O3
multiple interactions
EXP
Selenium results in decreased phosphorylation of and results in increased activity of FOXO3 protein
CTD
PMID:17339365
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FRAT1
FRAT regulator of WNT signaling pathway 1
increases expression
EXP
Selenium results in increased expression of FRAT1 mRNA
CTD
PMID:19244175
NCBI chr10:97,319,271...97,321,915
Ensembl chr10:97,319,271...97,321,915
G
FSHB
follicle stimulating hormone subunit beta
multiple interactions
ISO
Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of FSHB protein]
CTD
PMID:20957662
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
FTL
ferritin light chain
increases expression
EXP
Selenium results in increased expression of FTL mRNA
CTD
PMID:19244175
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
FUS
FUS RNA binding protein
increases expression
EXP
Selenium results in increased expression of FUS mRNA
CTD
PMID:19244175
NCBI chr16:31,180,110...31,194,871
Ensembl chr16:31,180,138...31,191,605
G
FXR1
FMR1 autosomal homolog 1
decreases expression
EXP
Selenium results in decreased expression of FXR1 mRNA
CTD
PMID:19244175
NCBI chr 3:180,912,670...180,982,753
Ensembl chr 3:180,868,141...180,982,753
G
FZD7
frizzled class receptor 7
decreases expression
EXP
Selenium results in decreased expression of FZD7 mRNA
CTD
PMID:19244175
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
G
FZR1
fizzy and cell division cycle 20 related 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA Selenium results in increased expression of FZR1 mRNA
CTD
PMID:19244175
NCBI chr19:3,506,311...3,538,334
Ensembl chr19:3,506,311...3,538,334
G
G0S2
G0/G1 switch 2
increases expression
EXP
Selenium results in increased expression of G0S2 mRNA
CTD
PMID:17293063
NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
G
GADD45A
growth arrest and DNA damage inducible alpha
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA
CTD
PMID:19244175
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GALNT1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Selenium results in decreased expression of GALNT1 mRNA
CTD
PMID:19244175
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
G
GANAB
glucosidase II alpha subunit
increases expression
EXP
Selenium results in increased expression of GANAB mRNA
CTD
PMID:19244175
NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,826...62,646,726
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP
Selenium results in increased expression of GAPDH mRNA
CTD
PMID:19244175
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
G
GAS8
growth arrest specific 8
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Selenium results in increased expression of GAS8 mRNA
CTD
PMID:19244175
NCBI chr16:90,019,633...90,044,960
Ensembl chr16:90,019,629...90,044,975
G
GATAD2A
GATA zinc finger domain containing 2A
increases expression
EXP
Selenium results in increased expression of GATAD2A mRNA
CTD
PMID:19244175
NCBI chr19:19,385,843...19,508,932
Ensembl chr19:19,385,826...19,508,932
G
GBP1
guanylate binding protein 1
decreases expression
EXP
Selenium results in decreased expression of GBP1 mRNA
CTD
PMID:19244175
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
G
GCAT
glycine C-acetyltransferase
increases expression
EXP
Selenium results in increased expression of GCAT mRNA
CTD
PMID:19244175
NCBI chr22:37,807,934...37,817,183
Ensembl chr22:37,807,905...37,817,176
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA
CTD
PMID:11444866
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GFUS
GDP-L-fucose synthase
increases expression
EXP
Selenium results in increased expression of GFUS mRNA
CTD
PMID:19244175
NCBI chr 8:143,612,618...143,618,048
Ensembl chr 8:143,612,618...143,618,048
G
GGPS1
geranylgeranyl diphosphate synthase 1
decreases expression
EXP
Selenium results in decreased expression of GGPS1 mRNA
CTD
PMID:19244175
NCBI chr 1:235,327,216...235,344,532
Ensembl chr 1:235,327,350...235,344,532
G
GGT1
gamma-glutamyltransferase 1
multiple interactions
EXP ISO
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]
CTD
PMID:19244175 PMID:24485406
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GIPC1
GIPC PDZ domain containing family member 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA Selenium results in increased expression of GIPC1 mRNA
CTD
PMID:19244175
NCBI chr19:14,477,762...14,496,127
Ensembl chr19:14,477,760...14,496,149
G
GJB1
gap junction protein beta 1
increases expression
EXP
Selenium results in increased expression of GJB1 mRNA
CTD
PMID:19244175
NCBI chr X:71,215,239...71,225,516
Ensembl chr X:71,212,811...71,225,516
G
GLG1
golgi glycoprotein 1
decreases expression increases expression
EXP
Selenium results in decreased expression of GLG1 mRNA Selenium results in increased expression of GLG1 mRNA
CTD
PMID:19244175
NCBI chr16:74,447,440...74,607,114
Ensembl chr16:74,447,427...74,607,144
G
GLI2
GLI family zinc finger 2
increases expression
EXP
Selenium results in increased expression of GLI2 mRNA
CTD
PMID:19244175
NCBI chr 2:120,735,868...120,992,653
Ensembl chr 2:120,735,623...120,992,653
G
GLMN
glomulin, FKBP associated protein
decreases expression
EXP
Selenium results in decreased expression of GLMN mRNA
CTD
PMID:19244175
NCBI chr 1:92,246,402...92,370,844
Ensembl chr 1:92,246,402...92,298,987
G
GLRX
glutaredoxin
increases expression affects expression
ISO
Selenium deficiency results in increased expression of GLRX mRNA; Selenium results in increased expression of GLRX mRNA Selenium affects the expression of GLRX mRNA
CTD
PMID:16170372 PMID:19351701
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GLRX2
glutaredoxin 2
affects activity affects expression
ISO
Selenium affects the activity of GLRX2 protein Selenium affects the expression of GLRX2 protein
CTD
PMID:19351701
NCBI chr 1:193,096,465...193,106,114
Ensembl chr 1:193,090,866...193,106,114
G
GLUD1
glutamate dehydrogenase 1
affects expression
ISO
Selenium affects the expression of GLUD1 protein
CTD
PMID:19351701
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
G
GMNN
geminin DNA replication inhibitor
decreases expression
EXP
Selenium results in decreased expression of GMNN mRNA
CTD
PMID:19244175
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GMPPA
GDP-mannose pyrophosphorylase A
increases expression
EXP
Selenium results in increased expression of GMPPA mRNA
CTD
PMID:19244175
NCBI chr 2:219,498,891...219,506,989
Ensembl chr 2:219,498,865...219,513,898
G
GMPR2
guanosine monophosphate reductase 2
increases expression
EXP
Selenium results in increased expression of GMPR2 mRNA
CTD
PMID:19244175
NCBI chr14:24,232,622...24,239,242
Ensembl chr14:24,232,422...24,239,242
G
GNAI2
G protein subunit alpha i2
increases expression
EXP
Selenium results in increased expression of GNAI2 mRNA
CTD
PMID:19244175
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
GNAS
GNAS complex locus
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA Selenium results in decreased expression of GNAS mRNA
CTD
PMID:19244175
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
G
GNB2
G protein subunit beta 2
increases expression
EXP
Selenium results in increased expression of GNB2 mRNA
CTD
PMID:19244175
NCBI chr 7:100,673,740...100,679,169
Ensembl chr 7:100,673,567...100,679,174
G
GNL1
G protein nucleolar 1 (putative)
increases expression
EXP
Selenium results in increased expression of GNL1 mRNA
CTD
PMID:19244175
NCBI chr 6:30,541,381...30,556,489
Ensembl chr 6:30,541,381...30,556,489
G
GNMT
glycine N-methyltransferase
affects activity
ISO
Selenium affects the activity of GNMT protein
CTD
PMID:16632891
NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880
G
GNRH2
gonadotropin releasing hormone 2
increases expression
EXP
Selenium results in increased expression of GNRH2 mRNA
CTD
PMID:19244175
NCBI chr20:3,043,622...3,045,747
Ensembl chr20:3,043,622...3,045,747
G
GNS
glucosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
Selenium results in decreased expression of GNS mRNA
CTD
PMID:19244175
NCBI chr12:64,713,449...64,759,406
Ensembl chr12:64,713,445...64,759,431
G
GOLGA3
golgin A3
increases expression multiple interactions
EXP
Selenium results in increased expression of GOLGA3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA
CTD
PMID:19244175
NCBI chr12:132,768,914...132,829,081
Ensembl chr12:132,768,902...132,829,143
G
GOLGA8A
golgin A8 family member A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GOLGA8A mRNA
CTD
PMID:19244175
NCBI chr15:34,379,068...34,437,808
Ensembl chr15:34,378,935...34,437,808
G
GORASP1
golgi reassembly stacking protein 1
increases expression
EXP
Selenium results in increased expression of GORASP1 mRNA
CTD
PMID:19244175
NCBI chr 3:39,096,599...39,107,627
Ensembl chr 3:39,095,222...39,108,369
G
GOSR1
golgi SNAP receptor complex member 1
decreases expression
EXP
Selenium results in decreased expression of GOSR1 mRNA
CTD
PMID:19244175
NCBI chr17:30,477,408...30,527,592
Ensembl chr17:30,477,362...30,527,592
G
GPI
glucose-6-phosphate isomerase
increases expression
EXP
Selenium results in increased expression of GPI mRNA
CTD
PMID:19244175
NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
G
GPKOW
G-patch domain and KOW motifs
increases expression
EXP
Selenium results in increased expression of GPKOW mRNA
CTD
PMID:19244175
NCBI chr X:49,113,407...49,123,735
Ensembl chr X:49,113,407...49,123,735
G
GPR107
G protein-coupled receptor 107
increases expression
EXP
Selenium results in increased expression of GPR107 mRNA
CTD
PMID:19244175
NCBI chr 9:130,053,906...130,140,164
Ensembl chr 9:130,053,426...130,140,169
G
GPR137
G protein-coupled receptor 137
increases expression
EXP
Selenium results in increased expression of GPR137 mRNA
CTD
PMID:19244175
NCBI chr11:64,270,531...64,289,500
Ensembl chr11:64,270,062...64,289,494
G
GPR137B
G protein-coupled receptor 137B
decreases expression
EXP
Selenium results in decreased expression of GPR137B mRNA
CTD
PMID:19244175
NCBI chr 1:236,142,539...236,208,907
Ensembl chr 1:236,142,505...236,221,865
G
GPRIN2
G protein regulated inducer of neurite outgrowth 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA
CTD
PMID:19244175
NCBI chr10:46,541,736...46,557,596
Ensembl chr10:46,541,736...46,556,658
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of GPT protein]; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in increased activity of GPT protein]; Selenium inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]
CTD
PMID:20688495 PMID:24485406 PMID:30031400 PMID:36464106
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
affects response to substance decreases activity increases activity increases expression decreases expression multiple interactions affects expression affects activity
EXP ISO
GPX1 gene polymorphism affects the susceptibility to Selenium; GPX1 protein polymorphism affects the susceptibility to Selenium Selenium deficiency results in decreased activity of GPX1 protein Selenium results in increased activity of GPX1 protein Selenium results in increased expression of GPX1 mRNA; Selenium results in increased expression of GPX1 protein Selenium deficiency results in decreased expression of GPX1 mRNA; Selenium deficiency results in decreased expression of GPX1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; Selenium inhibits the reaction [2-iodohexadecanal results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [arsenite results in decreased expression of GPX1 protein]; Selenium inhibits the reaction [Cisplatin results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of GPX1 mRNA]; Selenium results in increased expression of and results in decreased degradation of GPX1 mRNA Selenium affects the expression of GPX1 mRNA Selenium affects the activity of GPX1 protein Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein]; Selenium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of GPX1 protein]; Selenium deficiency results in decreased expression of and results in decreased activity of GPX1 protein Selenium affects the expression of GPX1 mRNA; Selenium affects the expression of GPX1 protein
CTD
PMID:10874123 PMID:10949970 PMID:11294903 PMID:11444866 PMID:11463357 PMID:11776067 PMID:12031252 PMID:12667700 PMID:12810669 PMID:15203190 PMID:15203381 PMID:15670848 PMID:15792362 PMID:15795427 PMID:16170372 PMID:16837816 PMID:17052796 PMID:17109141 PMID:17150329 PMID:17512462 PMID:17513408 PMID:17709542 PMID:19022953 PMID:19076066 PMID:19106321 PMID:19125369 PMID:19234057 PMID:19415410 PMID:21775527 PMID:29324385 PMID:38013145 More...
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX2
glutathione peroxidase 2
decreases activity decreases expression
ISO
Selenium deficiency results in decreased activity of GPX2 protein Selenium deficiency results in decreased expression of GPX2 mRNA
CTD
PMID:15795427
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX3
glutathione peroxidase 3
increases expression affects activity increases activity affects expression
EXP ISO
Selenium results in increased expression of GPX3 mRNA Selenium affects the activity of GPX3 protein Selenium results in increased activity of GPX3 protein Selenium affects the expression of GPX3 mRNA
CTD
PMID:15894816 PMID:19022953 PMID:19106321 PMID:19244175 PMID:19351701
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GPX4
glutathione peroxidase 4
increases activity decreases expression multiple interactions increases expression decreases activity affects activity decreases abundance
EXP ISO
Selenium analog results in increased activity of GPX4 protein Selenium deficiency results in decreased expression of GPX4 protein Selenomethionine inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein] [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in increased expression of GPX4 protein Selenium deficiency results in decreased expression of GPX4 mRNA Selenium results in increased expression of GPX4 mRNA Selenium deficiency results in decreased activity of GPX4 protein Selenium affects the activity of GPX4 protein Selenium results in increased activity of GPX4 protein GPX4 gene mutant form results in decreased abundance of Selenium Selenium results in increased expression of and results in increased activity of GPX4 protein Selenium results in increased expression of GPX4 mRNA; Selenium results in increased expression of GPX4 protein
CTD
PMID:11673642 PMID:12031252 PMID:15670848 PMID:15792362 PMID:16246897 PMID:17052796 PMID:17150329 PMID:19022953 PMID:19106321 PMID:19244175 PMID:34116104 PMID:34970773 More...
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GPX5
glutathione peroxidase 5
affects expression
ISO
Selenium affects the expression of GPX5
CTD
PMID:10542376
NCBI chr 6:28,525,881...28,534,955
Ensembl chr 6:28,525,881...28,534,955
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
EXP
Selenium results in decreased expression of GRIA2 mRNA
CTD
PMID:19244175
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
G
GRINA
glutamate ionotropic receptor NMDA type subunit associated protein 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA Selenium results in increased expression of GRINA mRNA
CTD
PMID:19244175
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
G
GRK6
G protein-coupled receptor kinase 6
increases expression
EXP
Selenium results in increased expression of GRK6 mRNA
CTD
PMID:19244175
NCBI chr 5:177,425,523...177,442,891
Ensembl chr 5:177,403,204...177,442,901
G
GRN
granulin precursor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Selenium results in increased expression of GRN mRNA
CTD
PMID:19244175
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
GSDME
gasdermin E
decreases expression
EXP
Selenium results in decreased expression of GSDME mRNA
CTD
PMID:19244175
NCBI chr 7:24,698,355...24,795,539
Ensembl chr 7:24,698,355...24,757,940
G
GSK3A
glycogen synthase kinase 3 alpha
increases expression
EXP
Selenium results in increased expression of GSK3A mRNA
CTD
PMID:19244175
NCBI chr19:42,230,190...42,242,602
Ensembl chr19:42,226,225...42,242,625
G
GSK3B
glycogen synthase kinase 3 beta
multiple interactions decreases phosphorylation decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] Selenium results in decreased phosphorylation of GSK3B protein Selenium results in decreased expression of GSK3B mRNA
CTD
PMID:17339365 PMID:19244175
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
increases expression
EXP
Selenium results in increased expression of GSN mRNA
CTD
PMID:19244175
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSR
glutathione-disulfide reductase
multiple interactions
ISO
Selenium inhibits the reaction [cyfluthrin results in decreased activity of GSR protein]
CTD
PMID:23595963
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA5
glutathione S-transferase alpha 5
increases expression
ISO
Selenium deficiency results in increased expression of GSTA5 mRNA; Selenium deficiency results in increased expression of GSTA5 protein
CTD
PMID:9331086
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
G
GSTP1
glutathione S-transferase pi 1
multiple interactions affects expression increases expression
EXP ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA Selenium affects the expression of GSTP1 protein Selenium results in increased expression of GSTP1 mRNA
CTD
PMID:7532609 PMID:19244175
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
increases expression
ISO
Selenium deficiency results in increased expression of GSTT1
CTD
PMID:9331086
G
GTF2F1
general transcription factor IIF subunit 1
increases expression
EXP
Selenium results in increased expression of GTF2F1 mRNA
CTD
PMID:19244175
NCBI chr19:6,379,572...6,393,164
Ensembl chr19:6,379,572...6,393,981
G
GTF2H2
general transcription factor IIH subunit 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of GTF2H2 mRNA Selenium results in decreased expression of GTF2H2 mRNA
CTD
PMID:19244175
NCBI chr 5:71,035,347...71,067,676
Ensembl chr 5:71,035,016...71,067,689
G
GTF3C1
general transcription factor IIIC subunit 1
increases expression
EXP
Selenium results in increased expression of GTF3C1 mRNA
CTD
PMID:19244175
NCBI chr16:27,460,613...27,549,913
Ensembl chr16:27,459,555...27,549,913
G
GTPBP8
GTP binding protein 8 (putative)
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA Selenium results in decreased expression of GTPBP8 mRNA
CTD
PMID:19244175
NCBI chr 3:112,990,984...113,001,969
Ensembl chr 3:112,990,984...113,015,060
G
GULP1
GULP PTB domain containing engulfment adaptor 1
decreases expression
EXP
Selenium results in decreased expression of GULP1 mRNA
CTD
PMID:19244175
NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931
G
GUSBP15
GUSB pseudogene 15
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of GUSBP15 mRNA Selenium results in decreased expression of GUSBP15 mRNA
CTD
PMID:19244175
NCBI chr 5:70,481,043...70,585,722
Ensembl chr 5:70,516,387...70,555,266
G
H2AX
H2A.X variant histone
increases expression
EXP
Selenium results in increased expression of H2AX mRNA
CTD
PMID:19244175
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
H3-3A
H3.3 histone A
decreases expression
EXP
Selenium results in decreased expression of H3-3A mRNA
CTD
PMID:19244175
NCBI chr 1:226,061,831...226,072,019
Ensembl chr 1:226,061,851...226,072,019
G
H4C6
H4 clustered histone 6
decreases expression
EXP
Selenium results in decreased expression of H4C6 mRNA
CTD
PMID:19244175
NCBI chr 6:26,240,393...26,240,793
Ensembl chr 6:26,240,393...26,240,793
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA Selenium results in increased expression of H6PD mRNA
CTD
PMID:19244175
NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337
G
HADHA
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
EXP
Selenium results in decreased expression of HADHA mRNA
CTD
PMID:19244175
NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672
G
HAGH
hydroxyacylglutathione hydrolase
increases expression
EXP
Selenium results in increased expression of HAGH mRNA
CTD
PMID:19244175
NCBI chr16:1,807,629...1,827,194
Ensembl chr16:1,795,620...1,827,157
G
HARS1
histidyl-tRNA synthetase 1
increases expression
EXP
Selenium results in increased expression of HARS1 mRNA
CTD
PMID:19244175
NCBI chr 5:140,673,905...140,691,370
Ensembl chr 5:140,673,035...140,691,537
G
HAUS3
HAUS augmin like complex subunit 3
decreases expression multiple interactions
EXP
Selenium results in decreased expression of HAUS3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA
CTD
PMID:19244175
NCBI chr 4:2,228,349...2,242,121
Ensembl chr 4:2,227,464...2,242,133
G
HAUS4
HAUS augmin like complex subunit 4
increases expression
EXP
Selenium results in increased expression of HAUS4 mRNA
CTD
PMID:19244175
NCBI chr14:22,946,228...22,957,090
Ensembl chr14:22,946,228...22,957,161
G
HBA2
hemoglobin subunit alpha 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA
CTD
PMID:19244175
NCBI chr16:172,876...173,710
Ensembl chr16:172,876...173,710
G
HDGF
heparin binding growth factor
increases expression
EXP
Selenium results in increased expression of HDGF mRNA
CTD
PMID:19244175
NCBI chr 1:156,742,107...156,767,366
Ensembl chr 1:156,742,109...156,766,925
G
HDLBP
high density lipoprotein binding protein
increases expression
EXP
Selenium results in increased expression of HDLBP mRNA
CTD
PMID:19244175
NCBI chr 2:241,227,291...241,315,672
Ensembl chr 2:241,227,264...241,317,061
G
HEPH
hephaestin
decreases expression
EXP
Selenium results in decreased expression of HEPH mRNA
CTD
PMID:19244175
NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867
G
HERC2P2
HERC2 pseudogene 2
decreases expression
EXP
Selenium results in decreased expression of HERC2P2 mRNA
CTD
PMID:19244175
NCBI chr15:22,494,837...22,590,831
Ensembl chr15:22,495,570...22,579,813
G
HES1
hes family bHLH transcription factor 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of HES1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA
CTD
PMID:19244175
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
G
HGS
hepatocyte growth factor-regulated tyrosine kinase substrate
increases expression
EXP
Selenium results in increased expression of HGS mRNA
CTD
PMID:19244175
NCBI chr17:81,684,011...81,702,121
Ensembl chr17:81,683,326...81,703,138
G
HHIP
hedgehog interacting protein
increases expression
EXP
Selenium results in increased expression of HHIP mRNA
CTD
PMID:18997278
NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271
G
HIP1R
huntingtin interacting protein 1 related
increases expression
EXP
Selenium results in increased expression of HIP1R mRNA
CTD
PMID:19244175
NCBI chr12:122,834,748...122,862,961
Ensembl chr12:122,834,453...122,862,961
G
HIPK2
homeodomain interacting protein kinase 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Selenium results in decreased expression of HIPK2 mRNA
CTD
PMID:19244175
NCBI chr 7:139,561,570...139,777,998
Ensembl chr 7:139,561,570...139,777,998
G
HIRIP3
HIRA interacting protein 3
increases expression
EXP
Selenium results in increased expression of HIRIP3 mRNA
CTD
PMID:19244175
NCBI chr16:29,992,321...29,996,096
Ensembl chr16:29,992,330...29,996,074
G
HLA-B
major histocompatibility complex, class I, B
increases expression
EXP
Selenium results in increased expression of HLA-B mRNA
CTD
PMID:19244175
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-C
major histocompatibility complex, class I, C
increases expression
EXP
Selenium results in increased expression of HLA-C mRNA
CTD
PMID:19244175
NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
increases expression
EXP
Selenium results in increased expression of HLA-DPA1 mRNA
CTD
PMID:19244175
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
increases expression
EXP
Selenium results in increased expression of HLA-DQB1 mRNA
CTD
PMID:19244175
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
increases expression
EXP
Selenium results in increased expression of HLA-DRA mRNA
CTD
PMID:19244175
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
increases expression
EXP
Selenium results in increased expression of HLA-DRB3 mRNA
CTD
PMID:19244175
G
HLA-E
major histocompatibility complex, class I, E
increases expression
EXP
Selenium results in increased expression of HLA-E mRNA
CTD
PMID:19244175
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
G
HLA-F
major histocompatibility complex, class I, F
decreases expression increases expression
EXP
Selenium results in decreased expression of HLA-F mRNA Selenium results in increased expression of HLA-F mRNA
CTD
PMID:19244175
NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528
G
HLA-G
major histocompatibility complex, class I, G
increases expression
EXP
Selenium results in increased expression of HLA-G mRNA
CTD
PMID:19244175
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
HLF
HLF transcription factor, PAR bZIP family member
decreases expression
EXP
Selenium results in decreased expression of HLF mRNA
CTD
PMID:19244175
NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187
G
HMBS
hydroxymethylbilane synthase
increases expression
EXP
Selenium results in increased expression of HMBS mRNA
CTD
PMID:19244175
NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
G
HMGB1
high mobility group box 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA
CTD
PMID:19244175
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]; Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]
CTD
PMID:16581047 PMID:30031400 PMID:36464106
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMGXB3
HMG-box containing 3
increases expression
EXP
Selenium results in increased expression of HMGXB3 mRNA
CTD
PMID:19244175
NCBI chr 5:150,000,739...150,053,128
Ensembl chr 5:150,000,046...150,053,142
G
HMGXB4
HMG-box containing 4
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Selenium results in decreased expression of HMGXB4 mRNA
CTD
PMID:19244175
NCBI chr22:35,241,536...35,295,807
Ensembl chr22:35,257,452...35,295,807
G
HMOX1
heme oxygenase 1
multiple interactions increases expression affects expression affects activity
EXP ISO
[Arsenic co-treated with Selenium] results in increased expression of HMOX1 mRNA; [Arsenic co-treated with Selenium] results in increased expression of HMOX1 protein; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of HMOX1 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of HMOX1 mRNA Selenium deficiency results in increased expression of HMOX1 mRNA Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein]; Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of HMOX1 mRNA]; Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein; Selenium inhibits the reaction [Cisplatin results in increased expression of HMOX1 protein] Selenium affects the expression of HMOX1 protein Selenium affects the activity of HMOX1 protein NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] Selenium results in increased expression of HMOX1 mRNA; Selenium results in increased expression of HMOX1 protein
CTD
PMID:12751798 PMID:16837816 PMID:18279678 PMID:20478284 PMID:21481475
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HMX1
H6 family homeobox 1
increases expression
EXP
Selenium results in increased expression of HMX1 mRNA
CTD
PMID:19244175
NCBI chr 4:8,846,076...8,871,839
Ensembl chr 4:8,846,076...8,871,839
G
HNF1B
HNF1 homeobox B
increases expression
ISO
Selenium results in increased expression of HNF1B mRNA
CTD
PMID:28810182
NCBI chr17:37,686,431...37,745,059
Ensembl chr17:37,686,431...37,745,059
G
HNMT
histamine N-methyltransferase
decreases expression multiple interactions
EXP
Selenium results in decreased expression of HNMT mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA
CTD
PMID:19244175
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
G
HNRNPD
heterogeneous nuclear ribonucleoprotein D
increases expression
EXP
Selenium results in increased expression of HNRNPD mRNA
CTD
PMID:19244175
NCBI chr 4:82,352,498...82,373,991
Ensembl chr 4:82,352,498...82,374,503
G
HNRNPM
heterogeneous nuclear ribonucleoprotein M
increases expression
EXP
Selenium results in increased expression of HNRNPM mRNA
CTD
PMID:19244175
NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
G
HOMER1
homer scaffold protein 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of HOMER1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA
CTD
PMID:19244175
NCBI chr 5:79,372,636...79,514,134
Ensembl chr 5:79,372,636...79,514,134
G
HOOK1
hook microtubule tethering protein 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Selenium results in decreased expression of HOOK1 mRNA
CTD
PMID:19244175
NCBI chr 1:59,814,949...59,876,322
Ensembl chr 1:59,814,786...59,876,322
G
HPCAL1
hippocalcin like 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA Selenium results in increased expression of HPCAL1 mRNA
CTD
PMID:19244175
NCBI chr 2:10,302,904...10,427,604
Ensembl chr 2:10,302,889...10,427,617
G
HPGDS
hematopoietic prostaglandin D synthase
multiple interactions
ISO
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with rosiglitazone] results in increased expression of HPGDS protein
CTD
PMID:21669866
NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876
G
HPN
hepsin
increases expression
EXP
Selenium results in increased expression of HPN mRNA
CTD
PMID:19244175
NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
G
HRAS
HRas proto-oncogene, GTPase
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA Selenium results in increased expression of HRAS mRNA
CTD
PMID:19244175
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
G
HS3ST3A1
heparan sulfate-glucosamine 3-sulfotransferase 3A1
decreases expression
EXP
Selenium results in decreased expression of HS3ST3A1 mRNA
CTD
PMID:19244175
NCBI chr17:13,494,032...13,601,929
Ensembl chr17:13,494,032...13,601,929
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions
ISO EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of HSD11B2 protein
CTD
PMID:11444866 PMID:35384129
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSD17B11
hydroxysteroid 17-beta dehydrogenase 11
increases expression
ISO
Selenium deficiency results in increased expression of HSD17B11 mRNA; Selenium results in increased expression of HSD17B11 mRNA
CTD
PMID:16170372
NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188
G
HSD17B8
hydroxysteroid 17-beta dehydrogenase 8
increases expression
EXP
Selenium results in increased expression of HSD17B8 mRNA
CTD
PMID:19244175
NCBI chr 6:33,204,655...33,206,831
Ensembl chr 6:33,204,655...33,206,831
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
increases expression
ISO
Selenium deficiency results in increased expression of HSD3B2 mRNA; Selenium results in increased expression of HSD3B2 mRNA
CTD
PMID:16170372
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA Selenium results in decreased expression of HSP90AA1 mRNA
CTD
PMID:19244175
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
increases expression
EXP
Selenium results in increased expression of HSP90AB1 mRNA
CTD
PMID:19244175
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
G
HSP90B1
heat shock protein 90 beta family member 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Selenium results in decreased expression of HSP90B1 mRNA
CTD
PMID:19244175
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
increases expression multiple interactions
EXP
Selenium results in increased expression of HSPA1A mRNA; Selenium results in increased expression of HSPA1A protein [Selenium co-treated with Fluorides] results in increased expression of HSPA1A mRNA; Fluorides promotes the reaction [Selenium results in increased expression of HSPA1A protein]
CTD
PMID:19244175 PMID:19652462
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA4
heat shock protein family A (Hsp70) member 4
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA
CTD
PMID:19244175
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPA9
heat shock protein family A (Hsp70) member 9
decreases expression multiple interactions
EXP
Selenium results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA
CTD
PMID:19244175
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
G
HSPB1
heat shock protein family B (small) member 1
increases expression
EXP
Selenium results in increased expression of HSPB1 mRNA
CTD
PMID:19244175
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
G
HSPB2
heat shock protein family B (small) member 2
decreases expression
EXP
Selenium results in decreased expression of HSPB2 mRNA
CTD
PMID:18997278
NCBI chr11:111,912,734...111,914,093
Ensembl chr11:111,912,734...111,914,093
G
HSPBAP1
HSPB1 associated protein 1
decreases expression
EXP
Selenium results in decreased expression of HSPBAP1 mRNA
CTD
PMID:19244175
NCBI chr 3:122,739,999...122,793,831
Ensembl chr 3:122,739,999...122,793,831
G
HTR4
5-hydroxytryptamine receptor 4
increases expression
EXP
Selenium results in increased expression of HTR4 mRNA
CTD
PMID:19244175
NCBI chr 5:148,451,032...148,654,527
Ensembl chr 5:148,446,042...148,677,235
G
IARS1
isoleucyl-tRNA synthetase 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Selenium results in decreased expression of IARS1 mRNA
CTD
PMID:19244175
NCBI chr 9:92,210,207...92,293,697
Ensembl chr 9:92,210,207...92,293,854
G
ICA1
islet cell autoantigen 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Selenium results in increased expression of ICA1 mRNA
CTD
PMID:19244175
NCBI chr 7:8,113,184...8,262,555
Ensembl chr 7:8,113,184...8,262,687
G
ID1
inhibitor of DNA binding 1
increases expression
EXP
Selenium results in increased expression of ID1 mRNA
CTD
PMID:19244175
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
Selenium results in decreased expression of ID2 mRNA
CTD
PMID:19244175
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
ID2B
inhibitor of DNA binding 2B (pseudogene)
decreases expression
EXP
Selenium results in decreased expression of ID2B mRNA
CTD
PMID:19244175
NCBI chr 3:62,123,426...62,124,718
G
IDH3B
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta
increases expression
EXP
Selenium results in increased expression of IDH3B mRNA
CTD
PMID:19244175
NCBI chr20:2,658,395...2,664,216
Ensembl chr20:2,658,395...2,664,219
G
IDH3G
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Selenium results in increased expression of IDH3G mRNA
CTD
PMID:19244175
NCBI chr X:153,785,768...153,794,375
Ensembl chr X:153,785,766...153,794,512
G
IDUA
alpha-L-iduronidase
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA Selenium results in increased expression of IDUA mRNA
CTD
PMID:19244175
NCBI chr 4:986,997...1,008,351
Ensembl chr 4:986,997...1,004,564
G
IER3
immediate early response 3
increases expression
EXP
Selenium results in increased expression of IER3 mRNA
CTD
PMID:17293063
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFI35
interferon induced protein 35
increases expression
EXP
Selenium results in increased expression of IFI35 mRNA
CTD
PMID:19244175
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
G
IFI6
interferon alpha inducible protein 6
increases expression
EXP
Selenium results in increased expression of IFI6 mRNA
CTD
PMID:19244175
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
G
IFITM1
interferon induced transmembrane protein 1
increases expression
EXP
Selenium results in increased expression of IFITM1 mRNA
CTD
PMID:19244175
NCBI chr11:314,040...315,272
Ensembl chr11:310,041...315,272
G
IFITM2
interferon induced transmembrane protein 2
increases expression
EXP
Selenium results in increased expression of IFITM2 mRNA
CTD
PMID:19244175
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
G
IFITM3
interferon induced transmembrane protein 3
increases expression
EXP
Selenium results in increased expression of IFITM3 mRNA
CTD
PMID:19244175
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IFNA1
interferon alpha 1
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of IFNA1 mRNA
CTD
PMID:21481475
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
G
IFNA10
interferon alpha 10
decreases expression
EXP
Selenium results in decreased expression of IFNA10 mRNA
CTD
PMID:19244175
NCBI chr 9:21,206,181...21,207,143
Ensembl chr 9:21,206,181...21,207,143
G
IFNG
interferon gamma
decreases expression
ISO
Selenium results in decreased expression of IFNG protein
CTD
PMID:14624943
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IFRD2
interferon related developmental regulator 2
increases expression
EXP
Selenium results in increased expression of IFRD2 mRNA
CTD
PMID:19244175
NCBI chr 3:50,287,732...50,292,429
Ensembl chr 3:50,287,732...50,292,918
G
IFT74
intraflagellar transport 74
decreases expression multiple interactions
EXP
Selenium results in decreased expression of IFT74 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA
CTD
PMID:19244175
NCBI chr 9:26,947,110...27,066,134
Ensembl chr 9:26,947,039...27,066,134
G
IFT81
intraflagellar transport 81
decreases expression
EXP
Selenium results in decreased expression of IFT81 mRNA
CTD
PMID:19244175
NCBI chr12:110,124,357...110,218,793
Ensembl chr12:110,124,335...110,218,793
G
IGF2R
insulin like growth factor 2 receptor
decreases expression
EXP
Selenium results in decreased expression of IGF2R mRNA
CTD
PMID:19244175
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IGFBP2
insulin like growth factor binding protein 2
increases expression
EXP
Selenium results in increased expression of IGFBP2 mRNA
CTD
PMID:19244175
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IGFBP3
insulin like growth factor binding protein 3
increases expression
EXP
Selenium results in increased expression of IGFBP3 mRNA; Selenium results in increased expression of IGFBP3 protein
CTD
PMID:15318950 PMID:18997278
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IGFBP4
insulin like growth factor binding protein 4
increases expression
EXP
Selenium results in increased expression of IGFBP4 mRNA
CTD
PMID:19244175
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFBP6
insulin like growth factor binding protein 6
increases expression
EXP
Selenium results in increased expression of IGFBP6 mRNA
CTD
PMID:19244175
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
G
IGHM
immunoglobulin heavy constant mu
increases expression
EXP
Selenium results in increased expression of IGHM mRNA
CTD
PMID:19244175
NCBI chr14:105,851,966...105,856,217
Ensembl chr14:105,851,705...105,856,218
G
IK
IK cytokine
increases expression
EXP
Selenium results in increased expression of IK mRNA
CTD
PMID:19244175
NCBI chr 5:140,647,829...140,662,480
Ensembl chr 5:140,647,058...140,662,480
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO EXP
Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of IKBKB protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IKBKB mRNA
CTD
PMID:17439952 PMID:21481475
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IL10
interleukin 10
multiple interactions
ISO EXP
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL10 protein] [Drugs, Chinese Herbal co-treated with Selenium] results in increased expression of IL10 mRNA [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL10 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL10 mRNA
CTD
PMID:15862027 PMID:21481475 PMID:24626144 PMID:26089086
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17RC
interleukin 17 receptor C
increases expression
EXP
Selenium results in increased expression of IL17RC mRNA
CTD
PMID:19244175
NCBI chr 3:9,917,098...9,933,621
Ensembl chr 3:9,917,074...9,933,630
G
IL1B
interleukin 1 beta
multiple interactions increases expression
EXP ISO
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL1B mRNA; Selenium affects the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium inhibits the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium promotes the reaction [T-2 Toxin results in increased expression of IL1B protein] Selenium deficiency results in increased expression of IL1B mRNA [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA] Selenium results in increased expression of IL1B mRNA
CTD
PMID:10802230 PMID:17293063 PMID:17630198 PMID:18196609 PMID:21481475 PMID:21775527 PMID:25187657 More...
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R2
interleukin 1 receptor type 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1R2 mRNA
CTD
PMID:21481475
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL1RAPL2
interleukin 1 receptor accessory protein like 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RAPL2 mRNA
CTD
PMID:21481475
NCBI chr X:104,566,199...105,767,829
Ensembl chr X:104,566,199...105,767,829
G
IL1RL2
interleukin 1 receptor like 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RL2 mRNA
CTD
PMID:21481475
NCBI chr 2:102,186,973...102,243,086
Ensembl chr 2:102,187,006...102,240,002
G
IL1RN
interleukin 1 receptor antagonist
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RN mRNA
CTD
PMID:21481475
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
affects expression
ISO
Selenium affects the expression of IL2 protein
CTD
PMID:19035182
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL37
interleukin 37
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL37 mRNA
CTD
PMID:21481475
NCBI chr 2:112,911,165...112,918,882
Ensembl chr 2:112,911,165...112,918,882
G
IL4
interleukin 4
decreases expression multiple interactions
ISO
Selenium results in decreased expression of IL4 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; [Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of TNF mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein
CTD
PMID:14624943 PMID:15862027 PMID:21775527
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA Selenium results in increased expression of IL4R mRNA
CTD
PMID:19244175
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
multiple interactions
EXP ISO
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL6 mRNA Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL6 protein]
CTD
PMID:21481475 PMID:26089086
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6ST
interleukin 6 cytokine family signal transducer
decreases expression
EXP
Selenium results in decreased expression of IL6ST mRNA
CTD
PMID:19244175
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
ILF3
interleukin enhancer binding factor 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA
CTD
PMID:19244175
NCBI chr19:10,654,346...10,692,400
Ensembl chr19:10,654,304...10,692,400
G
ILK
integrin linked kinase
increases expression
EXP
Selenium results in increased expression of ILK mRNA
CTD
PMID:19244175
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
G
ILRUN
inflammation and lipid regulator with UBA-like and NBR1-like domains
increases expression
EXP
Selenium results in increased expression of ILRUN mRNA
CTD
PMID:19244175
NCBI chr 6:34,587,288...34,696,767
Ensembl chr 6:34,587,288...34,696,859
G
INPP5K
inositol polyphosphate-5-phosphatase K
increases expression
EXP
Selenium results in increased expression of INPP5K mRNA
CTD
PMID:19244175
NCBI chr17:1,494,577...1,516,612
Ensembl chr17:1,494,577...1,516,742
G
INS
insulin
multiple interactions
EXP
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein]
CTD
PMID:27920530
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions
ISO
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein
CTD
PMID:20108212
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
INTS1
integrator complex subunit 1
increases expression
EXP
Selenium results in increased expression of INTS1 mRNA
CTD
PMID:19244175
NCBI chr 7:1,470,277...1,504,389
Ensembl chr 7:1,470,277...1,504,389
G
INTS15
integrator complex subunit 15
increases expression
EXP
Selenium results in increased expression of INTS15 mRNA
CTD
PMID:19244175
NCBI chr 7:6,590,021...6,608,726
Ensembl chr 7:6,590,021...6,608,726
G
INTS3
integrator complex subunit 3
increases expression
EXP
Selenium results in increased expression of INTS3 mRNA
CTD
PMID:19244175
NCBI chr 1:153,728,050...153,774,808
Ensembl chr 1:153,728,050...153,774,808
G
INTS6
integrator complex subunit 6
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA Selenium results in decreased expression of INTS6 mRNA
CTD
PMID:19244175
NCBI chr13:51,334,405...51,453,036
Ensembl chr13:51,354,077...51,454,264
G
IQCB1
IQ motif containing B1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA Selenium results in decreased expression of IQCB1 mRNA
CTD
PMID:19244175
NCBI chr 3:121,769,761...121,835,060
Ensembl chr 3:121,769,761...121,835,079
G
IQCK
IQ motif containing K
decreases expression multiple interactions
EXP
Selenium results in decreased expression of IQCK mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IQCK mRNA
CTD
PMID:19244175
NCBI chr16:19,718,271...19,858,467
Ensembl chr16:19,716,456...19,858,467
G
IRAK2
interleukin 1 receptor associated kinase 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IRAK2 mRNA
CTD
PMID:21481475
NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745
G
IRF3
interferon regulatory factor 3
increases expression
EXP
Selenium results in increased expression of IRF3 mRNA
CTD
PMID:19244175
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
G
IRF9
interferon regulatory factor 9
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of IRF9 mRNA Selenium results in increased expression of IRF9 mRNA
CTD
PMID:19244175
NCBI chr14:24,161,265...24,166,565
Ensembl chr14:24,161,234...24,168,043
G
ISYNA1
inositol-3-phosphate synthase 1
increases expression
EXP
Selenium results in increased expression of ISYNA1 mRNA
CTD
PMID:19244175
NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,167
G
ITGA3
integrin subunit alpha 3
increases expression multiple interactions
EXP
Selenium results in increased expression of ITGA3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ITGA3 mRNA
CTD
PMID:19244175
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGAE
integrin subunit alpha E
decreases expression
EXP
Selenium results in decreased expression of ITGAE mRNA
CTD
PMID:19244175
NCBI chr17:3,714,628...3,801,188
Ensembl chr17:3,714,628...3,801,188
G
ITM2C
integral membrane protein 2C
increases expression
EXP
Selenium results in increased expression of ITM2C mRNA
CTD
PMID:19244175
NCBI chr 2:230,864,185...230,879,254
Ensembl chr 2:230,864,639...230,879,248
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Iodine] results in increased expression of JUN mRNA; [Selenium co-treated with Iodine] results in increased expression of JUN protein Selenium results in increased expression of JUN mRNA; Selenium results in increased expression of JUN protein
CTD
PMID:12475444 PMID:12666833
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KANSL2
KAT8 regulatory NSL complex subunit 2
decreases expression
EXP
Selenium results in decreased expression of KANSL2 mRNA
CTD
PMID:19244175
NCBI chr12:48,653,211...48,682,238
Ensembl chr12:48,653,211...48,682,238
G
KAT5
lysine acetyltransferase 5
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of KAT5 mRNA
CTD
PMID:19244175
NCBI chr11:65,712,018...65,719,604
Ensembl chr11:65,711,996...65,719,604
G
KCNJ15
potassium inwardly rectifying channel subfamily J member 15
increases expression
EXP
Selenium results in increased expression of KCNJ15 mRNA
CTD
PMID:17293063
NCBI chr21:38,229,926...38,307,357
Ensembl chr21:38,155,549...38,307,357
G
KCTD17
potassium channel tetramerization domain containing 17
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of KCTD17 mRNA Selenium results in increased expression of KCTD17 mRNA
CTD
PMID:19244175
NCBI chr22:37,051,742...37,063,390
Ensembl chr22:37,051,739...37,063,390
G
KDM6B
lysine demethylase 6B
increases expression
EXP
Selenium results in increased expression of KDM6B mRNA
CTD
PMID:19244175
NCBI chr17:7,834,217...7,854,796
Ensembl chr17:7,834,217...7,854,796
G
KEAP1
kelch like ECH associated protein 1
increases expression
EXP
Selenium results in increased expression of KEAP1 mRNA
CTD
PMID:19244175
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KIAA0040
KIAA0040
increases expression
EXP
Selenium results in increased expression of KIAA0040 mRNA
CTD
PMID:19244175
NCBI chr 1:175,156,986...175,192,987
Ensembl chr 1:175,156,986...175,192,999
G
KIF1C
kinesin family member 1C
increases expression
EXP
Selenium results in increased expression of KIF1C mRNA
CTD
PMID:19244175
NCBI chr17:4,997,950...5,028,401
Ensembl chr17:4,997,950...5,028,401
G
KIF5C
kinesin family member 5C
decreases expression
EXP
Selenium results in decreased expression of KIF5C mRNA
CTD
PMID:19244175
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
G
KL
klotho
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of KL mRNA
CTD
PMID:19244175
NCBI chr13:33,016,243...33,066,143
Ensembl chr13:33,016,423...33,066,143
G
KLF12
KLF transcription factor 12
increases expression
EXP
Selenium results in increased expression of KLF12 mRNA
CTD
PMID:17293063
NCBI chr13:73,686,089...74,306,045
Ensembl chr13:73,686,089...74,134,404
G
KLF6
KLF transcription factor 6
increases expression
EXP
Selenium results in increased expression of KLF6 mRNA
CTD
PMID:19244175
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
G
KLF9
KLF transcription factor 9
decreases expression
EXP
Selenium results in decreased expression of KLF9 mRNA
CTD
PMID:19244175
NCBI chr 9:70,384,604...70,414,657
Ensembl chr 9:70,384,604...70,414,657
G
KLHDC10
kelch domain containing 10
decreases expression
EXP
Selenium results in decreased expression of KLHDC10 mRNA
CTD
PMID:19244175
NCBI chr 7:130,070,534...130,135,705
Ensembl chr 7:130,070,534...130,135,705
G
KLHL20
kelch like family member 20
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of KLHL20 mRNA Selenium results in decreased expression of KLHL20 mRNA
CTD
PMID:19244175
NCBI chr 1:173,714,981...173,786,692
Ensembl chr 1:173,714,941...173,786,692
G
KLHL24
kelch like family member 24
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of KLHL24 mRNA
CTD
PMID:19244175
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
G
KLHL9
kelch like family member 9
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA
CTD
PMID:19244175
NCBI chr 9:21,329,665...21,335,404
Ensembl chr 9:21,329,665...21,335,404
G
KLK3
kallikrein related peptidase 3
decreases expression
EXP
Selenium results in decreased expression of KLK3 mRNA; Selenium results in decreased expression of KLK3 protein
CTD
PMID:14729601
NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
G
KMT2B
lysine methyltransferase 2B
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of KMT2B mRNA Selenium results in increased expression of KMT2B mRNA
CTD
PMID:19244175
NCBI chr19:35,718,003...35,738,878
Ensembl chr19:35,717,973...35,738,880
G
KPNA1
karyopherin subunit alpha 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of KPNA1 mRNA Selenium results in decreased expression of KPNA1 mRNA
CTD
PMID:19244175
NCBI chr 3:122,421,902...122,514,939
Ensembl chr 3:122,421,902...122,514,945
G
KPNA6
karyopherin subunit alpha 6
increases expression
EXP
Selenium results in increased expression of KPNA6 mRNA
CTD
PMID:19244175
NCBI chr 1:32,108,056...32,176,563
Ensembl chr 1:32,108,056...32,176,563
G
KPNB1
karyopherin subunit beta 1
multiple interactions increases expression decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of KPNB1 mRNA Selenium results in increased expression of KPNB1 mRNA Selenium results in decreased expression of KPNB1 mRNA
CTD
PMID:19244175
NCBI chr17:47,649,919...47,685,505
Ensembl chr17:47,649,476...47,685,505
G
KRR1
KRR1 small subunit processome component homolog
decreases expression
EXP
Selenium results in decreased expression of KRR1 mRNA
CTD
PMID:19244175
NCBI chr12:75,490,863...75,511,609
Ensembl chr12:75,490,863...75,511,636
G
KRT17
keratin 17
increases expression
EXP
Selenium results in increased expression of KRT17 mRNA
CTD
PMID:19244175
NCBI chr17:41,619,442...41,624,575
Ensembl chr17:41,619,442...41,624,842
G
KRT18
keratin 18
increases expression
EXP
Selenium results in increased expression of KRT18 mRNA
CTD
PMID:19244175
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
KRT19
keratin 19
increases expression
EXP
Selenium results in increased expression of KRT19 mRNA
CTD
PMID:19244175
NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308
G
KRT7
keratin 7
increases expression
EXP
Selenium results in increased expression of KRT7 mRNA
CTD
PMID:19244175
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
KRT8
keratin 8
increases expression
EXP
Selenium results in increased expression of KRT8 mRNA
CTD
PMID:19244175
NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954
G
KTN1
kinectin 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of KTN1 mRNA Selenium results in decreased expression of KTN1 mRNA
CTD
PMID:19244175
NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526
G
LAMB3
laminin subunit beta 3
increases expression
EXP
Selenium results in increased expression of LAMB3 mRNA
CTD
PMID:19244175
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
G
LAMP1
lysosomal associated membrane protein 1
increases expression
EXP
Selenium results in increased expression of LAMP1 mRNA
CTD
PMID:19244175
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
G
LARP4B
La ribonucleoprotein 4B
increases expression
EXP
Selenium results in increased expression of LARP4B mRNA
CTD
PMID:19244175
NCBI chr10:806,914...988,341
Ensembl chr10:806,933...931,821
G
LBHD1
LBH domain containing 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of LBHD1 mRNA Selenium results in decreased expression of LBHD1 mRNA
CTD
PMID:19244175
NCBI chr11:62,662,817...62,672,267
Ensembl chr11:62,662,817...62,672,267
G
LCAT
lecithin-cholesterol acyltransferase
multiple interactions
ISO
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA]
CTD
PMID:30031400
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LDLR
low density lipoprotein receptor
multiple interactions increases expression increases activity decreases activity decreases expression
ISO
Selenium inhibits the reaction [Cholesterol results in decreased activity of LDLR protein]; Selenium inhibits the reaction [Cholesterol results in decreased expression of LDLR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA] Selenium results in increased expression of LDLR mRNA Selenium results in increased activity of LDLR protein Selenium deficiency results in decreased activity of LDLR protein Selenium deficiency results in decreased expression of LDLR mRNA
CTD
PMID:16271152 PMID:16317514 PMID:16937255 PMID:36464106
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LDLRAD4
low density lipoprotein receptor class A domain containing 4
increases expression
EXP
Selenium results in increased expression of LDLRAD4 mRNA
CTD
PMID:19244175
NCBI chr18:13,217,682...13,652,754
Ensembl chr18:13,217,498...13,652,755
G
LDLRAP1
low density lipoprotein receptor adaptor protein 1
increases expression
EXP
Selenium results in increased expression of ARH mRNA
CTD
PMID:19244175
NCBI chr 1:25,543,606...25,590,400
Ensembl chr 1:25,543,606...25,568,886
G
LEP
leptin
decreases abundance
EXP
LEP gene mutant form results in decreased abundance of Selenium
CTD
PMID:10965932
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LHB
luteinizing hormone subunit beta
multiple interactions
ISO
Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of LHB protein]
CTD
PMID:20957662
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
LIMCH1
LIM and calponin homology domains 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA Selenium results in decreased expression of LIMCH1 mRNA
CTD
PMID:19244175
NCBI chr 4:41,359,607...41,700,044
Ensembl chr 4:41,359,607...41,700,044
G
LIME1
Lck interacting transmembrane adaptor 1
increases expression
EXP
Selenium results in increased expression of LIME1 mRNA
CTD
PMID:19244175
NCBI chr20:63,735,701...63,739,103
Ensembl chr20:63,736,283...63,739,103
G
LIPT1
lipoyltransferase 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of LIPT1 mRNA Selenium results in decreased expression of LIPT1 mRNA
CTD
PMID:19244175
NCBI chr 2:99,154,967...99,163,137
Ensembl chr 2:99,154,955...99,163,157
G
LITAF
lipopolysaccharide induced TNF factor
increases expression
EXP
Selenium results in increased expression of LITAF mRNA
CTD
PMID:19244175
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
LMAN2
lectin, mannose binding 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of LMAN2 mRNA Selenium results in increased expression of LMAN2 mRNA
CTD
PMID:19244175
NCBI chr 5:177,331,567...177,351,668
Ensembl chr 5:177,315,805...177,351,840
G
LMNA
lamin A/C
increases expression
EXP
Selenium results in increased expression of LMNA mRNA
CTD
PMID:19244175
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,573...156,140,081
G
LPAR1
lysophosphatidic acid receptor 1
increases expression
EXP
Selenium results in increased expression of LPAR1 mRNA
CTD
PMID:19244175
NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470
G
LPAR2
lysophosphatidic acid receptor 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA
CTD
PMID:19244175
NCBI chr19:19,623,655...19,628,220
Ensembl chr19:19,623,655...19,628,930
G
LPIN1
lipin 1
decreases expression multiple interactions
EXP ISO
Selenium results in decreased expression of LPIN1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]
CTD
PMID:19244175 PMID:36464106
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
LRP8
LDL receptor related protein 8
affects response to substance affects abundance increases uptake
ISO
LRP8 protein affects the susceptibility to Selenium LRP8 protein affects the abundance of Selenium LRP8 protein results in increased uptake of Selenium
CTD
PMID:17314095 PMID:17553992 PMID:18172410 PMID:19007311
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LRRC41
leucine rich repeat containing 41
increases expression
EXP
Selenium results in increased expression of LRRC41 mRNA
CTD
PMID:19244175
NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616
G
LRRC47
leucine rich repeat containing 47
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of LRRC47 mRNA
CTD
PMID:19244175
NCBI chr 1:3,778,559...3,796,498
Ensembl chr 1:3,778,559...3,796,498
G
LRRFIP1
LRR binding FLII interacting protein 1
decreases expression
EXP
Selenium results in decreased expression of LRRFIP1 mRNA
CTD
PMID:19244175
NCBI chr 2:237,627,587...237,781,643
Ensembl chr 2:237,627,587...237,813,682
G
LSP1
lymphocyte specific protein 1
increases expression
EXP
Selenium results in increased expression of LSP1 mRNA
CTD
PMID:19244175
NCBI chr11:1,853,084...1,892,263
Ensembl chr11:1,850,904...1,892,267
G
LSR
lipolysis stimulated lipoprotein receptor
increases expression
EXP
Selenium results in increased expression of LSR mRNA
CTD
PMID:19244175
NCBI chr19:35,249,002...35,267,964
Ensembl chr19:35,248,330...35,267,964
G
LTBP3
latent transforming growth factor beta binding protein 3
increases expression
EXP
Selenium results in increased expression of LTBP3 mRNA
CTD
PMID:19244175
NCBI chr11:65,538,559...65,558,359
Ensembl chr11:65,538,559...65,558,930
G
LTBP4
latent transforming growth factor beta binding protein 4
increases expression
EXP
Selenium results in increased expression of LTBP4 mRNA
CTD
PMID:19244175
NCBI chr19:40,593,166...40,629,820
Ensembl chr19:40,592,883...40,629,818
G
LTBR
lymphotoxin beta receptor
increases expression
EXP
Selenium results in increased expression of LTBR mRNA
CTD
PMID:19244175
NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571
G
LUC7L2
LUC7 like 2, pre-mRNA splicing factor
decreases expression
EXP
Selenium results in decreased expression of LUC7L2 mRNA
CTD
PMID:19244175
NCBI chr 7:139,340,472...139,423,454
Ensembl chr 7:139,340,359...139,423,457
G
LUC7L3
LUC7 like 3 pre-mRNA splicing factor
decreases expression
EXP
Selenium results in decreased expression of LUC7L3 mRNA
CTD
PMID:19244175
NCBI chr17:50,719,603...50,756,219
Ensembl chr17:50,719,565...50,756,219
G
LY6E
lymphocyte antigen 6 family member E
increases expression
EXP
Selenium results in increased expression of LY6E mRNA
CTD
PMID:19244175
NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832
G
LYPLA1
lysophospholipase 1
decreases expression
EXP
Selenium results in decreased expression of LYPLA1 mRNA
CTD
PMID:19244175
NCBI chr 8:54,046,367...54,101,947
Ensembl chr 8:54,046,367...54,102,017
G
LYPLA2
lysophospholipase 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of LYPLA2 mRNA Selenium results in increased expression of LYPLA2 mRNA
CTD
PMID:19244175
NCBI chr 1:23,791,145...23,795,539
Ensembl chr 1:23,791,145...23,795,539
G
MACF1
microtubule actin crosslinking factor 1
decreases expression
EXP
Selenium results in decreased expression of MACF1 mRNA
CTD
PMID:19244175
NCBI chr 1:39,084,167...39,487,138
Ensembl chr 1:39,081,316...39,487,177
G
MACIR
macrophage immunometabolism regulator
decreases expression
EXP
Selenium results in decreased expression of MACIR mRNA
CTD
PMID:19244175
NCBI chr 5:103,258,374...103,278,660
Ensembl chr 5:103,258,763...103,278,660
G
MACROH2A2
macroH2A.2 histone
increases expression
EXP
Selenium results in increased expression of MACROH2A2 mRNA
CTD
PMID:19244175
NCBI chr10:70,052,846...70,112,282
Ensembl chr10:70,052,544...70,112,282
G
MAGED2
MAGE family member D2
increases expression
EXP
Selenium results in increased expression of MAGED2 mRNA
CTD
PMID:19244175
NCBI chr X:54,807,745...54,816,015
Ensembl chr X:54,807,599...54,816,015
G
MAGI2
membrane associated guanylate kinase, WW and PDZ domain containing 2
decreases expression
EXP
Selenium results in decreased expression of MAGI2 mRNA
CTD
PMID:19244175
NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667
G
MALL
mal, T cell differentiation protein like
increases expression
EXP
Selenium results in increased expression of MALL mRNA
CTD
PMID:19244175
NCBI chr 2:110,083,870...110,118,139
Ensembl chr 2:110,083,870...110,116,022
G
MALT1
MALT1 paracaspase
decreases expression
EXP
Selenium results in decreased expression of MALT1 mRNA
CTD
PMID:19244175
NCBI chr18:58,671,465...58,754,477
Ensembl chr18:58,671,465...58,754,477
G
MAN1B1
mannosidase alpha class 1B member 1
increases expression
EXP
Selenium results in increased expression of MAN1B1 mRNA
CTD
PMID:19244175
NCBI chr 9:137,086,985...137,109,183
Ensembl chr 9:137,086,857...137,109,189
G
MAN2B1
mannosidase alpha class 2B member 1
increases expression
EXP
Selenium results in increased expression of MAN2B1 mRNA
CTD
PMID:19244175
NCBI chr19:12,646,512...12,666,742
Ensembl chr19:12,646,511...12,666,742
G
MAP2K2
mitogen-activated protein kinase kinase 2
increases expression
EXP
Selenium results in increased expression of MAP2K2 mRNA
CTD
PMID:19244175
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
G
MAP2K3
mitogen-activated protein kinase kinase 3
increases expression
EXP
Selenium results in increased expression of MAP2K3 mRNA
CTD
PMID:19244175
NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
decreases expression
EXP
Selenium results in decreased expression of MAP3K5 mRNA
CTD
PMID:19244175
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
decreases expression
EXP
Selenium results in decreased expression of MAP3K7 mRNA
CTD
PMID:19244175
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA Selenium results in decreased expression of MAP3K8 mRNA
CTD
PMID:19244175
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
MAP4
microtubule associated protein 4
increases expression
EXP
Selenium results in increased expression of MAP4 mRNA
CTD
PMID:19244175
NCBI chr 3:47,850,695...48,088,848
Ensembl chr 3:47,850,690...48,089,272
G
MAP4K5
mitogen-activated protein kinase kinase kinase kinase 5
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MAP4K5 mRNA
CTD
PMID:11444866
NCBI chr14:50,418,521...50,561,126
Ensembl chr14:50,418,501...50,561,126
G
MAP7D1
MAP7 domain containing 1
increases expression
EXP
Selenium results in increased expression of MAP7D1 mRNA
CTD
PMID:19244175
NCBI chr 1:36,156,160...36,180,849
Ensembl chr 1:36,155,579...36,180,849
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
Selenium results in increased phosphorylation of and results in increased activity of MAPK1 protein
CTD
PMID:17997286
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK11
mitogen-activated protein kinase 11
increases expression
EXP
Selenium results in increased expression of MAPK11 mRNA
CTD
PMID:19244175
NCBI chr22:50,263,713...50,270,380
Ensembl chr22:50,263,713...50,270,767
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
Selenium results in increased phosphorylation of and results in increased activity of MAPK3 protein Selenium inhibits the reaction [arsenite results in decreased expression of MAPK3 protein]
CTD
PMID:17997286 PMID:29324385
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
decreases phosphorylation decreases expression multiple interactions
ISO EXP
Selenium results in decreased phosphorylation of MAPK8 protein Selenium results in decreased expression of MAPK8 mRNA Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]
CTD
PMID:17997286 PMID:26187450 PMID:28810182
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions
EXP
Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]
CTD
PMID:26187450
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
G
MAPT
microtubule associated protein tau
multiple interactions
ISO
Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of MAPT protein modified form]
CTD
PMID:30695686
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
G
MARCHF2
membrane associated ring-CH-type finger 2
increases expression
EXP
Selenium results in increased expression of MARCHF2 mRNA
CTD
PMID:19244175
NCBI chr19:8,413,305...8,439,017
Ensembl chr19:8,413,270...8,439,017
G
MARCHF6
membrane associated ring-CH-type finger 6
decreases expression
EXP
Selenium results in decreased expression of MARCHF6 mRNA
CTD
PMID:19244175
NCBI chr 5:10,353,695...10,440,388
Ensembl chr 5:10,353,695...10,440,388
G
MARCKS
myristoylated alanine rich protein kinase C substrate
increases expression
EXP
Selenium results in increased expression of MARCKS mRNA
CTD
PMID:19244175
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MAU2
MAU2 sister chromatid cohesion factor
decreases expression
EXP
Selenium results in decreased expression of MAU2 mRNA
CTD
PMID:19244175
NCBI chr19:19,320,829...19,358,754
Ensembl chr19:19,320,829...19,358,754
G
MAX
MYC associated factor X
increases expression
EXP
Selenium results in increased expression of MAX mRNA
CTD
PMID:19244175
NCBI chr14:65,006,101...65,102,695
Ensembl chr14:65,006,174...65,102,695
G
MAZ
MYC associated zinc finger protein
increases expression
EXP
Selenium results in increased expression of MAZ mRNA
CTD
PMID:19244175
NCBI chr16:29,806,124...29,811,164
Ensembl chr16:29,806,106...29,811,164
G
MBD1
methyl-CpG binding domain protein 1
decreases expression
EXP
Selenium results in decreased expression of MBD1 mRNA
CTD
PMID:19244175
NCBI chr18:50,266,885...50,281,767
Ensembl chr18:50,266,882...50,281,774
G
MBD3
methyl-CpG binding domain protein 3
increases expression
EXP
Selenium results in increased expression of MBD3 mRNA
CTD
PMID:19244175
NCBI chr19:1,573,596...1,592,865
Ensembl chr19:1,573,596...1,592,865
G
MBD4
methyl-CpG binding domain 4, DNA glycosylase
decreases expression
EXP
Selenium results in decreased expression of MBD4 mRNA
CTD
PMID:19244175
NCBI chr 3:129,430,947...129,439,948
Ensembl chr 3:129,430,947...129,440,179
G
MBNL1
muscleblind like splicing regulator 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of MBNL1 mRNA Selenium results in decreased expression of MBNL1 mRNA
CTD
PMID:19244175
NCBI chr 3:152,243,632...152,465,780
Ensembl chr 3:152,243,828...152,465,780
G
MBP
myelin basic protein
multiple interactions
ISO
Selenium inhibits the reaction [Iodine results in decreased expression of MBP mRNA]
CTD
PMID:16229266
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
decreases expression
EXP
Selenium results in decreased expression of MCCC1 mRNA
CTD
PMID:19244175
NCBI chr 3:183,015,218...183,116,196
Ensembl chr 3:183,015,218...183,116,075
G
MCF2L
MCF.2 cell line derived transforming sequence like
increases expression
EXP
Selenium results in increased expression of MCF2L mRNA
CTD
PMID:19244175
NCBI chr13:112,894,335...113,099,742
Ensembl chr13:112,894,378...113,099,742
G
MCM5
minichromosome maintenance complex component 5
increases expression
EXP
Selenium results in increased expression of MCM5 mRNA
CTD
PMID:19244175
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
G
MCM7
minichromosome maintenance complex component 7
increases expression
EXP
Selenium results in increased expression of MCM7 mRNA
CTD
PMID:19244175
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
G
MCRS1
microspherule protein 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MCRS1 mRNA Selenium results in increased expression of MCRS1 mRNA
CTD
PMID:19244175
NCBI chr12:49,558,299...49,568,142
Ensembl chr12:49,556,544...49,568,145
G
MDK
midkine
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA Selenium results in increased expression of MDK mRNA
CTD
PMID:19244175
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MDM1
Mdm1 nuclear protein
decreases expression multiple interactions
EXP
Selenium results in decreased expression of MDM1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MDM1 mRNA
CTD
PMID:19244175
NCBI chr12:68,294,566...68,332,362
Ensembl chr12:68,272,443...68,332,381
G
ME1
malic enzyme 1
decreases expression
EXP
Selenium results in decreased expression of ME1 mRNA
CTD
PMID:19244175
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MED13L
mediator complex subunit 13L
decreases expression
EXP
Selenium results in decreased expression of MED13L mRNA
CTD
PMID:19244175
NCBI chr12:115,958,576...116,277,693
Ensembl chr12:115,957,905...116,277,693
G
MED15
mediator complex subunit 15
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MED15 mRNA Selenium results in increased expression of MED15 mRNA
CTD
PMID:19244175
NCBI chr22:20,507,610...20,587,619
Ensembl chr22:20,495,913...20,587,632
G
MED24
mediator complex subunit 24
increases expression
EXP
Selenium results in increased expression of MED24 mRNA
CTD
PMID:19244175
NCBI chr17:40,019,104...40,054,408
Ensembl chr17:40,019,097...40,061,215
G
METAP2
methionyl aminopeptidase 2
decreases expression
EXP
Selenium results in decreased expression of METAP2 mRNA
CTD
PMID:19244175
NCBI chr12:95,474,152...95,515,839
Ensembl chr12:95,473,520...95,515,839
G
MFAP2
microfibril associated protein 2
increases expression
EXP
Selenium results in increased expression of MFAP2 mRNA
CTD
PMID:19244175
NCBI chr 1:16,974,502...16,981,583
Ensembl chr 1:16,974,502...16,980,632
G
MFGE8
milk fat globule EGF and factor V/VIII domain containing
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MFGE8 mRNA
CTD
PMID:19244175
NCBI chr15:88,898,683...88,913,379
Ensembl chr15:88,898,683...88,913,468
G
MFSD10
major facilitator superfamily domain containing 10
increases expression
EXP
Selenium results in increased expression of MFSD10 mRNA
CTD
PMID:19244175
NCBI chr 4:2,930,567...2,934,825
Ensembl chr 4:2,930,561...2,934,834
G
MGAT1
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
increases expression
EXP
Selenium results in increased expression of MGAT1 mRNA
CTD
PMID:19244175
NCBI chr 5:180,784,780...180,815,616
Ensembl chr 5:180,784,780...180,815,652
G
MIIP
migration and invasion inhibitory protein
increases expression
EXP
Selenium results in increased expression of MIIP mRNA
CTD
PMID:19244175
NCBI chr 1:12,019,498...12,032,045
Ensembl chr 1:12,019,466...12,032,045
G
MINK1
misshapen like kinase 1
increases expression
EXP
Selenium results in increased expression of MINK1 mRNA
CTD
PMID:19244175
NCBI chr17:4,833,340...4,898,061
Ensembl chr17:4,833,340...4,898,061
G
MIOS
meiosis regulator for oocyte development
decreases expression
EXP
Selenium results in decreased expression of MIOS mRNA
CTD
PMID:19244175
NCBI chr 7:7,566,884...7,609,144
Ensembl chr 7:7,566,875...7,608,932
G
MIS12
MIS12 kinetochore complex component
decreases expression
EXP
Selenium results in decreased expression of MIS12 mRNA
CTD
PMID:19244175
NCBI chr17:5,486,374...5,490,811
Ensembl chr17:5,486,285...5,490,814
G
MISP
mitotic spindle positioning
increases expression
EXP
Selenium results in increased expression of MISP mRNA
CTD
PMID:19244175
NCBI chr19:748,438...764,318
Ensembl chr19:751,112...764,318
G
MLEC
malectin
multiple interactions increases expression decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of MLEC mRNA Selenium results in increased expression of MLEC mRNA Selenium results in decreased expression of MLEC mRNA
CTD
PMID:19244175
NCBI chr12:120,687,149...120,701,859
Ensembl chr12:120,687,149...120,701,859
G
MLF2
myeloid leukemia factor 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA Selenium results in increased expression of MLF2 mRNA
CTD
PMID:19244175
NCBI chr12:6,747,996...6,753,141
Ensembl chr12:6,747,996...6,767,475
G
MLST8
MTOR associated protein, LST8 homolog
increases expression
EXP
Selenium results in increased expression of MLST8 mRNA
CTD
PMID:19244175
NCBI chr16:2,205,454...2,209,453
Ensembl chr16:2,204,248...2,209,453
G
MME
membrane metalloendopeptidase
multiple interactions
ISO
Selenium deficiency affects the expression of and affects the localization of MME protein
CTD
PMID:17109141
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP13
matrix metallopeptidase 13
multiple interactions
EXP
Selenium inhibits the reaction [T-2 Toxin results in increased expression of MMP13 mRNA]; Selenium inhibits the reaction [T-2 Toxin results in increased expression of MMP13 protein]
CTD
PMID:21144892
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP14
matrix metallopeptidase 14
decreases expression
EXP
Selenium results in decreased expression of MMP14 mRNA
CTD
PMID:17390030
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MMP15
matrix metallopeptidase 15
decreases expression
EXP
Selenium results in decreased expression of MMP15 mRNA
CTD
PMID:17390030
NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901
G
MMP16
matrix metallopeptidase 16
decreases expression
EXP
Selenium results in decreased expression of MMP16 mRNA
CTD
PMID:17390030
NCBI chr 8:88,032,011...88,327,483
Ensembl chr 8:88,032,011...88,328,025
G
MMP2
matrix metallopeptidase 2
decreases expression increases expression
EXP
Selenium results in decreased expression of MMP2 mRNA Selenium results in increased expression of MMP2 mRNA
CTD
PMID:17390030 PMID:19244175
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP24
matrix metallopeptidase 24
decreases expression increases expression
EXP
Selenium results in decreased expression of MMP24 mRNA Selenium results in increased expression of MMP24 mRNA
CTD
PMID:17390030 PMID:19244175
NCBI chr20:35,226,690...35,276,998
Ensembl chr20:35,226,690...35,276,998
G
MMP9
matrix metallopeptidase 9
decreases expression
EXP
Selenium results in decreased expression of MMP9 mRNA
CTD
PMID:17390030
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MMS19
MMS19 homolog, cytosolic iron-sulfur assembly component
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MMS19 mRNA Selenium results in increased expression of MMS19 mRNA
CTD
PMID:19244175
NCBI chr10:97,458,324...97,498,794
Ensembl chr10:97,458,324...97,498,794
G
MMUT
methylmalonyl-CoA mutase
decreases expression
EXP
Selenium results in decreased expression of MMUT mRNA
CTD
PMID:19244175
NCBI chr 6:49,430,360...49,463,253
Ensembl chr 6:49,430,360...49,463,253
G
MON1B
MON1 homolog B, secretory trafficking associated
increases expression
EXP
Selenium results in increased expression of MON1B mRNA
CTD
PMID:19244175
NCBI chr16:77,191,190...77,202,398
Ensembl chr16:77,190,835...77,202,398
G
MON2
MON2 homolog, regulator of endosome-to-Golgi trafficking
decreases expression
EXP
Selenium results in decreased expression of MON2 mRNA
CTD
PMID:19244175
NCBI chr12:62,466,826...62,600,476
Ensembl chr12:62,466,817...62,600,476
G
MPST
mercaptopyruvate sulfurtransferase
increases expression multiple interactions
EXP
Selenium results in increased expression of MPST mRNA [Selenium co-treated with Vitamin E] results in increased expression of MPST mRNA
CTD
PMID:19244175
NCBI chr22:37,019,742...37,029,815
Ensembl chr22:37,019,635...37,029,821
G
MPV17
mitochondrial inner membrane protein MPV17
increases expression
EXP
Selenium results in increased expression of MPV17 mRNA
CTD
PMID:19244175
NCBI chr 2:27,309,492...27,323,097
Ensembl chr 2:27,309,492...27,325,680
G
MRC1
mannose receptor C-type 1
multiple interactions
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA]; [Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA
CTD
PMID:21775527
NCBI chr10:17,809,348...17,911,164
Ensembl chr10:17,809,348...17,911,164
G
MRPL12
mitochondrial ribosomal protein L12
increases expression
EXP
Selenium results in increased expression of MRPL12 mRNA
CTD
PMID:19244175
NCBI chr17:81,703,367...81,707,517
Ensembl chr17:81,703,367...81,707,517
G
MRPL2
mitochondrial ribosomal protein L2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MRPL2 mRNA Selenium results in increased expression of MRPL2 mRNA
CTD
PMID:19244175
NCBI chr 6:43,054,029...43,059,863
Ensembl chr 6:43,054,029...43,059,438
G
MRPL34
mitochondrial ribosomal protein L34
increases expression
EXP
Selenium results in increased expression of MRPL34 mRNA
CTD
PMID:19244175
NCBI chr19:17,292,573...17,306,843
Ensembl chr19:17,292,609...17,306,843
G
MRPL4
mitochondrial ribosomal protein L4
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA Selenium results in increased expression of MRPL4 mRNA
CTD
PMID:19244175
NCBI chr19:10,251,951...10,260,055
Ensembl chr19:10,251,901...10,260,055
G
MRPL44
mitochondrial ribosomal protein L44
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of MRPL44 mRNA Selenium results in decreased expression of MRPL44 mRNA
CTD
PMID:19244175
NCBI chr 2:223,950,854...223,967,714
Ensembl chr 2:223,957,463...223,967,714
G
MRPL49
mitochondrial ribosomal protein L49
increases expression
EXP
Selenium results in increased expression of MRPL49 mRNA
CTD
PMID:19244175
NCBI chr11:65,122,183...65,127,371
Ensembl chr11:65,122,183...65,127,371
G
MRPL9
mitochondrial ribosomal protein L9
increases expression
EXP
Selenium results in increased expression of MRPL9 mRNA
CTD
PMID:19244175
NCBI chr 1:151,759,647...151,763,496
Ensembl chr 1:151,759,647...151,763,496
G
MRPS33
mitochondrial ribosomal protein S33
decreases expression
EXP
Selenium results in decreased expression of MRPS33 mRNA
CTD
PMID:19244175
NCBI chr 7:141,002,610...141,014,952
Ensembl chr 7:141,002,610...141,015,228
G
MSH5
mutS homolog 5
decreases expression
EXP
Selenium results in decreased expression of MSH5 mRNA
CTD
PMID:19244175
NCBI chr 6:31,740,005...31,762,676
Ensembl chr 6:31,739,677...31,762,676
G
MSN
moesin
increases expression
EXP
Selenium results in increased expression of MSN mRNA
CTD
PMID:19244175
NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931
G
MSRB1
methionine sulfoxide reductase B1
decreases expression multiple interactions
ISO
Selenium deficiency results in decreased expression of MSRB1 mRNA Selenium deficiency results in decreased expression of and results in decreased activity of MSRB1 protein
CTD
PMID:12792026 PMID:16170372
NCBI chr16:1,938,229...1,943,199
Ensembl chr16:1,938,229...1,943,199
G
MT3
metallothionein 3
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MT3 mRNA
CTD
PMID:11444866
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
MTCH2
mitochondrial carrier 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MTCH2 mRNA
CTD
PMID:19244175
NCBI chr11:47,604,317...47,642,559
Ensembl chr11:47,617,315...47,642,607
G
MTF1
metal regulatory transcription factor 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MTF1 mRNA
CTD
PMID:19244175
NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
G
MTF2
metal response element binding transcription factor 2
decreases expression
EXP
Selenium results in decreased expression of MTF2 mRNA
CTD
PMID:19244175
NCBI chr 1:93,079,283...93,139,076
Ensembl chr 1:93,079,235...93,139,079
G
MTMR9
myotubularin related protein 9
decreases expression
EXP
Selenium results in decreased expression of MTMR9 mRNA
CTD
PMID:19244175
NCBI chr 8:11,284,816...11,339,526
Ensembl chr 8:11,284,816...11,328,146
G
MTOR
mechanistic target of rapamycin kinase
multiple interactions
ISO
Selenium inhibits the reaction [arsenite results in decreased expression of and results in decreased phosphorylation of MTOR protein]
CTD
PMID:29324385
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MUC4
mucin 4, cell surface associated
increases expression
EXP
Selenium results in increased expression of MUC4 mRNA
CTD
PMID:19244175
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
decreases expression
EXP
Selenium results in decreased expression of MUC5AC mRNA
CTD
PMID:17512462
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MVK
mevalonate kinase
increases expression
EXP
Selenium results in increased expression of MVK mRNA
CTD
PMID:19244175
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
MVP
major vault protein
increases expression
EXP
Selenium results in increased expression of MVP mRNA
CTD
PMID:19244175
NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039
G
MX1
MX dynamin like GTPase 1
increases expression
EXP
Selenium results in increased expression of MX1 mRNA
CTD
PMID:19244175
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
G
MYC
MYC proto-oncogene, bHLH transcription factor
decreases expression multiple interactions
EXP ISO
Selenium deficiency results in decreased expression of MYC mRNA; Selenium results in decreased expression of MYC mRNA Selenium inhibits the reaction [Cadmium Chloride results in increased expression of MYC protein]
CTD
PMID:11925459 PMID:16600092 PMID:17948765
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYH9
myosin heavy chain 9
increases expression
EXP
Selenium results in increased expression of MYH9 mRNA
CTD
PMID:19244175
NCBI chr22:36,281,280...36,387,967
Ensembl chr22:36,281,280...36,388,010
G
MYL6
myosin light chain 6
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA Selenium results in increased expression of MYL6 mRNA
CTD
PMID:19244175
NCBI chr12:56,158,359...56,161,579
Ensembl chr12:56,158,346...56,163,496
G
MYO18A
myosin XVIIIA
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of MYO18A mRNA Selenium results in increased expression of MYO18A mRNA
CTD
PMID:19244175
NCBI chr17:29,071,122...29,180,398
Ensembl chr17:29,071,122...29,180,398
G
MYO6
myosin VI
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA Selenium results in decreased expression of MYO6 mRNA
CTD
PMID:19244175
NCBI chr 6:75,749,239...75,919,537
Ensembl chr 6:75,749,201...75,919,537
G
MZF1
myeloid zinc finger 1
increases expression
EXP
Selenium results in increased expression of MZF1 mRNA
CTD
PMID:19244175
NCBI chr19:58,561,932...58,573,573
Ensembl chr19:58,561,931...58,573,575
G
N4BP2L2
NEDD4 binding protein 2 like 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of N4BP2L2 mRNA Selenium results in decreased expression of N4BP2L2 mRNA
CTD
PMID:19244175
NCBI chr13:32,432,485...32,538,868
Ensembl chr13:32,432,417...32,538,885
G
NAA10
N-alpha-acetyltransferase 10, NatA catalytic subunit
increases expression
EXP
Selenium results in increased expression of NAA10 mRNA
CTD
PMID:19244175
NCBI chr X:153,929,225...153,935,037
Ensembl chr X:153,929,225...153,935,080
G
NACA
nascent polypeptide associated complex subunit alpha
decreases expression
EXP
Selenium results in decreased expression of NACA mRNA
CTD
PMID:19244175
NCBI chr12:56,712,427...56,725,299
Ensembl chr12:56,712,305...56,731,628
G
NAGK
N-acetylglucosamine kinase
increases expression
EXP
Selenium results in increased expression of NAGK mRNA
CTD
PMID:19244175
NCBI chr 2:71,068,296...71,079,808
Ensembl chr 2:71,064,344...71,079,808
G
NAGLU
N-acetyl-alpha-glucosaminidase
increases expression
EXP
Selenium results in increased expression of NAGLU mRNA
CTD
PMID:19244175
NCBI chr17:42,536,241...42,544,449
Ensembl chr17:42,536,241...42,544,449
G
NAPA
NSF attachment protein alpha
increases expression
EXP
Selenium results in increased expression of NAPA mRNA
CTD
PMID:19244175
NCBI chr19:47,484,530...47,515,063
Ensembl chr19:47,487,637...47,515,091
G
NASP
nuclear autoantigenic sperm protein
increases expression
EXP
Selenium results in increased expression of NASP mRNA
CTD
PMID:19244175
NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904
G
NAV2
neuron navigator 2
decreases expression
EXP
Selenium results in decreased expression of NAV2 mRNA
CTD
PMID:19244175
NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601
G
NCDN
neurochondrin
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NCDN mRNA Selenium results in increased expression of NCDN mRNA
CTD
PMID:19244175
NCBI chr 1:35,557,799...35,566,779
Ensembl chr 1:35,557,473...35,567,274
G
NCOA2
nuclear receptor coactivator 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NCOA2 mRNA Selenium results in decreased expression of NCOA2 mRNA
CTD
PMID:19244175
NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
G
NDUFA1
NADH:ubiquinone oxidoreductase subunit A1
decreases expression
EXP
Selenium results in decreased expression of NDUFA1 mRNA
CTD
PMID:19244175
NCBI chr X:119,871,832...119,876,662
Ensembl chr X:119,871,832...119,876,662
G
NDUFA4
NDUFA4 mitochondrial complex associated
decreases expression
EXP
Selenium results in decreased expression of NDUFA4 mRNA
CTD
PMID:19244175
NCBI chr 7:10,931,943...10,940,153
Ensembl chr 7:10,931,943...10,940,153
G
NDUFA7
NADH:ubiquinone oxidoreductase subunit A7
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA
CTD
PMID:19244175
NCBI chr19:8,308,595...8,321,375
Ensembl chr19:8,308,768...8,321,375
G
NDUFB1
NADH:ubiquinone oxidoreductase subunit B1
decreases expression
EXP
Selenium results in decreased expression of NDUFB1 mRNA
CTD
PMID:19244175
NCBI chr14:92,116,123...92,121,706
Ensembl chr14:92,116,122...92,121,917
G
NDUFB2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
EXP
Selenium results in decreased expression of NDUFB2 mRNA
CTD
PMID:19244175
NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,722,790
G
NDUFS3
NADH:ubiquinone oxidoreductase core subunit S3
increases expression
EXP
Selenium results in increased expression of NDUFS3 mRNA
CTD
PMID:19244175
NCBI chr11:47,579,074...47,584,562
Ensembl chr11:47,565,336...47,584,562
G
NDUFS4
NADH:ubiquinone oxidoreductase subunit S4
decreases expression
EXP
Selenium results in decreased expression of NDUFS4 mRNA
CTD
PMID:19244175
NCBI chr 5:53,560,639...53,683,338
Ensembl chr 5:53,560,633...53,683,338
G
NDUFV1
NADH:ubiquinone oxidoreductase core subunit V1
increases expression
EXP
Selenium results in increased expression of NDUFV1 mRNA
CTD
PMID:19244175
NCBI chr11:67,606,936...67,612,554
Ensembl chr11:67,605,653...67,612,554
G
NECTIN2
nectin cell adhesion molecule 2
increases expression
EXP
Selenium results in increased expression of NECTIN2 mRNA
CTD
PMID:19244175
NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223
G
NEDD8
NEDD8 ubiquitin like modifier
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NEDD8 mRNA
CTD
PMID:19244175
NCBI chr14:24,216,857...24,232,367
Ensembl chr14:24,216,857...24,232,367
G
NEK1
NIMA related kinase 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of NEK1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NEK1 mRNA
CTD
PMID:19244175
NCBI chr 4:169,392,809...169,612,583
Ensembl chr 4:169,369,704...169,612,632
G
NEK2
NIMA related kinase 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NEK2 mRNA Selenium results in decreased expression of NEK2 mRNA
CTD
PMID:19244175
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NELFA
negative elongation factor complex member A
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA Selenium results in increased expression of NELFA mRNA
CTD
PMID:19244175
NCBI chr 4:1,982,723...2,008,974
Ensembl chr 4:1,982,717...2,041,903
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NF2 mRNA Selenium results in increased expression of NF2 mRNA
CTD
PMID:19244175
NCBI chr22:29,603,556...29,698,600
Ensembl chr22:29,603,556...29,698,598
G
NFAT5
nuclear factor of activated T cells 5
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA Selenium results in decreased expression of NFAT5 mRNA
CTD
PMID:19244175
NCBI chr16:69,565,966...69,704,654
Ensembl chr16:69,565,094...69,704,666
G
NFE2L2
NFE2 like bZIP transcription factor 2
decreases expression multiple interactions affects activity
EXP ISO
Selenium results in decreased expression of NFE2L2 mRNA [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein Selenium affects the activity of NFE2L2 protein NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA
CTD
PMID:18279678 PMID:19244175 PMID:37415728
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFIC
nuclear factor I C
increases expression
EXP
Selenium results in increased expression of NFIC mRNA
CTD
PMID:19244175
NCBI chr19:3,359,630...3,469,217
Ensembl chr19:3,314,403...3,469,217
G
NFKB2
nuclear factor kappa B subunit 2
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of NFKB2 mRNA
CTD
PMID:21481475
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
ISO EXP
[Drugs, Chinese Herbal co-treated with Selenium] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased degradation of NFKBIA protein]; Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of NFKBIA mRNA
CTD
PMID:17439952 PMID:17630198 PMID:21481475 PMID:24626144
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIB
NFKB inhibitor beta
increases expression
EXP
Selenium results in increased expression of NFKBIB mRNA
CTD
PMID:19244175
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NFS1
NFS1 cysteine desulfurase
decreases expression
EXP
Selenium results in decreased expression of NFS1 mRNA
CTD
PMID:19244175
NCBI chr20:35,668,052...35,699,352
Ensembl chr20:35,668,052...35,699,355
G
NIBAN1
niban apoptosis regulator 1
decreases expression
EXP
Selenium results in decreased expression of NIBAN1 mRNA
CTD
PMID:19244175
NCBI chr 1:184,791,032...184,974,508
Ensembl chr 1:184,790,724...184,974,508
G
NID2
nidogen 2
decreases expression
EXP
Selenium results in decreased expression of NID2 mRNA
CTD
PMID:19244175
NCBI chr14:52,004,809...52,069,059
Ensembl chr14:52,004,809...52,069,059
G
NINJ1
ninjurin 1
increases expression
EXP
Selenium results in increased expression of NINJ1 mRNA
CTD
PMID:19244175
NCBI chr 9:93,121,496...93,134,251
Ensembl chr 9:93,121,496...93,134,251
G
NIPBL
NIPBL cohesin loading factor
decreases expression
EXP
Selenium results in decreased expression of NIPBL mRNA
CTD
PMID:19244175
NCBI chr 5:36,876,769...37,066,413
Ensembl chr 5:36,876,769...37,066,413
G
NKTR
natural killer cell triggering receptor
decreases expression
EXP
Selenium results in decreased expression of NKTR mRNA
CTD
PMID:19244175
NCBI chr 3:42,600,612...42,648,735
Ensembl chr 3:42,600,655...42,648,735
G
NLRP3
NLR family pyrin domain containing 3
increases expression
EXP
Selenium results in increased expression of NLRP3 mRNA
CTD
PMID:17293063
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
NOC3L
NOC3 like DNA replication regulator
decreases expression
EXP
Selenium results in decreased expression of NOC3L mRNA
CTD
PMID:19244175
NCBI chr10:94,314,907...94,362,939
Ensembl chr10:94,333,226...94,362,959
G
NOL3
nucleolar protein 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA
CTD
PMID:19244175
NCBI chr16:67,170,538...67,175,737
Ensembl chr16:67,170,154...67,175,737
G
NOL8
nucleolar protein 8
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA Selenium results in decreased expression of NOL8 mRNA
CTD
PMID:19244175
NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636
G
NOLC1
nucleolar and coiled-body phosphoprotein 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA
CTD
PMID:19244175
NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871
G
NOMO3
NODAL modulator 3
increases expression
EXP
Selenium results in increased expression of NOMO3 mRNA
CTD
PMID:19244175
NCBI chr16:16,232,528...16,294,811
Ensembl chr16:16,232,506...16,300,806
G
NOP10
NOP10 ribonucleoprotein
decreases expression
EXP
Selenium results in decreased expression of NOLA3 mRNA
CTD
PMID:19244175
NCBI chr15:34,341,719...34,343,136
Ensembl chr15:34,339,159...34,343,180
G
NOP56
NOP56 ribonucleoprotein
decreases expression multiple interactions
EXP
Selenium results in decreased expression of NOP56 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NOP56 mRNA
CTD
PMID:19244175
NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
[Drugs, Chinese Herbal co-treated with Selenium] results in decreased expression of NOS2 mRNA; [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:14734799 PMID:17630198 PMID:24626144
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
increases expression
ISO
Selenium results in increased expression of NOS3 mRNA
CTD
PMID:28810182
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NOSIP
nitric oxide synthase interacting protein
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NOSIP mRNA
CTD
PMID:19244175
NCBI chr19:49,555,468...49,580,556
Ensembl chr19:49,555,468...49,590,262
G
NOTCH3
notch receptor 3
increases expression
EXP
Selenium results in increased expression of NOTCH3 mRNA
CTD
PMID:19244175
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NOX4
NADPH oxidase 4
increases expression
ISO
Selenium deficiency results in increased expression of NOX4 mRNA
CTD
PMID:16170372
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NPEPL1
aminopeptidase like 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NPEPL1 mRNA Selenium results in increased expression of NPEPL1 mRNA
CTD
PMID:19244175
NCBI chr20:58,689,131...58,715,844
Ensembl chr20:58,689,131...58,719,238
G
NPM1
nucleophosmin 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA
CTD
PMID:11444866
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
G
NQO1
NAD(P)H quinone dehydrogenase 1
affects activity decreases activity multiple interactions increases expression
ISO
Selenium affects the activity of NQO1 protein Selenium results in decreased activity of NQO1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA; Selenium promotes the reaction [Plant Extracts results in increased activity of NQO1 protein] Selenium deficiency results in increased expression of NQO1 mRNA
CTD
PMID:11444866 PMID:18279678 PMID:19650632 PMID:28810182
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1H3
nuclear receptor subfamily 1 group H member 3
multiple interactions
ISO
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] affects the reaction [Dietary Fats results in increased expression of NR1H3 mRNA]
CTD
PMID:30031400
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR2C1
nuclear receptor subfamily 2 group C member 1
decreases expression
EXP
Selenium results in decreased expression of NR2C1 mRNA
CTD
PMID:19244175
NCBI chr12:95,020,229...95,073,618
Ensembl chr12:95,020,229...95,073,628
G
NR3C1
nuclear receptor subfamily 3 group C member 1
decreases expression
EXP
Selenium results in decreased expression of NR3C1 mRNA
CTD
PMID:19244175
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NRF1
nuclear respiratory factor 1
multiple interactions increases expression
ISO
NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA] Selenium results in increased expression of NRF1 mRNA
CTD
PMID:17936198
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
G
NSMAF
neutral sphingomyelinase activation associated factor
decreases expression
EXP
Selenium results in decreased expression of NSMAF mRNA
CTD
PMID:19244175
NCBI chr 8:58,583,504...58,659,853
Ensembl chr 8:58,583,508...58,659,853
G
NT5DC2
5'-nucleotidase domain containing 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA Selenium results in increased expression of NT5DC2 mRNA
CTD
PMID:19244175
NCBI chr 3:52,524,387...52,535,027
Ensembl chr 3:52,524,385...52,535,054
G
NUCB1
nucleobindin 1
increases expression
EXP
Selenium results in increased expression of NUCB1 mRNA
CTD
PMID:19244175
NCBI chr19:48,900,312...48,923,372
Ensembl chr19:48,900,050...48,923,473
G
NUCKS1
nuclear casein kinase and cyclin dependent kinase substrate 1
decreases expression
EXP
Selenium results in decreased expression of NUCKS1 mRNA
CTD
PMID:19244175
NCBI chr 1:205,712,822...205,750,182
Ensembl chr 1:205,712,822...205,750,182
G
NUDC
nuclear distribution C, dynein complex regulator
increases expression
EXP
Selenium results in increased expression of NUDC mRNA
CTD
PMID:19244175
NCBI chr 1:26,900,161...26,946,871
Ensembl chr 1:26,900,238...26,946,871
G
NUP93
nucleoporin 93
increases expression
EXP
Selenium results in increased expression of NUP93 mRNA
CTD
PMID:19244175
NCBI chr16:56,730,129...56,850,286
Ensembl chr16:56,730,118...56,850,286
G
NUTF2
nuclear transport factor 2
increases expression
EXP
Selenium results in increased expression of NUTF2 mRNA
CTD
PMID:19244175
NCBI chr16:67,846,933...67,872,567
Ensembl chr16:67,846,882...67,872,567
G
OAZ1
ornithine decarboxylase antizyme 1
increases expression
EXP
Selenium results in increased expression of OAZ1 mRNA
CTD
PMID:19244175
NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
G
OAZ2
ornithine decarboxylase antizyme 2
increases expression
EXP
Selenium results in increased expression of OAZ2 mRNA
CTD
PMID:19244175
NCBI chr15:64,687,574...64,703,281
Ensembl chr15:64,687,573...64,703,281
G
OBSL1
obscurin like cytoskeletal adaptor 1
increases expression
EXP
Selenium results in increased expression of OBSL1 mRNA
CTD
PMID:19244175
NCBI chr 2:219,547,206...219,571,539
Ensembl chr 2:219,550,728...219,571,859
G
OCLN
occludin
multiple interactions
EXP
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; Selenium results in increased expression of and results in increased localization of OCLN protein
CTD
PMID:16514648
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
OGFR
opioid growth factor receptor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA Selenium results in increased expression of OGFR mRNA
CTD
PMID:19244175
NCBI chr20:62,804,835...62,814,000
Ensembl chr20:62,804,835...62,814,000
G
OGG1
8-oxoguanine DNA glycosylase
multiple interactions increases expression
EXP
[Selenium co-treated with Arsenic] results in increased expression of OGG1 protein Selenium results in increased expression of OGG1 protein
CTD
PMID:20478284
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
G
OLA1
Obg like ATPase 1
decreases expression
EXP
Selenium results in decreased expression of OLA1 mRNA
CTD
PMID:19244175
NCBI chr 2:174,072,447...174,248,532
Ensembl chr 2:174,072,447...174,248,599
G
OPA1
OPA1 mitochondrial dynamin like GTPase
decreases expression
EXP
Selenium results in decreased expression of OPA1 mRNA
CTD
PMID:19244175
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
G
OPTN
optineurin
increases expression
EXP
Selenium results in increased expression of OPTN mRNA
CTD
PMID:19244175
NCBI chr10:13,100,082...13,138,308
Ensembl chr10:13,099,449...13,138,308
G
ORM1
orosomucoid 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of ORM1 mRNA
CTD
PMID:11444866
NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
G
OS9
OS9 endoplasmic reticulum lectin
increases expression
EXP
Selenium results in increased expression of OS9 mRNA
CTD
PMID:19244175
NCBI chr12:57,694,132...57,721,557
Ensembl chr12:57,693,841...57,728,342
G
OSBP2
oxysterol binding protein 2
increases expression
EXP
Selenium results in increased expression of OSBP2 mRNA
CTD
PMID:19244175
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
G
OSBPL1A
oxysterol binding protein like 1A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of OSBPL1A mRNA Selenium results in decreased expression of OSBPL1A mRNA
CTD
PMID:19244175
NCBI chr18:24,162,045...24,397,824
Ensembl chr18:24,162,045...24,397,880
G
OSGEP
O-sialoglycoprotein endopeptidase
increases expression
EXP
Selenium results in increased expression of OSGEP mRNA
CTD
PMID:19244175
NCBI chr14:20,446,401...20,454,812
Ensembl chr14:20,446,401...20,455,089
G
OTULINL
OTU deubiquitinase with linear linkage specificity like
decreases expression
EXP
Selenium results in decreased expression of OTULINL mRNA
CTD
PMID:19244175
NCBI chr 5:14,581,792...14,616,180
Ensembl chr 5:14,581,792...14,616,180
G
OVGP1
oviductal glycoprotein 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of OVGP1 mRNA Selenium results in increased expression of OVGP1 mRNA
CTD
PMID:19244175
NCBI chr 1:111,414,319...111,427,735
Ensembl chr 1:111,414,319...111,427,735
G
PA2G4
proliferation-associated 2G4
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA
CTD
PMID:19244175
NCBI chr12:56,104,559...56,113,910
Ensembl chr12:56,104,537...56,113,910
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PAFAH1B1 mRNA
CTD
PMID:19244175
NCBI chr17:2,593,183...2,685,615
Ensembl chr17:2,593,210...2,685,615
G
PAFAH1B3
platelet activating factor acetylhydrolase 1b catalytic subunit 3
increases expression
EXP
Selenium results in increased expression of PAFAH1B3 mRNA
CTD
PMID:19244175
NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546
G
PAGE4
PAGE family member 4
decreases expression
EXP
Selenium results in decreased expression of PAGE4 mRNA
CTD
PMID:19244175
NCBI chr X:49,829,260...49,834,264
Ensembl chr X:49,829,260...49,834,264
G
PAK4
p21 (RAC1) activated kinase 4
increases expression
EXP
Selenium results in increased expression of PAK4 mRNA
CTD
PMID:19244175
NCBI chr19:39,125,786...39,182,816
Ensembl chr19:39,125,770...39,182,816
G
PALLD
palladin, cytoskeletal associated protein
decreases expression
EXP
Selenium results in decreased expression of PALLD mRNA
CTD
PMID:19244175
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
G
PALM2AKAP2
PALM2 and AKAP2 fusion
increases expression
EXP
Selenium results in increased expression of PALM2AKAP2 mRNA
CTD
PMID:19244175
NCBI chr 9:109,640,787...110,172,512
Ensembl chr 9:109,498,325...110,172,512
G
PAM
peptidylglycine alpha-amidating monooxygenase
decreases expression
EXP
Selenium results in decreased expression of PAM mRNA
CTD
PMID:19244175
NCBI chr 5:102,754,783...103,031,105
Ensembl chr 5:102,753,981...103,029,730
G
PANK4
pantothenate kinase 4 (inactive)
increases expression
EXP
Selenium results in increased expression of PANK4 mRNA
CTD
PMID:19244175
NCBI chr 1:2,508,537...2,526,596
Ensembl chr 1:2,508,537...2,526,597
G
PAOX
polyamine oxidase
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PAOX mRNA
CTD
PMID:19244175
NCBI chr10:133,379,262...133,391,694
Ensembl chr10:133,379,261...133,391,694
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions
EXP
[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]
CTD
PMID:17339365
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PAXBP1
PAX3 and PAX7 binding protein 1
decreases expression
EXP
Selenium results in decreased expression of PAXBP1 mRNA
CTD
PMID:19244175
NCBI chr21:32,733,899...32,771,755
Ensembl chr21:32,733,899...32,771,792
G
PC
pyruvate carboxylase
increases expression
EXP
Selenium results in increased expression of PC mRNA
CTD
PMID:19244175
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PCBP1
poly(rC) binding protein 1
increases expression
EXP
Selenium results in increased expression of PCBP1 mRNA
CTD
PMID:19244175
NCBI chr 2:70,087,477...70,089,203
Ensembl chr 2:70,087,477...70,089,203
G
PCDHGC3
protocadherin gamma subfamily C, 3
increases expression
EXP
Selenium results in increased expression of PCDHGC3 mRNA
CTD
PMID:19244175
NCBI chr 5:141,475,966...141,512,975
Ensembl chr 5:141,475,947...141,512,977
G
PCM1
pericentriolar material 1
decreases expression
EXP
Selenium results in decreased expression of PCM1 mRNA
CTD
PMID:19244175
NCBI chr 8:17,922,988...18,029,948
Ensembl chr 8:17,922,842...18,029,948
G
PCNA
proliferating cell nuclear antigen
decreases expression
EXP
Selenium deficiency results in decreased expression of PCNA mRNA
CTD
PMID:11925459
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PCOLCE
procollagen C-endopeptidase enhancer
increases expression
EXP
Selenium results in increased expression of PCOLCE mRNA
CTD
PMID:19244175
NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
G
PCP4
Purkinje cell protein 4
decreases expression
EXP
Selenium results in decreased expression of PCP4 mRNA
CTD
PMID:19244175
NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397
G
PCSK5
proprotein convertase subtilisin/kexin type 5
decreases expression
EXP
Selenium results in decreased expression of PCSK5 mRNA
CTD
PMID:19244175
NCBI chr 9:75,889,809...76,362,975
Ensembl chr 9:75,890,644...76,362,975
G
PCSK7
proprotein convertase subtilisin/kexin type 7
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PCSK7 mRNA Selenium results in increased expression of PCSK7 mRNA
CTD
PMID:19244175
NCBI chr11:117,204,337...117,232,073
Ensembl chr11:117,204,337...117,232,525
G
PCYOX1L
prenylcysteine oxidase 1 like
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PCYOX1L mRNA Selenium results in decreased expression of PCYOX1L mRNA
CTD
PMID:19244175
NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653
G
PDE8A
phosphodiesterase 8A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PDE8A mRNA Selenium results in decreased expression of PDE8A mRNA
CTD
PMID:19244175
NCBI chr15:84,980,467...85,139,142
Ensembl chr15:84,980,440...85,139,145
G
PDGFA
platelet derived growth factor subunit A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PDGFA mRNA
CTD
PMID:19244175
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDLIM4
PDZ and LIM domain 4
increases expression
EXP
Selenium results in increased expression of PDLIM4 mRNA
CTD
PMID:19244175
NCBI chr 5:132,257,696...132,273,454
Ensembl chr 5:132,257,696...132,273,454
G
PDLIM7
PDZ and LIM domain 7
increases expression
EXP
Selenium results in increased expression of PDLIM7 mRNA
CTD
PMID:19244175
NCBI chr 5:177,483,394...177,497,604
Ensembl chr 5:177,483,394...177,497,606
G
PDPK1
3-phosphoinositide dependent protein kinase 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA
CTD
PMID:19244175
NCBI chr16:2,538,021...2,603,188
Ensembl chr16:2,537,979...2,603,188
G
PDS5B
PDS5 cohesin associated factor B
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA Selenium results in decreased expression of APRIN mRNA
CTD
PMID:19244175
NCBI chr13:32,586,452...32,778,019
Ensembl chr13:32,586,452...32,778,019
G
PDSS2
decaprenyl diphosphate synthase subunit 2
decreases expression
EXP
Selenium results in decreased expression of PDSS2 mRNA
CTD
PMID:19244175
NCBI chr 6:107,152,562...107,459,564
Ensembl chr 6:107,152,562...107,459,564
G
PEA15
proliferation and apoptosis adaptor protein 15
increases expression
EXP
Selenium results in increased expression of PEA15 mRNA
CTD
PMID:19244175
NCBI chr 1:160,205,384...160,215,372
Ensembl chr 1:160,205,380...160,215,376
G
PEF1
penta-EF-hand domain containing 1
increases expression
EXP
Selenium results in increased expression of PEF1 mRNA
CTD
PMID:19244175
NCBI chr 1:31,629,866...31,644,876
Ensembl chr 1:31,629,866...31,644,896
G
PER3
period circadian regulator 3
decreases expression
EXP
Selenium results in decreased expression of PER3 mRNA
CTD
PMID:19244175
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
G
PES1
pescadillo ribosomal biogenesis factor 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PES1 mRNA Selenium results in increased expression of PES1 mRNA
CTD
PMID:19244175
NCBI chr22:30,576,625...30,607,013
Ensembl chr22:30,576,625...30,607,083
G
PEX1
peroxisomal biogenesis factor 1
decreases expression
EXP
Selenium results in decreased expression of PEX1 mRNA
CTD
PMID:19244175
NCBI chr 7:92,487,025...92,528,520
Ensembl chr 7:92,487,020...92,528,520
G
PEX14
peroxisomal biogenesis factor 14
increases expression
EXP
Selenium results in increased expression of PEX14 mRNA
CTD
PMID:19244175
NCBI chr 1:10,474,950...10,630,758
Ensembl chr 1:10,472,288...10,630,758
G
PEX3
peroxisomal biogenesis factor 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PEX3 mRNA Selenium results in decreased expression of PEX3 mRNA
CTD
PMID:19244175
NCBI chr 6:143,450,805...143,490,616
Ensembl chr 6:143,450,805...143,490,616
G
PEX7
peroxisomal biogenesis factor 7
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PEX7 mRNA
CTD
PMID:19244175
NCBI chr 6:136,822,592...136,913,934
Ensembl chr 6:136,822,564...136,913,934
G
PFKFB3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression
ISO
Selenium results in increased expression of PFKFB3 mRNA
CTD
PMID:28810182
NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,934...6,254,644
G
PFKL
phosphofructokinase, liver type
increases expression
EXP
Selenium results in increased expression of PFKL mRNA
CTD
PMID:19244175
NCBI chr21:44,300,053...44,327,373
Ensembl chr21:44,300,051...44,327,376
G
PFN1
profilin 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PFN1 mRNA Selenium results in increased expression of PFN1 mRNA
CTD
PMID:19244175
NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061
G
PGAP1
post-GPI attachment to proteins inositol deacylase 1
decreases expression
EXP
Selenium results in decreased expression of PGAP1 mRNA
CTD
PMID:19244175
NCBI chr 2:196,833,004...196,926,707
Ensembl chr 2:196,833,004...196,927,796
G
PGAP2
post-GPI attachment to proteins 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PGAP2 mRNA Selenium results in increased expression of PGAP2 mRNA
CTD
PMID:19244175
NCBI chr11:3,797,724...3,826,371
Ensembl chr11:3,797,724...3,826,371
G
PGLYRP3
peptidoglycan recognition protein 3
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PGLYRP3 mRNA
CTD
PMID:21481475
NCBI chr 1:153,297,116...153,312,952
Ensembl chr 1:153,297,116...153,312,952
G
PGM3
phosphoglucomutase 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA Selenium results in decreased expression of PGM3 mRNA
CTD
PMID:19244175
NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,147,324...83,193,936
G
PHACTR2
phosphatase and actin regulator 2
decreases expression
EXP
Selenium results in decreased expression of PHACTR2 mRNA
CTD
PMID:19244175
NCBI chr 6:143,536,878...143,831,185
Ensembl chr 6:143,536,845...143,831,185
G
PHF3
PHD finger protein 3
decreases expression
EXP
Selenium results in decreased expression of PHF3 mRNA
CTD
PMID:19244175
NCBI chr 6:63,635,802...63,726,011
Ensembl chr 6:63,635,802...63,779,336
G
PHLDA1
pleckstrin homology like domain family A member 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PHLDA1 mRNA
CTD
PMID:19244175
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PIAS4
protein inhibitor of activated STAT 4
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PIAS4 mRNA
CTD
PMID:19244175
NCBI chr19:4,007,736...4,039,386
Ensembl chr19:4,007,736...4,039,386
G
PIEZO1
piezo type mechanosensitive ion channel component 1 (Er blood group)
increases expression
EXP
Selenium results in increased expression of PIEZO1 mRNA
CTD
PMID:19244175
NCBI chr16:88,715,338...88,785,220
Ensembl chr16:88,715,338...88,785,220
G
PIGG
phosphatidylinositol glycan anchor biosynthesis class G (EMM blood group)
decreases expression
EXP
Selenium results in decreased expression of PIGG mRNA
CTD
PMID:19244175
NCBI chr 4:499,210...540,200
Ensembl chr 4:499,210...540,200
G
PIGK
phosphatidylinositol glycan anchor biosynthesis class K
decreases expression
EXP
Selenium results in decreased expression of PIGK mRNA
CTD
PMID:19244175
NCBI chr 1:77,088,989...77,219,430
Ensembl chr 1:77,088,989...77,219,430
G
PIGP
phosphatidylinositol glycan anchor biosynthesis class P
decreases expression
EXP
Selenium results in decreased expression of PIGP mRNA
CTD
PMID:19244175
NCBI chr21:37,065,364...37,073,071
Ensembl chr21:37,062,846...37,073,170
G
PIH1D1
PIH1 domain containing 1
increases expression multiple interactions
EXP
Selenium results in increased expression of PIH1D1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIH1D1 mRNA
CTD
PMID:19244175
NCBI chr19:49,446,298...49,451,814
Ensembl chr19:49,446,298...49,453,497
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
increases expression multiple interactions
EXP
Selenium results in increased expression of PIK3CD mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIK3CD mRNA
CTD
PMID:19244175
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
Selenium results in increased expression of PIK3R1 mRNA
CTD
PMID:28810182
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PITPNA
phosphatidylinositol transfer protein alpha
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PITPNA mRNA Selenium results in increased expression of PITPNA mRNA
CTD
PMID:19244175
NCBI chr17:1,517,718...1,562,792
Ensembl chr17:1,517,718...1,562,792
G
PITPNM1
phosphatidylinositol transfer protein membrane associated 1
increases expression
EXP
Selenium results in increased expression of PITPNM1 mRNA
CTD
PMID:19244175
NCBI chr11:67,491,768...67,506,266
Ensembl chr11:67,491,768...67,506,263
G
PITX1
paired like homeodomain 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PITX1 mRNA Selenium results in increased expression of PITX1 mRNA
CTD
PMID:19244175
NCBI chr 5:135,027,734...135,034,789
Ensembl chr 5:135,027,734...135,034,813
G
PJA1
praja ring finger ubiquitin ligase 1
increases expression
EXP
Selenium results in increased expression of PJA1 mRNA
CTD
PMID:19244175
NCBI chr X:69,160,746...69,165,453
Ensembl chr X:69,160,851...69,165,521
G
PKD1
polycystin 1, transient receptor potential channel interacting
increases expression
EXP
Selenium results in increased expression of PKD1 mRNA
CTD
PMID:19244175
NCBI chr16:2,088,708...2,135,898
Ensembl chr16:2,088,708...2,135,898
G
PKM
pyruvate kinase M1/2
increases expression
EXP
Selenium results in increased expression of PKM mRNA
CTD
PMID:19244175
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
G
PKN2
protein kinase N2
decreases expression
EXP
Selenium results in decreased expression of PKN2 mRNA
CTD
PMID:19244175
NCBI chr 1:88,684,273...88,836,255
Ensembl chr 1:88,684,222...88,836,255
G
PLA2G12A
phospholipase A2 group XIIA
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA Selenium results in decreased expression of PLA2G12A mRNA
CTD
PMID:19244175
NCBI chr 4:109,709,989...109,730,070
Ensembl chr 4:109,709,989...109,730,070
G
PLAAT3
phospholipase A and acyltransferase 3
increases expression
EXP
Selenium results in increased expression of PLAAT3 mRNA
CTD
PMID:19244175
NCBI chr11:63,574,462...63,616,927
Ensembl chr11:63,573,195...63,616,883
G
PLCB4
phospholipase C beta 4
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PLCB4 mRNA Selenium results in decreased expression of PLCB4 mRNA
CTD
PMID:19244175
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
G
PLEC
plectin
increases expression
EXP
Selenium results in increased expression of PLEC mRNA
CTD
PMID:19244175
NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,153...143,976,734
G
PLEKHA5
pleckstrin homology domain containing A5
decreases expression
EXP
Selenium results in decreased expression of PLEKHA5 mRNA
CTD
PMID:19244175
NCBI chr12:19,129,733...19,376,400
Ensembl chr12:19,129,669...19,376,400
G
PLEKHJ1
pleckstrin homology domain containing J1
increases expression
EXP
Selenium results in increased expression of PLEKHJ1 mRNA
CTD
PMID:19244175
NCBI chr19:2,229,981...2,236,329
Ensembl chr19:2,230,084...2,237,704
G
PLEKHO1
pleckstrin homology domain containing O1
increases expression
EXP
Selenium results in increased expression of PLEKHO1 mRNA
CTD
PMID:19244175
NCBI chr 1:150,149,646...150,160,065
Ensembl chr 1:150,149,183...150,164,720
G
PLLP
plasmolipin
increases expression
EXP
Selenium results in increased expression of PLLP mRNA
CTD
PMID:19244175
NCBI chr16:57,256,097...57,284,672
Ensembl chr16:57,248,547...57,284,672
G
PLOD2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
decreases expression
EXP
Selenium results in decreased expression of PLOD2 mRNA
CTD
PMID:19244175
NCBI chr 3:146,069,440...146,161,184
Ensembl chr 3:146,035,139...146,163,725
G
PLPP3
phospholipid phosphatase 3
decreases expression
EXP
Selenium results in decreased expression of PLPP3 mRNA
CTD
PMID:19244175
NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301
G
PLVAP
plasmalemma vesicle associated protein
increases expression
EXP
Selenium results in increased expression of PLVAP mRNA
CTD
PMID:19244175
NCBI chr19:17,351,455...17,377,342
Ensembl chr19:17,351,450...17,377,342
G
PLXNB2
plexin B2
increases expression
EXP
Selenium results in increased expression of PLXNB2 mRNA
CTD
PMID:19244175
NCBI chr22:50,274,979...50,307,646
Ensembl chr22:50,274,979...50,307,646
G
PML
PML nuclear body scaffold
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PML mRNA Selenium results in increased expression of PML mRNA
CTD
PMID:19244175
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
G
PMPCB
peptidase, mitochondrial processing subunit beta
decreases expression
EXP
Selenium results in decreased expression of PMPCB mRNA
CTD
PMID:19244175
NCBI chr 7:103,297,435...103,347,542
Ensembl chr 7:103,297,407...103,331,818
G
PMS1
PMS1 homolog 1, mismatch repair system component
decreases expression
EXP
Selenium results in decreased expression of PMS1 mRNA
CTD
PMID:19244175
NCBI chr 2:189,784,450...189,877,629
Ensembl chr 2:189,784,085...189,877,629
G
PNISR
PNN interacting serine and arginine rich protein
decreases expression
EXP
Selenium results in decreased expression of PNISR mRNA
CTD
PMID:19244175
NCBI chr 6:99,398,050...99,425,308
Ensembl chr 6:99,397,629...99,425,331
G
PNKP
polynucleotide kinase 3'-phosphatase
increases expression
EXP
Selenium results in increased expression of PNKP mRNA
CTD
PMID:19244175
NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351
G
PNPLA6
patatin like phospholipase domain containing 6
increases expression
EXP
Selenium results in increased expression of PNPLA6 mRNA
CTD
PMID:19244175
NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764
G
POLA2
DNA polymerase alpha 2, accessory subunit
increases expression
EXP
Selenium results in increased expression of POLA2 mRNA
CTD
PMID:19244175
NCBI chr11:65,261,962...65,305,985
Ensembl chr11:65,261,913...65,305,959
G
POLDIP3
DNA polymerase delta interacting protein 3
increases expression
EXP
Selenium results in increased expression of POLDIP3 mRNA
CTD
PMID:19244175
NCBI chr22:42,583,721...42,614,883
Ensembl chr22:42,583,721...42,614,962
G
POLL
DNA polymerase lambda
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA Selenium results in increased expression of POLL mRNA
CTD
PMID:19244175
NCBI chr10:101,578,882...101,588,270
Ensembl chr10:101,578,882...101,588,270
G
POLR2A
RNA polymerase II subunit A
increases expression
EXP
Selenium results in increased expression of POLR2A mRNA
CTD
PMID:19244175
NCBI chr17:7,484,366...7,514,616
Ensembl chr17:7,484,366...7,514,616
G
POLR2C
RNA polymerase II subunit C
increases expression
EXP
Selenium results in increased expression of POLR2C mRNA
CTD
PMID:19244175
NCBI chr16:57,462,679...57,472,009
Ensembl chr16:57,462,660...57,472,009
G
POLR2K
RNA polymerase II, I and III subunit K
decreases expression
EXP
Selenium results in decreased expression of POLR2K mRNA
CTD
PMID:19244175
NCBI chr 8:100,150,636...100,154,003
Ensembl chr 8:100,150,623...100,154,003
G
POLR2M
RNA polymerase II subunit M
decreases expression
EXP
Selenium results in decreased expression of POLR2M mRNA
CTD
PMID:19244175
NCBI chr15:57,706,714...57,717,557
Ensembl chr15:57,706,695...57,782,762
G
PON1
paraoxonase 1
multiple interactions
EXP
Selenium inhibits the reaction [Mercury results in decreased activity of PON1 protein]; Selenium inhibits the reaction [Methylmercury Compounds results in decreased activity of PON1 protein]
CTD
PMID:21543280
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PON2
paraoxonase 2
decreases expression
EXP
Selenium results in decreased expression of PON2 mRNA
CTD
PMID:19244175
NCBI chr 7:95,404,862...95,435,028
Ensembl chr 7:95,404,862...95,435,329
G
POR
cytochrome p450 oxidoreductase
increases expression
EXP
Selenium results in increased expression of POR mRNA
CTD
PMID:19244175
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
POSTN
periostin
decreases expression
EXP
Selenium results in decreased expression of POSTN mRNA
CTD
PMID:19244175
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
PPARA
peroxisome proliferator activated receptor alpha
increases expression
ISO
Selenium results in increased expression of PPARA mRNA
CTD
PMID:28810182
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]; Selenium promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein]
CTD
PMID:17439952
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARGC1A
PPARG coactivator 1 alpha
decreases expression
ISO
Selenium results in decreased expression of PPARGC1A mRNA
CTD
PMID:28810182
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PPAT mRNA Selenium results in decreased expression of PPAT mRNA
CTD
PMID:19244175
NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615
G
PPFIBP1
PPFIA binding protein 1
decreases expression
EXP
Selenium results in decreased expression of PPFIBP1 mRNA
CTD
PMID:19244175
NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564
G
PPIB
peptidylprolyl isomerase B
increases expression
EXP
Selenium results in increased expression of PPIB mRNA
CTD
PMID:19244175
NCBI chr15:64,155,817...64,163,022
Ensembl chr15:64,155,740...64,163,134
G
PPIG
peptidylprolyl isomerase G
decreases expression
EXP
Selenium results in decreased expression of PPIG mRNA
CTD
PMID:19244175
NCBI chr 2:169,584,351...169,641,406
Ensembl chr 2:169,584,342...169,641,406
G
PPIL2
peptidylprolyl isomerase like 2
increases expression
EXP
Selenium results in increased expression of PPIL2 mRNA
CTD
PMID:19244175
NCBI chr22:21,666,012...21,700,015
Ensembl chr22:21,666,000...21,700,015
G
PPM1J
protein phosphatase, Mg2+/Mn2+ dependent 1J
increases expression
EXP
Selenium results in increased expression of PPM1J mRNA
CTD
PMID:19244175
NCBI chr 1:112,709,998...112,715,332
Ensembl chr 1:112,709,994...112,715,332
G
PPME1
protein phosphatase methylesterase 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA Selenium results in increased expression of PPME1 mRNA
CTD
PMID:19244175
NCBI chr11:74,171,289...74,254,703
Ensembl chr11:74,171,267...74,254,703
G
PPP1CA
protein phosphatase 1 catalytic subunit alpha
increases expression
EXP
Selenium results in increased expression of PPP1CA mRNA
CTD
PMID:19244175
NCBI chr11:67,398,183...67,401,858
Ensembl chr11:67,398,181...67,421,183
G
PPP1R10
protein phosphatase 1 regulatory subunit 10
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R10 mRNA Selenium results in increased expression of PPP1R10 mRNA
CTD
PMID:19244175
NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612
G
PPP1R14B
protein phosphatase 1 regulatory inhibitor subunit 14B
increases expression
EXP
Selenium results in increased expression of PPP1R14B mRNA
CTD
PMID:19244175
NCBI chr11:64,244,479...64,246,943
Ensembl chr11:64,244,479...64,246,943
G
PPP1R9A
protein phosphatase 1 regulatory subunit 9A
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA Selenium results in decreased expression of PPP1R9A mRNA
CTD
PMID:19244175
NCBI chr 7:94,907,236...95,296,415
Ensembl chr 7:94,907,202...95,296,415
G
PPP2R1A
protein phosphatase 2 scaffold subunit Aalpha
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PPP2R1A mRNA Selenium results in increased expression of PPP2R1A mRNA
CTD
PMID:19244175
NCBI chr19:52,190,052...52,229,518
Ensembl chr19:52,170,936...52,229,518
G
PPP2R5D
protein phosphatase 2 regulatory subunit B'delta
increases expression
EXP
Selenium results in increased expression of PPP2R5D mRNA
CTD
PMID:19244175
NCBI chr 6:42,984,570...43,012,342
Ensembl chr 6:42,984,553...43,012,342
G
PPP2R5E
protein phosphatase 2 regulatory subunit B'epsilon
decreases expression
EXP
Selenium results in decreased expression of PPP2R5E mRNA
CTD
PMID:19244175
NCBI chr14:63,371,364...63,543,377
Ensembl chr14:63,371,364...63,543,377
G
PPP4C
protein phosphatase 4 catalytic subunit
increases expression
EXP
Selenium results in increased expression of PPP4C mRNA
CTD
PMID:19244175
NCBI chr16:30,075,994...30,085,376
Ensembl chr16:30,075,978...30,085,376
G
PPP6R2
protein phosphatase 6 regulatory subunit 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PPP6R2 mRNA Selenium results in increased expression of PPP6R2 mRNA
CTD
PMID:19244175
NCBI chr22:50,330,774...50,445,090
Ensembl chr22:50,343,304...50,445,090
G
PRAF2
PRA1 domain family member 2
increases expression
EXP
Selenium results in increased expression of PRAF2 mRNA
CTD
PMID:19244175
NCBI chr X:49,071,161...49,074,002
Ensembl chr X:49,071,161...49,074,002
G
PRDM2
PR/SET domain 2
increases expression
EXP
Selenium results in increased expression of PRDM2 mRNA
CTD
PMID:19244175
NCBI chr 1:13,700,188...13,825,079
Ensembl chr 1:13,700,188...13,825,079
G
PRDX2
peroxiredoxin 2
decreases expression
ISO
Selenium deficiency results in decreased expression of PRDX2 mRNA
CTD
PMID:15792362
NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
G
PRICKLE2
prickle planar cell polarity protein 2
decreases methylation
EXP
Selenium results in decreased methylation of PRICKLE2 gene
CTD
PMID:21606628
NCBI chr 3:64,092,236...64,268,173
Ensembl chr 3:64,092,236...64,445,476
G
PRKAG1
protein kinase AMP-activated non-catalytic subunit gamma 1
increases expression
EXP
Selenium results in increased expression of PRKAG1 mRNA
CTD
PMID:19244175
NCBI chr12:49,002,274...49,018,776
Ensembl chr12:49,002,274...49,018,807
G
PRKCB
protein kinase C beta
decreases expression
EXP
Selenium results in decreased expression of PRKCB mRNA
CTD
PMID:19244175
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PRKCI
protein kinase C iota
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PRKCI mRNA Selenium results in decreased expression of PRKCI mRNA
CTD
PMID:19244175
NCBI chr 3:170,222,424...170,305,977
Ensembl chr 3:170,222,424...170,305,977
G
PRKD2
protein kinase D2
increases expression
EXP
Selenium results in increased expression of PRKD2 mRNA
CTD
PMID:19244175
NCBI chr19:46,674,316...46,717,114
Ensembl chr19:46,674,275...46,717,127
G
PRMT1
protein arginine methyltransferase 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PRMT1 mRNA Selenium results in increased expression of PRMT1 mRNA
CTD
PMID:19244175
NCBI chr19:49,676,153...49,688,447
Ensembl chr19:49,675,786...49,689,029
G
PRMT2
protein arginine methyltransferase 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PRMT2 mRNA Selenium results in increased expression of PRMT2 mRNA
CTD
PMID:19244175
NCBI chr21:46,635,674...46,665,124
Ensembl chr21:46,635,595...46,665,124
G
PRMT3
protein arginine methyltransferase 3
decreases expression
EXP
Selenium results in decreased expression of PRMT3 mRNA
CTD
PMID:19244175
NCBI chr11:20,387,716...20,509,338
Ensembl chr11:20,387,558...20,509,338
G
PRMT5
protein arginine methyltransferase 5
increases expression
EXP
Selenium results in increased expression of PRMT5 mRNA
CTD
PMID:19244175
NCBI chr14:22,920,529...22,929,376
Ensembl chr14:22,920,525...22,929,408
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of PROC mRNA
CTD
PMID:21481475
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PRP4K
pre-mRNA processing factor kinase PRP4K
decreases expression
EXP
Selenium results in decreased expression of PRP4K mRNA
CTD
PMID:19244175
NCBI chr 6:4,021,300...4,064,983
Ensembl chr 6:4,021,267...4,064,983
G
PRPF40A
pre-mRNA processing factor 40 homolog A
decreases expression
EXP
Selenium results in decreased expression of PRPF40A mRNA
CTD
PMID:19244175
NCBI chr 2:152,651,732...152,718,019
Ensembl chr 2:152,651,593...152,718,012
G
PRPF6
pre-mRNA processing factor 6
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PRPF6 mRNA Selenium results in increased expression of PRPF6 mRNA
CTD
PMID:19244175
NCBI chr20:63,981,132...64,033,100
Ensembl chr20:63,981,132...64,033,100
G
PRPF8
pre-mRNA processing factor 8
increases expression
EXP
Selenium results in increased expression of PRPF8 mRNA
CTD
PMID:19244175
NCBI chr17:1,650,629...1,684,867
Ensembl chr17:1,650,629...1,684,867
G
PRRC2C
proline rich coiled-coil 2C
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PRRC2C mRNA Selenium results in decreased expression of PRRC2C mRNA
CTD
PMID:19244175
NCBI chr 1:171,485,530...171,593,511
Ensembl chr 1:171,485,530...171,593,511
G
PRSS8
serine protease 8
increases expression
EXP
Selenium results in increased expression of PRSS8 mRNA
CTD
PMID:19244175
NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727
G
PRUNE1
prune exopolyphosphatase 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PRUNE1 mRNA
CTD
PMID:19244175
NCBI chr 1:151,008,449...151,035,713
Ensembl chr 1:151,008,420...151,035,713
G
PRX
periaxin
increases expression
EXP
Selenium results in increased expression of PRX mRNA
CTD
PMID:19244175
NCBI chr19:40,393,764...40,414,789
Ensembl chr19:40,393,766...40,414,793
G
PSAP
prosaposin
increases expression
EXP
Selenium results in increased expression of PSAP mRNA
CTD
PMID:19244175
NCBI chr10:71,816,298...71,851,251
Ensembl chr10:71,816,298...71,851,251
G
PSIP1
PC4 and SRSF1 interacting protein 1
decreases expression
EXP
Selenium results in decreased expression of PSIP1 mRNA
CTD
PMID:19244175
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
G
PSMB10
proteasome 20S subunit beta 10
increases expression
EXP
Selenium results in increased expression of PSMB10 mRNA
CTD
PMID:19244175
NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864
G
PSMB4
proteasome 20S subunit beta 4
increases expression
EXP
Selenium results in increased expression of PSMB4 mRNA
CTD
PMID:19244175
NCBI chr 1:151,399,573...151,401,937
Ensembl chr 1:151,399,560...151,401,937
G
PSMC1
proteasome 26S subunit, ATPase 1
increases expression
EXP
Selenium results in increased expression of PSMC1 mRNA
CTD
PMID:19244175
NCBI chr14:90,256,553...90,275,429
Ensembl chr14:90,256,527...90,275,429
G
PSMC4
proteasome 26S subunit, ATPase 4
increases expression
EXP
Selenium results in increased expression of PSMC4 mRNA
CTD
PMID:19244175
NCBI chr19:39,971,165...39,981,764
Ensembl chr19:39,971,165...39,981,764
G
PSMD4
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
increases expression
EXP
Selenium results in increased expression of PSMD4 mRNA
CTD
PMID:19244175
NCBI chr 1:151,254,734...151,267,479
Ensembl chr 1:151,254,709...151,267,479
G
PSMD6
proteasome 26S subunit, non-ATPase 6
increases expression
EXP
Selenium results in increased expression of PSMD6 mRNA
CTD
PMID:19244175
NCBI chr 3:64,010,551...64,024,007
Ensembl chr 3:64,010,550...64,024,010
G
PSMD8
proteasome 26S subunit, non-ATPase 8
increases expression
EXP
Selenium results in increased expression of PSMD8 mRNA
CTD
PMID:19244175
NCBI chr19:38,374,571...38,383,824
Ensembl chr19:38,374,563...38,383,850
G
PSME1
proteasome activator subunit 1
increases expression
EXP
Selenium results in increased expression of PSME1 mRNA
CTD
PMID:19244175
NCBI chr14:24,136,194...24,138,962
Ensembl chr14:24,136,163...24,138,967
G
PTAFR
platelet activating factor receptor
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PTAFR mRNA
CTD
PMID:21481475
NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936
G
PTGDS
prostaglandin D2 synthase
increases expression
EXP
Selenium results in increased expression of PTGDS mRNA
CTD
PMID:19244175
NCBI chr 9:136,977,504...136,981,742
Ensembl chr 9:136,975,092...136,981,742
G
PTGES
prostaglandin E synthase
multiple interactions increases expression
EXP ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of PTGES mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of PTGES protein Selenium results in increased expression of PTGES mRNA
CTD
PMID:19244175 PMID:21669866
NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
G
PTGR1
prostaglandin reductase 1
affects expression
ISO
Selenium affects the expression of PTGR1 protein
CTD
PMID:19351701
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]; Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Selenium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA]; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 protein
CTD
PMID:11978490 PMID:17439952 PMID:22223226 PMID:30526071
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTMS
parathymosin
increases expression
EXP
Selenium results in increased expression of PTMS mRNA
CTD
PMID:19244175
NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952
G
PTOV1
PTOV1 extended AT-hook containing adaptor protein
increases expression
EXP
Selenium results in increased expression of PTOV1 mRNA
CTD
PMID:19244175
NCBI chr19:49,850,705...49,860,742
Ensembl chr19:49,850,735...49,860,744
G
PTPA
protein phosphatase 2 phosphatase activator
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PTPA mRNA Selenium results in increased expression of PTPA mRNA
CTD
PMID:19244175
NCBI chr 9:129,110,950...129,148,946
Ensembl chr 9:129,110,950...129,148,946
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
increases expression multiple interactions decreases glutathionylation
ISO
Selenium results in increased expression of PTPN1 protein Selenium inhibits the reaction [Potassium Iodide results in decreased expression of PTPN1 mRNA] Selenium results in decreased glutathionylation of PTPN1 protein
CTD
PMID:19022953 PMID:38013145
NCBI chr20:50,510,383...50,585,241
Ensembl chr20:50,510,321...50,585,241
G
PTPN18
protein tyrosine phosphatase non-receptor type 18
increases expression
EXP
Selenium results in increased expression of PTPN18 mRNA
CTD
PMID:19244175
NCBI chr 2:130,356,056...130,375,405
Ensembl chr 2:130,356,045...130,375,405
G
PTPN6
protein tyrosine phosphatase non-receptor type 6
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of PTPN6 mRNA Selenium results in increased expression of PTPN6 mRNA
CTD
PMID:19244175
NCBI chr12:6,946,577...6,961,316
Ensembl chr12:6,946,468...6,961,316
G
PTPRO
protein tyrosine phosphatase receptor type O
decreases expression
EXP
Selenium results in decreased expression of PTPRO mRNA
CTD
PMID:19244175
NCBI chr12:15,322,508...15,598,331
Ensembl chr12:15,322,257...15,602,175
G
PTX3
pentraxin 3
increases expression
EXP
Selenium results in increased expression of PTX3 mRNA
CTD
PMID:17293063
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
PUF60
poly(U) binding splicing factor 60
increases expression
EXP
Selenium results in increased expression of PUF60 mRNA
CTD
PMID:19244175
NCBI chr 8:143,816,344...143,829,315
Ensembl chr 8:143,816,344...143,830,709
G
PWP1
PWP1 homolog, endonuclein
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PWP1 mRNA Selenium results in decreased expression of PWP1 mRNA
CTD
PMID:19244175
NCBI chr12:107,685,799...107,713,162
Ensembl chr12:107,685,799...107,713,162
G
PYCARD
PYD and CARD domain containing
increases expression
EXP
Selenium results in increased expression of PYCARD mRNA
CTD
PMID:19244175
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
G
PYCR3
pyrroline-5-carboxylate reductase 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PYCR3 mRNA
CTD
PMID:19244175
NCBI chr 8:143,603,210...143,609,575
Ensembl chr 8:143,603,210...143,609,773
G
PYGB
glycogen phosphorylase B
increases expression
EXP
Selenium results in increased expression of PYGB mRNA
CTD
PMID:19244175
NCBI chr20:25,248,085...25,298,012
Ensembl chr20:25,248,085...25,298,012
G
QTRT1
queuine tRNA-ribosyltransferase catalytic subunit 1
increases expression multiple interactions
EXP
Selenium results in increased expression of QTRT1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of QTRT1 mRNA
CTD
PMID:19244175
NCBI chr19:10,701,439...10,713,365
Ensembl chr19:10,701,430...10,713,437
G
R3HDM1
R3H domain containing 1
decreases expression
EXP
Selenium results in decreased expression of R3HDM1 mRNA
CTD
PMID:19244175
NCBI chr 2:135,531,484...135,725,269
Ensembl chr 2:135,531,455...135,725,270
G
RAB11B
RAB11B, member RAS oncogene family
increases expression
EXP
Selenium results in increased expression of RAB11B mRNA
CTD
PMID:19244175
NCBI chr19:8,390,360...8,404,434
Ensembl chr19:8,389,981...8,404,434
G
RAB14
RAB14, member RAS oncogene family
decreases expression
EXP
Selenium results in decreased expression of RAB14 mRNA
CTD
PMID:19244175
NCBI chr 9:121,178,133...121,201,869
Ensembl chr 9:121,178,133...121,223,014
G
RAB25
RAB25, member RAS oncogene family
increases expression
EXP
Selenium results in increased expression of RAB25 mRNA
CTD
PMID:19244175
NCBI chr 1:156,061,160...156,070,504
Ensembl chr 1:156,061,160...156,070,504
G
RAB2A
RAB2A, member RAS oncogene family
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RAB2 mRNA Selenium results in increased expression of RAB2 mRNA
CTD
PMID:19244175
NCBI chr 8:60,516,910...60,623,644
Ensembl chr 8:60,516,936...60,623,644
G
RABAC1
Rab acceptor 1
increases expression
EXP
Selenium results in increased expression of RABAC1 mRNA
CTD
PMID:19244175
NCBI chr19:41,956,683...41,959,321
Ensembl chr19:41,956,681...41,959,321
G
RABGAP1
RAB GTPase activating protein 1
decreases expression
EXP
Selenium results in decreased expression of RABGAP1 mRNA
CTD
PMID:19244175
NCBI chr 9:122,931,671...123,104,866
Ensembl chr 9:122,940,833...123,104,866
G
RAD23A
RAD23 homolog A, nucleotide excision repair protein
increases expression
EXP
Selenium results in increased expression of RAD23A mRNA
CTD
PMID:19244175
NCBI chr19:12,945,862...12,953,642
Ensembl chr19:12,945,855...12,953,642
G
RAD23B
RAD23 homolog B, nucleotide excision repair protein
decreases expression
EXP
Selenium results in decreased expression of RAD23B mRNA
CTD
PMID:19244175
NCBI chr 9:107,283,279...107,332,194
Ensembl chr 9:107,283,137...107,332,192
G
RALBP1
ralA binding protein 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of RALBP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA
CTD
PMID:19244175
NCBI chr18:9,475,009...9,538,114
Ensembl chr18:9,475,009...9,538,114
G
RALGPS1
Ral GEF with PH domain and SH3 binding motif 1
decreases expression
EXP
Selenium results in decreased expression of RALGPS1 mRNA
CTD
PMID:19244175
NCBI chr 9:126,914,782...127,223,166
Ensembl chr 9:126,914,774...127,223,166
G
RALY
RALY heterogeneous nuclear ribonucleoprotein
increases expression
EXP
Selenium results in increased expression of RALY mRNA
CTD
PMID:19244175
NCBI chr20:33,993,911...34,084,884
Ensembl chr20:33,993,646...34,108,308
G
RANBP2
RAN binding protein 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA Selenium results in decreased expression of RANBP2 mRNA
CTD
PMID:19244175
NCBI chr 2:108,719,482...109,842,301
Ensembl chr 2:108,719,482...108,785,810
G
RANBP3
RAN binding protein 3
increases expression
EXP
Selenium results in increased expression of RANBP3 mRNA
CTD
PMID:19244175
NCBI chr19:5,916,139...5,978,140
Ensembl chr19:5,916,139...5,978,142
G
RANBP9
RAN binding protein 9
decreases expression
EXP
Selenium results in decreased expression of RANBP9 mRNA
CTD
PMID:19244175
NCBI chr 6:13,621,498...13,711,835
Ensembl chr 6:13,621,498...13,711,835
G
RANGAP1
Ran GTPase activating protein 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA Selenium results in increased expression of RANGAP1 mRNA
CTD
PMID:19244175
NCBI chr22:41,244,779...41,302,369
Ensembl chr22:41,244,779...41,286,187
G
RAPGEF6
Rap guanine nucleotide exchange factor 6
decreases expression
EXP
Selenium results in decreased expression of RAPGEF6 mRNA
CTD
PMID:19244175
NCBI chr 5:131,423,921...131,635,229
Ensembl chr 5:131,423,921...131,635,231
G
RASSF1
Ras association domain family member 1
increases expression
EXP
Selenium results in increased expression of RASSF1 mRNA
CTD
PMID:19244175
NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980
G
RASSF7
Ras association domain family member 7
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA
CTD
PMID:19244175
NCBI chr11:560,970...564,025
Ensembl chr11:560,404...564,025
G
RBBP4
RB binding protein 4, chromatin remodeling factor
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RBBP4 mRNA
CTD
PMID:19244175
NCBI chr 1:32,651,208...32,686,211
Ensembl chr 1:32,651,142...32,686,211
G
RBBP6
RB binding protein 6, ubiquitin ligase
decreases expression multiple interactions
EXP
Selenium results in decreased expression of RBBP6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RBBP6 mRNA
CTD
PMID:19244175
NCBI chr16:24,539,566...24,572,863
Ensembl chr16:24,537,693...24,572,863
G
RBCK1
RANBP2-type and C3HC4-type zinc finger containing 1
increases expression
EXP
Selenium results in increased expression of RBCK1 mRNA
CTD
PMID:19244175
NCBI chr20:408,299...432,139
Ensembl chr20:407,498...432,139
G
RBM10
RNA binding motif protein 10
increases expression
EXP
Selenium results in increased expression of RBM10 mRNA
CTD
PMID:19244175
NCBI chr X:47,145,221...47,186,813
Ensembl chr X:47,145,221...47,186,813
G
RBM14
RNA binding motif protein 14
increases expression
EXP
Selenium results in increased expression of RBM14 mRNA
CTD
PMID:19244175
NCBI chr11:66,616,630...66,629,934
Ensembl chr11:66,616,626...66,629,934
G
RBM25
RNA binding motif protein 25
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RBM25 mRNA Selenium results in decreased expression of RBM25 mRNA
CTD
PMID:19244175
NCBI chr14:73,058,534...73,123,899
Ensembl chr14:73,058,532...73,123,899
G
RBM4
RNA binding motif protein 4
decreases expression
EXP
Selenium results in decreased expression of RBM4 mRNA
CTD
PMID:19244175
NCBI chr11:66,638,703...66,668,380
Ensembl chr11:66,638,667...66,668,374
G
RBM42
RNA binding motif protein 42
increases expression
EXP
Selenium results in increased expression of RBM42 mRNA
CTD
PMID:19244175
NCBI chr19:35,629,036...35,637,685
Ensembl chr19:35,629,030...35,637,686
G
RBM5
RNA binding motif protein 5
increases expression
EXP
Selenium results in increased expression of RBM5 mRNA
CTD
PMID:19244175
NCBI chr 3:50,088,919...50,119,021
Ensembl chr 3:50,088,919...50,119,021
G
RBMS1
RNA binding motif single stranded interacting protein 1
decreases expression increases expression
EXP
Selenium results in decreased expression of RBMS1 mRNA Selenium results in increased expression of RBMS1 mRNA
CTD
PMID:19244175
NCBI chr 2:160,272,151...160,493,807
Ensembl chr 2:160,272,151...160,493,807
G
RBPMS
RNA binding protein, mRNA processing factor
increases expression
EXP
Selenium results in increased expression of RBPMS mRNA
CTD
PMID:19244175
NCBI chr 8:30,384,541...30,572,256
Ensembl chr 8:30,384,511...30,572,256
G
RCHY1
ring finger and CHY zinc finger domain containing 1
decreases expression
EXP
Selenium results in decreased expression of RCHY1 mRNA
CTD
PMID:19244175
NCBI chr 4:75,479,033...75,514,715
Ensembl chr 4:75,479,033...75,514,764
G
RCOR3
REST corepressor 3
decreases expression
EXP
Selenium results in decreased expression of RCOR3 mRNA
CTD
PMID:19244175
NCBI chr 1:211,259,366...211,316,385
Ensembl chr 1:211,258,377...211,316,385
G
RDH11
retinol dehydrogenase 11
decreases expression
EXP
Selenium results in decreased expression of RDH11 mRNA
CTD
PMID:19244175
NCBI chr14:67,676,800...67,695,764
Ensembl chr14:67,676,800...67,695,793
G
RECK
reversion inducing cysteine rich protein with kazal motifs
decreases expression
EXP
Selenium results in decreased expression of RECK mRNA
CTD
PMID:19244175
NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455
G
RECQL
RecQ like helicase
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RECQL mRNA Selenium results in decreased expression of RECQL mRNA
CTD
PMID:19244175
NCBI chr12:21,468,910...21,501,635
Ensembl chr12:21,468,910...21,501,669
G
RECQL5
RecQ like helicase 5
increases expression
EXP
Selenium results in increased expression of RECQL5 mRNA
CTD
PMID:19244175
NCBI chr17:75,626,854...75,667,154
Ensembl chr17:75,626,845...75,667,189
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression
ISO EXP
Selenium inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] [Vitamin E co-treated with Selenium] results in decreased activity of RELA protein; Selenium inhibits the reaction [arsenite results in decreased expression of RELA protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of RELA protein Selenium results in increased expression of RELA mRNA
CTD
PMID:14734799 PMID:19244175 PMID:21481475 PMID:22223226 PMID:29324385
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RETREG2
reticulophagy regulator family member 2
increases expression
EXP
Selenium results in increased expression of RETREG2 mRNA
CTD
PMID:19244175
NCBI chr 2:219,178,275...219,185,475
Ensembl chr 2:219,176,225...219,185,475
G
RFTN1
raftlin, lipid raft linker 1
increases expression
EXP
Selenium results in increased expression of RFTN1 mRNA
CTD
PMID:19244175
NCBI chr 3:16,315,845...16,513,699
Ensembl chr 3:16,313,574...16,514,026
G
RGPD8
RANBP2 like and GRIP domain containing 8
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RGPD8 mRNA Selenium results in decreased expression of RGPD8 mRNA
CTD
PMID:19244175
NCBI chr 2:112,368,369...112,433,645
Ensembl chr 2:112,368,369...112,434,488 Ensembl chr 2:112,368,369...112,434,488
G
RHBDD3
rhomboid domain containing 3
increases expression
EXP
Selenium results in increased expression of RHBDD3 mRNA
CTD
PMID:19244175
NCBI chr22:29,259,852...29,268,163
Ensembl chr22:29,259,872...29,268,209
G
RHOBTB1
Rho related BTB domain containing 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB1 mRNA Selenium results in decreased expression of RHOBTB1 mRNA
CTD
PMID:19244175
NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,440
G
RHOBTB3
Rho related BTB domain containing 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA Selenium results in decreased expression of RHOBTB3 mRNA
CTD
PMID:19244175
NCBI chr 5:95,717,624...95,796,361
Ensembl chr 5:95,713,522...95,824,383
G
RHOG
ras homolog family member G
increases expression
EXP
Selenium results in increased expression of RHOG mRNA
CTD
PMID:19244175
NCBI chr11:3,826,978...3,840,959
Ensembl chr11:3,826,978...3,840,959
G
RING1
ring finger protein 1
increases expression
EXP
Selenium results in increased expression of RING1 mRNA
CTD
PMID:19244175
NCBI chr 6:33,208,500...33,212,716
Ensembl chr 6:33,208,500...33,212,722
G
RNASEH1
ribonuclease H1
decreases expression
EXP
Selenium results in decreased expression of RNASEH1 mRNA
CTD
PMID:19244175
NCBI chr 2:3,531,813...3,558,333
Ensembl chr 2:3,541,430...3,558,333
G
RND1
Rho family GTPase 1
increases expression
EXP
Selenium results in increased expression of RND1 mRNA
CTD
PMID:19244175
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
G
RND3
Rho family GTPase 3
decreases expression
EXP
Selenium results in decreased expression of RND3 mRNA
CTD
PMID:19244175
NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011
G
RNF111
ring finger protein 111
decreases expression
EXP
Selenium results in decreased expression of RNF111 mRNA
CTD
PMID:19244175
NCBI chr15:58,987,663...59,097,419
Ensembl chr15:58,865,175...59,097,419
G
RNF114
ring finger protein 114
increases expression
EXP
Selenium results in increased expression of RNF114 mRNA
CTD
PMID:19244175
NCBI chr20:49,936,397...49,953,885
Ensembl chr20:49,936,336...49,953,885
G
RNF220
ring finger protein 220
increases expression
EXP
Selenium results in increased expression of RNF220 mRNA
CTD
PMID:19244175
NCBI chr 1:44,404,783...44,651,724
Ensembl chr 1:44,405,194...44,651,723
G
RNF40
ring finger protein 40
increases expression
EXP
Selenium results in increased expression of RNF40 mRNA
CTD
PMID:19244175
NCBI chr16:30,761,612...30,776,307
Ensembl chr16:30,761,745...30,776,307
G
RNH1
ribonuclease/angiogenin inhibitor 1
increases expression
EXP
Selenium results in increased expression of RNH1 mRNA
CTD
PMID:19244175
NCBI chr11:494,515...507,242
Ensembl chr11:494,512...507,300
G
RNPEP
arginyl aminopeptidase
increases expression
EXP
Selenium results in increased expression of RNPEP mRNA
CTD
PMID:19244175
NCBI chr 1:201,982,648...202,006,143
Ensembl chr 1:201,982,372...202,006,147
G
RNPS1
RNA binding protein with serine rich domain 1
increases expression
EXP
Selenium results in increased expression of RNPS1 mRNA
CTD
PMID:19244175
NCBI chr16:2,253,116...2,268,126
Ensembl chr16:2,253,116...2,268,397
G
RO60
Ro60, Y RNA binding protein
decreases expression
EXP
Selenium results in decreased expression of RO60 mRNA
CTD
PMID:19244175
NCBI chr 1:193,059,612...193,091,777
Ensembl chr 1:193,059,454...193,091,777
G
RPL10A
ribosomal protein L10a
decreases expression
EXP
Selenium results in decreased expression of RPL10A mRNA
CTD
PMID:19244175
NCBI chr 6:35,468,401...35,470,780
Ensembl chr 6:35,468,401...35,470,785
G
RPL14
ribosomal protein L14
decreases expression
EXP
Selenium results in decreased expression of RPL14 mRNA
CTD
PMID:19244175
NCBI chr 3:40,457,339...40,468,587
Ensembl chr 3:40,457,292...40,468,587
G
RPL23
ribosomal protein L23
decreases expression
EXP
Selenium results in decreased expression of RPL23 mRNA
CTD
PMID:19244175
NCBI chr17:38,847,860...38,853,721
Ensembl chr17:38,847,860...38,853,764
G
RPL27
ribosomal protein L27
decreases expression
EXP
Selenium results in decreased expression of RPL27 mRNA
CTD
PMID:19244175
NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,959
G
RPL31
ribosomal protein L31
decreases expression
EXP
Selenium results in decreased expression of RPL31 mRNA
CTD
PMID:19244175
NCBI chr 2:101,002,289...101,019,724
Ensembl chr 2:101,002,229...101,024,032
G
RPL37A
ribosomal protein L37a
decreases expression
EXP
Selenium results in decreased expression of RPL37A mRNA
CTD
PMID:19244175
NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,825...216,579,180
G
RPL38
ribosomal protein L38
decreases expression
EXP
Selenium results in decreased expression of RPL38 mRNA
CTD
PMID:19244175
NCBI chr17:74,203,678...74,210,655
Ensembl chr17:74,203,582...74,210,655
G
RPL39
ribosomal protein L39
decreases expression
EXP
Selenium results in decreased expression of RPL39 mRNA
CTD
PMID:19244175
NCBI chr X:119,786,504...119,791,630
Ensembl chr X:119,786,504...119,791,630
G
RPL7
ribosomal protein L7
decreases expression
EXP
Selenium results in decreased expression of RPL7 mRNA
CTD
PMID:19244175
NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789
G
RPRD2
regulation of nuclear pre-mRNA domain containing 2
increases expression
EXP
Selenium results in increased expression of RPRD2 mRNA
CTD
PMID:19244175
NCBI chr 1:150,364,147...150,476,566
Ensembl chr 1:150,363,091...150,476,566
G
RPS20
ribosomal protein S20
decreases expression
EXP
Selenium results in decreased expression of RPS20 mRNA
CTD
PMID:19244175
NCBI chr 8:56,067,254...56,074,506
Ensembl chr 8:56,067,254...56,074,510
G
RPS21
ribosomal protein S21
decreases expression
EXP
Selenium results in decreased expression of RPS21 mRNA
CTD
PMID:19244175
NCBI chr20:62,387,103...62,388,520
Ensembl chr20:62,387,103...62,388,520
G
RPS25
ribosomal protein S25
decreases expression
EXP
Selenium results in decreased expression of RPS25 mRNA
CTD
PMID:19244175
NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,712...119,018,691
G
RPS27
ribosomal protein S27
decreases expression
EXP
Selenium results in decreased expression of RPS27 mRNA
CTD
PMID:19244175
NCBI chr 1:153,990,762...153,992,155
Ensembl chr 1:153,990,762...153,992,155
G
RPS27L
ribosomal protein S27 like
decreases expression
EXP
Selenium results in decreased expression of RPS27L mRNA
CTD
PMID:19244175
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
RPS29
ribosomal protein S29
decreases expression
EXP
Selenium results in decreased expression of RPS29 mRNA
CTD
PMID:19244175
NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164
G
RPS6KA1
ribosomal protein S6 kinase A1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA Selenium results in increased expression of RPS6KA1 mRNA
CTD
PMID:19244175
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
RPS6KA2
ribosomal protein S6 kinase A2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA Selenium results in increased expression of RPS6KA2 mRNA
CTD
PMID:19244175
NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451
G
RPS7
ribosomal protein S7
decreases expression
EXP
Selenium results in decreased expression of RPS7 mRNA
CTD
PMID:19244175
NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
G
RRBP1
ribosome binding protein 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA
CTD
PMID:19244175
NCBI chr20:17,613,679...17,682,242
Ensembl chr20:17,613,678...17,682,295
G
RRP1
ribosomal RNA processing 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of RRP1 mRNA Selenium results in increased expression of RRP1 mRNA
CTD
PMID:19244175
NCBI chr21:43,789,577...43,805,293
Ensembl chr21:43,789,513...43,805,293
G
RRP7A
ribosomal RNA processing 7 homolog A
increases expression
EXP
Selenium results in increased expression of RRP7A mRNA
CTD
PMID:19244175
NCBI chr22:42,508,344...42,519,796
Ensembl chr22:42,508,344...42,519,796
G
RSAD1
radical S-adenosyl methionine domain containing 1
increases expression
EXP
Selenium results in increased expression of RSAD1 mRNA
CTD
PMID:19244175
NCBI chr17:50,478,860...50,485,974
Ensembl chr17:50,478,860...50,485,974
G
RSRC2
arginine and serine rich coiled-coil 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RSRC2 mRNA Selenium results in decreased expression of RSRC2 mRNA
CTD
PMID:19244175
NCBI chr12:122,503,454...122,526,936
Ensembl chr12:122,503,454...122,527,000
G
RSRP1
arginine and serine rich protein 1
decreases expression
EXP
Selenium results in decreased expression of RSRP1 mRNA
CTD
PMID:19244175
NCBI chr 1:25,242,249...25,338,254
Ensembl chr 1:25,242,249...25,338,213
G
RTL8A
retrotransposon Gag like 8A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RTL8A mRNA
CTD
PMID:19244175
NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196
G
RUFY3
RUN and FYVE domain containing 3
decreases expression
EXP
Selenium results in decreased expression of RUFY3 mRNA
CTD
PMID:19244175
NCBI chr 4:70,703,767...70,808,619
Ensembl chr 4:70,704,204...70,808,619
G
RUNX1T1
RUNX1 partner transcriptional co-repressor 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:19244175
NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,972...92,103,385
G
RUSC2
RUN and SH3 domain containing 2
increases expression
EXP
Selenium results in increased expression of RUSC2 mRNA
CTD
PMID:19244175
NCBI chr 9:35,490,111...35,561,895
Ensembl chr 9:35,490,111...35,561,898
G
RUVBL1
RuvB like AAA ATPase 1
increases expression
EXP
Selenium results in increased expression of RUVBL1 mRNA
CTD
PMID:19244175
NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914
G
RUVBL2
RuvB like AAA ATPase 2
increases expression
EXP
Selenium results in increased expression of RUVBL2 mRNA
CTD
PMID:19244175
NCBI chr19:48,993,448...49,015,995
Ensembl chr19:48,993,562...49,015,970
G
RXRA
retinoid X receptor alpha
increases expression
EXP
Selenium results in increased expression of RXRA protein
CTD
PMID:15318950
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
RYBP
RING1 and YY1 binding protein
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of RYBP mRNA Selenium results in decreased expression of RYBP mRNA
CTD
PMID:19244175
NCBI chr 3:72,374,597...72,446,623
Ensembl chr 3:72,371,825...72,446,621
G
S100A11
S100 calcium binding protein A11
increases expression
EXP
Selenium results in increased expression of S100A11 mRNA
CTD
PMID:19244175
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
G
S100A6
S100 calcium binding protein A6
increases expression
EXP
Selenium results in increased expression of S100A6 mRNA
CTD
PMID:19244175
NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244
G
SACS
sacsin molecular chaperone
decreases expression
EXP
Selenium results in decreased expression of SACS mRNA
CTD
PMID:19244175
NCBI chr13:23,328,830...23,433,702
Ensembl chr13:23,288,689...23,433,763
G
SAFB
scaffold attachment factor B
increases expression
EXP
Selenium results in increased expression of SAFB mRNA
CTD
PMID:19244175
NCBI chr19:5,623,083...5,668,478
Ensembl chr19:5,623,035...5,668,478
G
SAFB2
scaffold attachment factor B2
increases expression
EXP
Selenium results in increased expression of SAFB2 mRNA
CTD
PMID:19244175
NCBI chr19:5,586,999...5,622,776
Ensembl chr19:5,586,999...5,624,046
G
SAMM50
SAMM50 sorting and assembly machinery component
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA
CTD
PMID:19244175
NCBI chr22:43,955,442...43,996,529
Ensembl chr22:43,955,442...44,010,531
G
SAR1B
secretion associated Ras related GTPase 1B
decreases expression
EXP
Selenium results in decreased expression of SAR1B mRNA
CTD
PMID:19244175
NCBI chr 5:134,601,149...134,632,828
Ensembl chr 5:134,601,149...134,649,271
G
SARDH
sarcosine dehydrogenase
increases expression
EXP
Selenium results in increased expression of SARDH mRNA
CTD
PMID:19244175
NCBI chr 9:133,659,418...133,739,955
Ensembl chr 9:133,663,560...133,739,955
G
SART1
spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP
increases expression
EXP
Selenium results in increased expression of SART1 mRNA
CTD
PMID:19244175
NCBI chr11:65,961,734...65,980,137
Ensembl chr11:65,961,728...65,980,137
G
SART3
spliceosome associated factor 3, U4/U6 recycling protein
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SART3 mRNA
CTD
PMID:19244175
NCBI chr12:108,522,214...108,561,173
Ensembl chr12:108,522,214...108,561,400
G
SAT1
spermidine/spermine N1-acetyltransferase 1
decreases expression
EXP
Selenium results in decreased expression of SAT1 mRNA
CTD
PMID:19244175
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SATB1
SATB homeobox 1
decreases expression
EXP
Selenium results in decreased expression of SATB1 mRNA
CTD
PMID:19244175
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SCAF11
SR-related CTD associated factor 11
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SCAF11 mRNA
CTD
PMID:19244175
NCBI chr12:45,919,131...45,992,059
Ensembl chr12:45,919,131...45,992,120
G
SCAF4
SR-related CTD associated factor 4
decreases expression
EXP
Selenium results in decreased expression of SCAF4 mRNA
CTD
PMID:19244175
NCBI chr21:31,671,000...31,732,118
Ensembl chr21:31,671,000...31,732,118
G
SCAMP1
secretory carrier membrane protein 1
decreases expression
EXP
Selenium results in decreased expression of SCAMP1 mRNA
CTD
PMID:19244175
NCBI chr 5:78,360,617...78,480,739
Ensembl chr 5:78,360,611...78,480,739
G
SCAMP3
secretory carrier membrane protein 3
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SCAMP3 mRNA Selenium results in increased expression of SCAMP3 mRNA
CTD
PMID:19244175
NCBI chr 1:155,255,981...155,262,360
Ensembl chr 1:155,255,979...155,262,430
G
SCAPER
S-phase cyclin A associated protein in the ER
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SCAPER mRNA Selenium results in decreased expression of SCAPER mRNA
CTD
PMID:19244175
NCBI chr15:76,347,904...76,905,340
Ensembl chr15:76,347,904...76,905,444
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
Selenium results in decreased expression of SCD4 mRNA
CTD
PMID:19244175
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SCML1
Scm polycomb group protein like 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA Selenium results in decreased expression of SCML1 mRNA
CTD
PMID:19244175
NCBI chr X:17,737,128...17,754,985
Ensembl chr X:17,737,449...17,754,988
G
SCML2
Scm polycomb group protein like 2
decreases expression
EXP
Selenium results in decreased expression of SCML2 mRNA
CTD
PMID:19244175
NCBI chr X:18,239,313...18,355,118
Ensembl chr X:18,239,313...18,354,688
G
SCO2
synthesis of cytochrome C oxidase 2
increases expression
EXP
Selenium results in increased expression of SCO2 mRNA
CTD
PMID:19244175
NCBI chr22:50,523,568...50,526,442
Ensembl chr22:50,523,568...50,526,461
G
SCRG1
stimulator of chondrogenesis 1
decreases expression
EXP
Selenium results in decreased expression of SCRG1 mRNA
CTD
PMID:19244175
NCBI chr 4:173,384,701...173,519,144
Ensembl chr 4:173,384,701...173,406,380
G
SDC3
syndecan 3
increases expression
EXP
Selenium results in increased expression of SDC3 mRNA
CTD
PMID:19244175
NCBI chr 1:30,869,466...30,909,735
Ensembl chr 1:30,869,466...30,908,758
G
SDCCAG8
SHH signaling and ciliogenesis regulator SDCCAG8
decreases expression multiple interactions
EXP
Selenium results in decreased expression of SDCCAG8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SDCCAG8 mRNA
CTD
PMID:19244175
NCBI chr 1:243,256,041...243,500,091
Ensembl chr 1:243,256,034...243,500,091
G
SEC13
SEC13 homolog, nuclear pore and COPII coat complex component
increases expression
EXP
Selenium results in increased expression of SEC13 mRNA
CTD
PMID:19244175
NCBI chr 3:10,300,931...10,321,112
Ensembl chr 3:10,293,131...10,321,112
G
SEC16A
SEC16 homolog A, endoplasmic reticulum export factor
decreases expression
EXP
Selenium results in decreased expression of SEC16A mRNA
CTD
PMID:19244175
NCBI chr 9:136,440,105...136,484,740
Ensembl chr 9:136,440,096...136,483,759
G
SEC22B
SEC22 homolog B, vesicle trafficking protein
decreases expression
EXP
Selenium results in decreased expression of SEC22B mRNA
CTD
PMID:19244175
NCBI chr 1:120,150,898...120,176,520
Ensembl chr 1:120,150,898...120,176,520
G
SEC23B
SEC23 homolog B, COPII coat complex component
increases expression
EXP
Selenium results in increased expression of SEC23B mRNA
CTD
PMID:19244175
NCBI chr20:18,507,548...18,561,415
Ensembl chr20:18,507,520...18,561,415
G
SEC24B
SEC24 homolog B, COPII coat complex component
decreases expression
EXP
Selenium results in decreased expression of SEC24B mRNA
CTD
PMID:19244175
NCBI chr 4:109,433,815...109,540,896
Ensembl chr 4:109,433,772...109,540,896
G
SEC31A
SEC31 homolog A, COPII coat complex component
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SEC31A mRNA
CTD
PMID:19244175
NCBI chr 4:82,818,509...82,900,569
Ensembl chr 4:82,818,509...82,901,166
G
SEC62
SEC62 homolog, preprotein translocation factor
decreases expression multiple interactions
EXP
Selenium results in decreased expression of SEC62 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SEC62 mRNA
CTD
PMID:19244175
NCBI chr 3:169,966,807...169,998,373
Ensembl chr 3:169,966,635...169,998,373
G
SECISBP2L
SECIS binding protein 2 like
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA Selenium results in decreased expression of SECISBP2L mRNA
CTD
PMID:19244175
NCBI chr15:48,988,638...49,046,446
Ensembl chr15:48,988,476...49,046,447
G
SELENBP1
selenium binding protein 1
increases expression
EXP
Selenium results in increased expression of SELENBP1 mRNA; Selenium results in increased expression of SELENBP1 protein
CTD
PMID:16380993
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SELENOF
selenoprotein F
decreases expression decreases response to substance
ISO EXP
Selenium deficiency results in decreased expression of SELENOF protein SELENOF gene polymorphism results in decreased susceptibility to Selenium
CTD
PMID:15107826 PMID:16170372
NCBI chr 1:86,862,445...86,914,577
Ensembl chr 1:86,862,445...86,914,424
G
SELENOH
selenoprotein H
affects expression
ISO
Selenium affects the expression of SELH mRNA
CTD
PMID:19076066 PMID:19106321
NCBI chr11:57,741,491...57,743,550
Ensembl chr11:57,741,491...57,743,554
G
SELENOK
selenoprotein K
affects expression
ISO
Selenium affects the expression of SELENOK mRNA
CTD
PMID:19106321
NCBI chr 3:53,884,417...53,891,859
Ensembl chr 3:53,884,417...53,891,885
G
SELENOP
selenoprotein P
multiple interactions affects abundance decreases expression increases transport affects expression affects response to substance
EXP ISO
[Mercury results in increased expression of SELENOP protein] which results in increased abundance of Selenium; SELENOP gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium]; TUBA4A mutant form results in increased abundance of [Selenium binds to SELENOP protein] SELENOP protein affects the transport of and affects the abundance of Selenium SELENOP protein affects the abundance of Selenium Selenium deficiency results in decreased expression of SELENOP mRNA SELENOP protein results in increased transport of Selenium Selenium affects the expression of SELENOP protein SELENOP protein affects the susceptibility to Selenium SELENOP gene SNP affects the susceptibility to Selenium Selenium results in decreased expression of SELENOP mRNA
CTD
PMID:12521380 PMID:12574155 PMID:15638810 PMID:17014962 PMID:17314095 PMID:17709542 PMID:17961124 PMID:18172410 PMID:19074884 PMID:19234057 PMID:19244175 PMID:19351701 PMID:23038251 PMID:27989593 PMID:28478440 More...
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SELENOW
selenoprotein W
decreases expression increases expression increases degradation affects expression
EXP ISO
Selenium deficiency results in decreased expression of SELENOW mRNA Selenium results in increased expression of SELENOW mRNA Selenium deficiency results in increased degradation of SELENOW mRNA Selenium affects the expression of SELENOW mRNA; Selenium deficiency affects the expression of SELENOW protein
CTD
PMID:11330475 PMID:12405536 PMID:15670848 PMID:15823556 PMID:16170372 PMID:19076066 PMID:19106321 PMID:19234057 PMID:28810182 More...
NCBI chr19:47,778,703...47,784,682
Ensembl chr19:47,778,677...47,784,686
G
SELL
selectin L
increases expression
ISO
Selenium results in increased expression of SELL mRNA
CTD
PMID:28810182
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
G
SEM1
SEM1 26S proteasome subunit
decreases expression
EXP
Selenium results in decreased expression of SEM1 mRNA
CTD
PMID:19244175
NCBI chr 7:96,481,626...96,709,846
Ensembl chr 7:96,481,626...96,709,880
G
SEMA3B
semaphorin 3B
increases expression
EXP
Selenium results in increased expression of SEMA3B mRNA
CTD
PMID:19244175
NCBI chr 3:50,267,652...50,277,546
Ensembl chr 3:50,267,558...50,277,546
G
SEPHS2
selenophosphate synthetase 2
affects expression
ISO
Selenium affects the expression of SEPHS2 mRNA
CTD
PMID:19106321
NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
G
SERBP1
SERPINE1 mRNA binding protein 1
decreases expression
EXP
Selenium results in decreased expression of SERBP1 mRNA
CTD
PMID:19244175
NCBI chr 1:67,407,810...67,430,402
Ensembl chr 1:67,407,810...67,430,415
G
SERPINA1
serpin family A member 1
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of SERPINA1 mRNA
CTD
PMID:21481475
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINA3
serpin family A member 3
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of SERPINA3N mRNA
CTD
PMID:11444866
NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
G
SERPINF1
serpin family F member 1
increases expression
EXP
Selenium results in increased expression of SERPINF1 mRNA
CTD
PMID:19244175
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SERTAD2
SERTA domain containing 2
decreases expression
EXP
Selenium results in decreased expression of SERTAD2 mRNA
CTD
PMID:19244175
NCBI chr 2:64,631,621...64,653,913
Ensembl chr 2:64,631,621...64,751,005
G
SET
SET nuclear proto-oncogene
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA
CTD
PMID:19244175
NCBI chr 9:128,683,424...128,696,396
Ensembl chr 9:128,683,424...128,696,400
G
SETBP1
SET binding protein 1
decreases expression
EXP
Selenium results in decreased expression of SETBP1 mRNA
CTD
PMID:19244175
NCBI chr18:44,680,073...45,068,510
Ensembl chr18:44,680,173...45,068,510
G
SETD6
SET domain containing 6, protein lysine methyltransferase
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SETD6 mRNA Selenium results in decreased expression of SETD6 mRNA
CTD
PMID:19244175
NCBI chr16:58,515,479...58,523,842
Ensembl chr16:58,515,479...58,523,842
G
SETMAR
SET domain and mariner transposase fusion gene
decreases expression
EXP
Selenium results in decreased expression of SETMAR mRNA
CTD
PMID:19244175
NCBI chr 3:4,303,369...4,317,265
Ensembl chr 3:4,303,332...4,317,265
G
SF1
splicing factor 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SF1 mRNA Selenium results in decreased expression of SF1 mRNA
CTD
PMID:19244175
NCBI chr11:64,764,606...64,778,542
Ensembl chr11:64,764,606...64,778,786
G
SF3A2
splicing factor 3a subunit 2
increases expression multiple interactions
EXP
Selenium results in increased expression of SF3A2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SF3A2 mRNA
CTD
PMID:19244175
NCBI chr19:2,236,824...2,248,655
Ensembl chr19:2,236,824...2,248,655
G
SF3B1
splicing factor 3b subunit 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SF3B1 mRNA Selenium results in decreased expression of SF3B1 mRNA
CTD
PMID:19244175
NCBI chr 2:197,389,784...197,435,093
Ensembl chr 2:197,388,515...197,435,079
G
SF3B4
splicing factor 3b subunit 4
increases expression
EXP
Selenium results in increased expression of SF3B4 mRNA
CTD
PMID:19244175
NCBI chr 1:149,923,317...149,927,803
Ensembl chr 1:149,923,317...149,927,803
G
SGF29
SAGA complex associated factor 29
increases expression
EXP
Selenium results in increased expression of SGF29 mRNA
CTD
PMID:19244175
NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790
G
SGSH
N-sulfoglucosamine sulfohydrolase
increases expression
EXP
Selenium results in increased expression of SGSH mRNA
CTD
PMID:19244175
NCBI chr17:80,200,673...80,220,333
Ensembl chr17:80,206,716...80,220,923
G
SGSM3
small G protein signaling modulator 3
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SGSM3 mRNA
CTD
PMID:19244175
NCBI chr22:40,370,594...40,410,289
Ensembl chr22:40,370,591...40,410,289
G
SHANK2
SH3 and multiple ankyrin repeat domains 2
decreases expression
EXP
Selenium results in decreased expression of SHANK2 mRNA
CTD
PMID:19244175
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
G
SHB
SH2 domain containing adaptor protein B
increases expression
EXP
Selenium results in increased expression of SHB mRNA
CTD
PMID:19244175
NCBI chr 9:37,915,898...38,069,227
Ensembl chr 9:37,915,898...38,069,227
G
SHMT1
serine hydroxymethyltransferase 1
increases expression
ISO
Selenium results in increased expression of SHMT1 mRNA
CTD
PMID:28810182
NCBI chr17:18,327,873...18,363,550
Ensembl chr17:18,327,873...18,363,550
G
SIAH1
siah E3 ubiquitin protein ligase 1
decreases expression
EXP
Selenium results in decreased expression of SIAH1 mRNA
CTD
PMID:19244175
NCBI chr16:48,360,531...48,387,246
Ensembl chr16:48,356,364...48,448,402
G
SIGIRR
single Ig and TIR domain containing
increases expression
EXP
Selenium results in increased expression of SIGIRR mRNA
CTD
PMID:19244175
NCBI chr11:405,716...417,397
Ensembl chr11:405,716...417,455
G
SIN3B
SIN3 transcription regulator family member B
increases expression
EXP
Selenium results in increased expression of SIN3B mRNA
CTD
PMID:19244175
NCBI chr19:16,829,398...16,880,349
Ensembl chr19:16,829,398...16,880,353
G
SIPA1L3
signal induced proliferation associated 1 like 3
increases expression
EXP
Selenium results in increased expression of SIPA1L3 mRNA
CTD
PMID:19244175
NCBI chr19:37,907,208...38,208,369
Ensembl chr19:37,907,208...38,208,369
G
SIRPA
signal regulatory protein alpha
increases expression
EXP
Selenium results in increased expression of SIRPA mRNA
CTD
PMID:19244175
NCBI chr20:1,894,167...1,940,592
Ensembl chr20:1,894,167...1,940,592
G
SIRT1
sirtuin 1
decreases expression
EXP
Selenium results in decreased expression of SIRT1 mRNA
CTD
PMID:19244175
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SKI
SKI proto-oncogene
increases expression
EXP
Selenium results in increased expression of SKI mRNA
CTD
PMID:19244175
NCBI chr 1:2,228,319...2,310,213
Ensembl chr 1:2,227,388...2,310,213
G
SKIC3
SKI3 subunit of superkiller complex
decreases expression
EXP
Selenium results in decreased expression of SKIC3 mRNA
CTD
PMID:19244175
NCBI chr 5:95,463,894...95,554,977
Ensembl chr 5:95,461,755...95,555,050
G
SLC11A2
solute carrier family 11 member 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA
CTD
PMID:19244175
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC12A2
solute carrier family 12 member 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SLC12A2 mRNA
CTD
PMID:19244175
NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
G
SLC13A4
solute carrier family 13 member 4
affects transport multiple interactions
ISO
SLC13A4 protein affects the transport of Selenium Selenium inhibits the reaction [SLC13A4 protein affects the transport of Sulfates]
CTD
PMID:16129486
NCBI chr 7:135,681,231...135,728,186
Ensembl chr 7:135,681,231...135,729,258
G
SLC19A1
solute carrier family 19 member 1
decreases expression
EXP
Selenium results in decreased expression of SLC19A1 mRNA
CTD
PMID:19244175
NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,365
G
SLC19A2
solute carrier family 19 member 2
decreases expression
EXP
Selenium results in decreased expression of SLC19A2 mRNA
CTD
PMID:19244175
NCBI chr 1:169,463,909...169,485,970
Ensembl chr 1:169,463,909...169,485,944
G
SLC1A1
solute carrier family 1 member 1
decreases expression
EXP
Selenium results in decreased expression of SLC1A1 mRNA
CTD
PMID:19244175
NCBI chr 9:4,490,468...4,587,469
Ensembl chr 9:4,490,468...4,587,469
G
SLC22A18
solute carrier family 22 member 18
increases expression
EXP
Selenium results in increased expression of SLC22A18 mRNA
CTD
PMID:19244175
NCBI chr11:2,899,691...2,925,246
Ensembl chr11:2,899,721...2,925,246
G
SLC25A1
solute carrier family 25 member 1
increases expression
EXP
Selenium results in increased expression of SLC25A1 mRNA
CTD
PMID:19244175
NCBI chr22:19,175,581...19,178,736
Ensembl chr22:19,175,581...19,178,739
G
SLC25A12
solute carrier family 25 member 12
decreases expression
EXP
Selenium results in decreased expression of SLC25A12 mRNA
CTD
PMID:19244175
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
SLC25A16
solute carrier family 25 member 16
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA Selenium results in decreased expression of SLC25A16 mRNA
CTD
PMID:19244175
NCBI chr10:68,477,998...68,527,523
Ensembl chr10:68,477,998...68,527,523
G
SLC25A17
solute carrier family 25 member 17
decreases expression
EXP
Selenium results in decreased expression of SLC25A17 mRNA
CTD
PMID:19244175
NCBI chr22:40,769,630...40,819,346
Ensembl chr22:40,769,630...40,819,399
G
SLC25A22
solute carrier family 25 member 22
increases expression
EXP
Selenium results in increased expression of SLC25A22 mRNA
CTD
PMID:19244175
NCBI chr11:790,475...798,281
Ensembl chr11:790,475...798,281
G
SLC25A36
solute carrier family 25 member 36
decreases expression
EXP
Selenium results in decreased expression of SLC25A36 mRNA
CTD
PMID:19244175
NCBI chr 3:140,941,836...140,980,995
Ensembl chr 3:140,941,830...140,980,995
G
SLC25A37
solute carrier family 25 member 37
increases expression
EXP
Selenium results in increased expression of SLC25A37 mRNA
CTD
PMID:19244175
NCBI chr 8:23,528,956...23,575,463
Ensembl chr 8:23,528,956...23,575,463
G
SLC25A6
solute carrier family 25 member 6
increases expression
EXP
Selenium results in increased expression of SLC25A6 mRNA
CTD
PMID:19244175
NCBI chr X:1,386,152...1,392,113 NCBI chr Y:1,386,152...1,392,113
Ensembl chr X:1,386,152...1,392,113 Ensembl chr Y:1,386,152...1,392,113
G
SLC29A1
solute carrier family 29 member 1 (Augustine blood group)
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA
CTD
PMID:19244175
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
G
SLC35D1
solute carrier family 35 member D1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SLC35D1 mRNA Selenium results in decreased expression of SLC35D1 mRNA
CTD
PMID:19244175
NCBI chr 1:66,972,976...67,054,148
Ensembl chr 1:66,999,350...67,054,148
G
SLC39A1
solute carrier family 39 member 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA
CTD
PMID:19244175
NCBI chr 1:153,959,110...153,968,184
Ensembl chr 1:153,959,099...153,968,184
G
SLC39A7
solute carrier family 39 member 7
increases expression
EXP
Selenium results in increased expression of SLC39A7 mRNA
CTD
PMID:19244175
NCBI chr 6:33,200,867...33,204,437
Ensembl chr 6:33,200,305...33,204,439
G
SLC3A2
solute carrier family 3 member 2
increases expression
EXP
Selenium results in increased expression of SLC3A2 mRNA
CTD
PMID:19244175
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC44A4
solute carrier family 44 member 4
increases expression
EXP
Selenium results in increased expression of SLC44A4 mRNA
CTD
PMID:19244175
NCBI chr 6:31,863,192...31,878,997
Ensembl chr 6:31,863,192...31,879,046
G
SLC4A4
solute carrier family 4 member 4
decreases expression
EXP
Selenium results in decreased expression of SLC4A4 mRNA
CTD
PMID:19244175
NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087
G
SLC4A7
solute carrier family 4 member 7
decreases expression
EXP
Selenium results in decreased expression of SLC4A7 mRNA
CTD
PMID:19244175
NCBI chr 3:27,372,723...27,484,384
Ensembl chr 3:27,372,723...27,484,420
G
SLC5A5
solute carrier family 5 member 5
multiple interactions increases expression
ISO
Selenium inhibits the reaction [Potassium Iodide results in decreased expression of SLC5A5 mRNA] Selenium results in increased expression of SLC5A5 mRNA
CTD
PMID:38013145
NCBI chr19:17,871,945...17,895,174
Ensembl chr19:17,871,945...17,895,174
G
SLC6A2
solute carrier family 6 member 2
decreases expression
EXP
Selenium results in decreased expression of SLC6A2 mRNA
CTD
PMID:19244175
NCBI chr16:55,655,988...55,706,192
Ensembl chr16:55,655,988...55,707,645
G
SLC6A3
solute carrier family 6 member 3
increases activity increases expression
ISO
Selenium deficiency results in increased activity of DAT protein Selenium deficiency results in increased expression of DAT mRNA
CTD
PMID:11113527
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SLC6A8
solute carrier family 6 member 8
increases expression
EXP
Selenium results in increased expression of SLC6A8 mRNA
CTD
PMID:19244175
NCBI chr X:153,687,926...153,696,593
Ensembl chr X:153,687,926...153,696,588
G
SLC7A11
solute carrier family 7 member 11
increases import
EXP
SLC7A11 mRNA results in increased import of Selenium
CTD
PMID:28070112
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC7A5
solute carrier family 7 member 5
increases expression
EXP
Selenium results in increased expression of SLC7A5 mRNA
CTD
PMID:19244175
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SLC7A8
solute carrier family 7 member 8
increases expression
EXP
Selenium results in increased expression of SLC7A8 mRNA
CTD
PMID:19244175
NCBI chr14:23,125,295...23,183,660
Ensembl chr14:23,125,295...23,183,674
G
SLIT2
slit guidance ligand 2
decreases expression
EXP
Selenium results in decreased expression of SLIT2 mRNA
CTD
PMID:19244175
NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
G
SMARCA4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
increases expression
EXP
Selenium results in increased expression of SMARCA4 mRNA
CTD
PMID:19244175
NCBI chr19:10,961,030...11,062,273
Ensembl chr19:10,960,932...11,079,426
G
SMARCA5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
decreases expression
EXP
Selenium results in decreased expression of SMARCA5 mRNA
CTD
PMID:19244175
NCBI chr 4:143,513,702...143,557,486
Ensembl chr 4:143,513,702...143,557,486
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of SMARCC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA
CTD
PMID:19244175
NCBI chr 3:47,585,269...47,781,893
Ensembl chr 3:47,585,269...47,782,106
G
SMARCD2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SMARCD2 mRNA Selenium results in increased expression of SMARCD2 mRNA
CTD
PMID:19244175
NCBI chr17:63,832,081...63,842,685
Ensembl chr17:63,832,081...63,843,065
G
SMARCD3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
increases expression
EXP
Selenium results in increased expression of SMARCD3 mRNA
CTD
PMID:19244175
NCBI chr 7:151,238,780...151,277,149
Ensembl chr 7:151,238,764...151,277,896
G
SMCHD1
structural maintenance of chromosomes flexible hinge domain containing 1
decreases expression
EXP
Selenium results in decreased expression of SMCHD1 mRNA
CTD
PMID:19244175
NCBI chr18:2,655,726...2,805,017
Ensembl chr18:2,655,726...2,805,017
G
SMG5
SMG5 nonsense mediated mRNA decay factor
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA Selenium results in increased expression of SMG5 mRNA
CTD
PMID:19244175
NCBI chr 1:156,249,224...156,291,516
Ensembl chr 1:156,249,224...156,282,825
G
SMG7
SMG7 nonsense mediated mRNA decay factor
increases expression
EXP
Selenium results in increased expression of SMG7 mRNA
CTD
PMID:19244175
NCBI chr 1:183,472,499...183,554,191
Ensembl chr 1:183,472,216...183,598,246
G
SMOX
spermine oxidase
increases expression
EXP
Selenium results in increased expression of SMOX mRNA
CTD
PMID:19244175
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SMTN
smoothelin
increases expression
EXP
Selenium results in increased expression of SMTN mRNA
CTD
PMID:19244175
NCBI chr22:31,064,118...31,104,624
Ensembl chr22:31,064,105...31,104,757
G
SMURF1
SMAD specific E3 ubiquitin protein ligase 1
increases expression
EXP
Selenium results in increased expression of SMURF1 mRNA
CTD
PMID:19244175
NCBI chr 7:99,027,440...99,144,108
Ensembl chr 7:99,027,440...99,144,108
G
SMURF2
SMAD specific E3 ubiquitin protein ligase 2
decreases expression
EXP
Selenium results in decreased expression of SMURF2 mRNA
CTD
PMID:19244175
NCBI chr17:64,542,282...64,662,307
Ensembl chr17:64,542,282...64,662,307
G
SNAP25
synaptosome associated protein 25
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA Selenium results in decreased expression of SNAP25 mRNA
CTD
PMID:19244175
NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258
G
SNF8
SNF8 subunit of ESCRT-II
increases expression
EXP
Selenium results in increased expression of EAP30 mRNA
CTD
PMID:19244175
NCBI chr17:48,929,316...48,944,842
Ensembl chr17:48,929,316...48,944,842
G
SNRNP27
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
decreases expression
EXP
Selenium results in decreased expression of SNRNP27 mRNA
CTD
PMID:19244175
NCBI chr 2:69,893,956...69,905,236
Ensembl chr 2:69,893,956...69,905,575
G
SNRNP35
small nuclear ribonucleoprotein U11/U12 subunit 35
increases expression
EXP
Selenium results in increased expression of SNRNP35 mRNA
CTD
PMID:19244175
NCBI chr12:123,458,139...123,473,154
Ensembl chr12:123,458,088...123,473,154
G
SNRPB
small nuclear ribonucleoprotein polypeptides B and B1
increases expression
EXP
Selenium results in increased expression of SNRPB mRNA
CTD
PMID:19244175
NCBI chr20:2,461,642...2,470,789
Ensembl chr20:2,461,634...2,470,853
G
SNU13
small nuclear ribonucleoprotein 13
increases expression
EXP
Selenium results in increased expression of SNU13 mRNA
CTD
PMID:19244175
NCBI chr22:41,673,933...41,690,480
Ensembl chr22:41,673,933...41,690,504
G
SNX1
sorting nexin 1
increases expression
EXP
Selenium results in increased expression of SNX1 mRNA
CTD
PMID:19244175
NCBI chr15:64,095,982...64,144,231
Ensembl chr15:64,094,123...64,146,090
G
SNX17
sorting nexin 17
increases expression
EXP
Selenium results in increased expression of SNX17 mRNA
CTD
PMID:19244175
NCBI chr 2:27,370,616...27,377,535
Ensembl chr 2:27,370,496...27,377,535
G
SOBP
sine oculis binding protein homolog
decreases expression
EXP
Selenium results in decreased expression of SOBP mRNA
CTD
PMID:19244175
NCBI chr 6:107,490,117...107,661,306
Ensembl chr 6:107,490,106...107,661,306
G
SOD1
superoxide dismutase 1
decreases expression
ISO
Selenium deficiency results in decreased expression of SOD1 mRNA
CTD
PMID:11260395
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
increases expression affects response to substance multiple interactions
EXP
Selenium results in increased expression of SOD2 mRNA SOD2 gene polymorphism affects the susceptibility to Selenium; SOD2 gene SNP affects the susceptibility to Selenium SELENOP gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium]
CTD
PMID:17293063 PMID:19074884 PMID:19528373
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SON
SON DNA and RNA binding protein
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SON mRNA Selenium results in decreased expression of SON mRNA
CTD
PMID:19244175
NCBI chr21:33,543,038...33,577,481
Ensembl chr21:33,543,038...33,577,481
G
SORBS3
sorbin and SH3 domain containing 3
increases expression
EXP
Selenium results in increased expression of SORBS3 mRNA
CTD
PMID:19244175
NCBI chr 8:22,544,973...22,575,788
Ensembl chr 8:22,544,986...22,575,788
G
SORD
sorbitol dehydrogenase
increases expression
ISO
Selenium results in increased expression of SORD protein
CTD
PMID:1588439
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
G
SOS1
SOS Ras/Rac guanine nucleotide exchange factor 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SOS1 mRNA Selenium results in decreased expression of SOS1 mRNA
CTD
PMID:19244175
NCBI chr 2:38,981,549...39,124,868
Ensembl chr 2:38,962,206...39,124,345
G
SOX4
SRY-box transcription factor 4
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SOX4 mRNA Selenium results in decreased expression of SOX4 mRNA
CTD
PMID:19244175
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SOX9
SRY-box transcription factor 9
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA Selenium results in decreased expression of SOX9 mRNA
CTD
PMID:19244175
NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
G
SP1
Sp1 transcription factor
multiple interactions
EXP ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SP1 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of SP1 protein
CTD
PMID:35384129
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
G
SP100
SP100 nuclear antigen
decreases expression
EXP
Selenium results in decreased expression of SP100 mRNA
CTD
PMID:19244175
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
G
SPCS2
signal peptidase complex subunit 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SPCS2 mRNA Selenium results in decreased expression of SPCS2 mRNA
CTD
PMID:19244175
NCBI chr11:74,949,266...74,979,033
Ensembl chr11:74,949,261...74,979,033
G
SPEN
spen family transcriptional repressor
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SPEN mRNA Selenium results in decreased expression of SPEN mRNA
CTD
PMID:19244175
NCBI chr 1:15,847,707...15,940,456
Ensembl chr 1:15,836,095...15,940,456
G
SPG7
SPG7 matrix AAA peptidase subunit, paraplegin
increases expression
EXP
Selenium results in increased expression of SPG7 mRNA
CTD
PMID:19244175
NCBI chr16:89,508,388...89,557,768
Ensembl chr16:89,490,719...89,557,766
G
SPINT1
serine peptidase inhibitor, Kunitz type 1
increases expression
EXP
Selenium results in increased expression of SPINT1 mRNA
CTD
PMID:19244175
NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
G
SPP1
secreted phosphoprotein 1
decreases expression
ISO
Selenium results in decreased expression of SPP1 protein
CTD
PMID:15318939
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPSB3
splA/ryanodine receptor domain and SOCS box containing 3
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SPSB3 mRNA Selenium results in increased expression of SPSB3 mRNA
CTD
PMID:19244175
NCBI chr16:1,776,712...1,782,571
Ensembl chr16:1,776,712...1,793,700
G
SPTAN1
spectrin alpha, non-erythrocytic 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SPTAN1 mRNA Selenium results in increased expression of SPTAN1 mRNA
CTD
PMID:19244175
NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662
G
SQSTM1
sequestosome 1
multiple interactions
ISO
Selenium inhibits the reaction [arsenite results in increased expression of SQSTM1 protein]
CTD
PMID:29324385
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SREBF1
sterol regulatory element binding transcription factor 1
increases expression multiple interactions
ISO
Selenium results in increased expression of SREBF1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA] [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
CTD
PMID:19022953 PMID:28810182 PMID:30031400 PMID:36464106
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
increases expression
EXP
Selenium results in increased expression of SREBF2 mRNA
CTD
PMID:19244175
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
SRPK1
SRSF protein kinase 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SRPK1 mRNA Selenium results in decreased expression of SRPK1 mRNA
CTD
PMID:19244175
NCBI chr 6:35,832,966...35,921,098
Ensembl chr 6:35,832,966...35,921,342
G
SRRM2
serine/arginine repetitive matrix 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA
CTD
PMID:19244175
NCBI chr16:2,752,638...2,771,412
Ensembl chr16:2,752,626...2,772,538
G
SRSF1
serine and arginine rich splicing factor 1
increases expression
EXP
Selenium results in increased expression of SRSF1 mRNA
CTD
PMID:19244175
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
G
SRSF10
serine and arginine rich splicing factor 10
decreases expression
EXP
Selenium results in decreased expression of SRSF10 mRNA
CTD
PMID:19244175
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
G
SRSF11
serine and arginine rich splicing factor 11
decreases expression
EXP
Selenium results in decreased expression of SRSF11 mRNA
CTD
PMID:19244175
NCBI chr 1:70,205,696...70,253,052
Ensembl chr 1:70,205,682...70,253,052
G
SRSF7
serine and arginine rich splicing factor 7
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of SRSF7 mRNA Selenium results in decreased expression of SRSF7 mRNA
CTD
PMID:19244175
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
G
SRSF9
serine and arginine rich splicing factor 9
increases expression
EXP
Selenium results in increased expression of SRSF9 mRNA
CTD
PMID:19244175
NCBI chr12:120,461,672...120,469,748
Ensembl chr12:120,461,672...120,495,946
G
SS18L2
SS18 like 2
decreases expression
EXP
Selenium results in decreased expression of SS18L2 mRNA
CTD
PMID:19244175
NCBI chr 3:42,581,840...42,596,934
Ensembl chr 3:42,581,840...42,596,934
G
SSNA1
SS nuclear autoantigen 1
increases expression
EXP
Selenium results in increased expression of SSNA1 mRNA
CTD
PMID:19244175
NCBI chr 9:137,188,676...137,190,366
Ensembl chr 9:137,188,660...137,190,370
G
SSRP1
structure specific recognition protein 1
increases expression
EXP
Selenium results in increased expression of SSRP1 mRNA
CTD
PMID:19244175
NCBI chr11:57,325,988...57,335,892
Ensembl chr11:57,325,986...57,335,892
G
SSX2IP
SSX family member 2 interacting protein
decreases expression
EXP
Selenium results in decreased expression of SSX2IP mRNA
CTD
PMID:19244175
NCBI chr 1:84,643,706...84,690,745
Ensembl chr 1:84,643,706...84,690,803
G
ST13
ST13 Hsp70 interacting protein
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ST13 mRNA
CTD
PMID:11444866
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
ST14
ST14 transmembrane serine protease matriptase
increases expression
EXP
Selenium results in increased expression of ST14 mRNA
CTD
PMID:19244175
NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362
G
STAB1
stabilin 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of STAB1 mRNA Selenium results in increased expression of STAB1 mRNA
CTD
PMID:19244175
NCBI chr 3:52,495,338...52,524,495
Ensembl chr 3:52,495,338...52,524,495
G
STAG2
STAG2 cohesin complex component
decreases expression
EXP
Selenium results in decreased expression of STAG2 mRNA
CTD
PMID:19244175
NCBI chr X:123,960,560...124,102,656
Ensembl chr X:123,960,212...124,422,664
G
STARD5
StAR related lipid transfer domain containing 5
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of STARD5 mRNA
CTD
PMID:19244175
NCBI chr15:81,309,053...81,324,141
Ensembl chr15:81,309,053...81,324,183
G
STBD1
starch binding domain 1
increases expression
EXP
Selenium results in increased expression of STBD1 mRNA
CTD
PMID:19244175
NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
G
STK11
serine/threonine kinase 11
increases expression
EXP
Selenium results in increased expression of STK11 mRNA
CTD
PMID:19244175
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
G
STK24
serine/threonine kinase 24
increases expression
EXP
Selenium results in increased expression of STK24 mRNA
CTD
PMID:19244175
NCBI chr13:98,445,185...98,577,107
Ensembl chr13:98,445,185...98,577,940
G
STK38L
serine/threonine kinase 38 like
decreases expression
EXP
Selenium results in decreased expression of STK38L mRNA
CTD
PMID:19244175
NCBI chr12:27,244,286...27,325,959
Ensembl chr12:27,243,968...27,325,959
G
STOML2
stomatin like 2
increases expression
EXP
Selenium results in increased expression of STOML2 mRNA
CTD
PMID:19244175
NCBI chr 9:35,099,776...35,103,195
Ensembl chr 9:35,099,776...35,103,195
G
STT3A
STT3 oligosaccharyltransferase complex catalytic subunit A
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of STT3A mRNA Selenium results in increased expression of STT3A mRNA
CTD
PMID:19244175
NCBI chr11:125,591,769...125,623,091
Ensembl chr11:125,591,712...125,625,215
G
STUB1
STIP1 homology and U-box containing protein 1
increases expression
EXP
Selenium results in increased expression of STUB1 mRNA
CTD
PMID:19244175
NCBI chr16:680,410...682,801
Ensembl chr16:680,224...682,870
G
STYXL1
serine/threonine/tyrosine interacting like 1
increases expression
EXP
Selenium results in increased expression of STYXL1 mRNA
CTD
PMID:19244175
NCBI chr 7:75,996,337...76,048,000
Ensembl chr 7:75,996,338...76,048,004
G
SULF1
sulfatase 1
decreases expression
EXP
Selenium results in decreased expression of SULF1 mRNA
CTD
PMID:19244175
NCBI chr 8:69,466,781...69,660,912
Ensembl chr 8:69,466,624...69,660,915
G
SUMO2
small ubiquitin like modifier 2
increases expression
EXP
Selenium results in increased expression of SUMO2 mRNA
CTD
PMID:19244175
NCBI chr17:75,165,586...75,182,959
Ensembl chr17:75,165,586...75,182,959
G
SUPT5H
SPT5 homolog, DSIF elongation factor subunit
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of SUPT5H mRNA Selenium results in increased expression of SUPT5H mRNA
CTD
PMID:19244175
NCBI chr19:39,445,582...39,476,670
Ensembl chr19:39,436,156...39,476,670
G
SUPT7L
SPT7 like, STAGA complex subunit gamma
decreases expression
EXP
Selenium results in decreased expression of SUPT7L mRNA
CTD
PMID:19244175
NCBI chr 2:27,642,568...27,663,614
Ensembl chr 2:27,650,809...27,663,840
G
SUZ12
SUZ12 polycomb repressive complex 2 subunit
decreases expression
EXP
Selenium results in decreased expression of SUZ12 mRNA
CTD
PMID:19244175
NCBI chr17:31,937,007...32,001,038
Ensembl chr17:31,937,007...32,001,038
G
SYNCRIP
synaptotagmin binding cytoplasmic RNA interacting protein
decreases expression
EXP
Selenium results in decreased expression of SYNCRIP mRNA
CTD
PMID:19244175
NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063
G
SYNJ2
synaptojanin 2
increases expression
EXP
Selenium results in increased expression of SYNJ2 mRNA
CTD
PMID:19244175
NCBI chr 6:157,981,296...158,099,176
Ensembl chr 6:157,981,863...158,099,176
G
SYNPO
synaptopodin
increases expression
EXP
Selenium results in increased expression of SYNPO mRNA
CTD
PMID:19244175
NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207
G
TADA3
transcriptional adaptor 3
increases expression
EXP
Selenium results in increased expression of TADA3 mRNA
CTD
PMID:19244175
NCBI chr 3:9,779,967...9,793,011
Ensembl chr 3:9,779,967...9,793,011
G
TAF10
TATA-box binding protein associated factor 10
increases expression
EXP
Selenium results in increased expression of TAF10 mRNA
CTD
PMID:19244175
NCBI chr11:6,606,294...6,612,216
Ensembl chr11:6,606,294...6,612,539
G
TAF2
TATA-box binding protein associated factor 2
decreases expression
EXP
Selenium results in decreased expression of TAF2 mRNA
CTD
PMID:19244175
NCBI chr 8:119,730,774...119,832,841
Ensembl chr 8:119,730,774...119,832,863
G
TAF5L
TATA-box binding protein associated factor 5 like
decreases expression
EXP
Selenium results in decreased expression of TAF5L mRNA
CTD
PMID:19244175
NCBI chr 1:229,593,134...229,626,122
Ensembl chr 1:229,593,134...229,626,122
G
TAGLN2
transgelin 2
increases expression
EXP
Selenium results in increased expression of TAGLN2 mRNA
CTD
PMID:19244175
NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507
G
TALDO1
transaldolase 1
increases expression
EXP
Selenium results in increased expression of TALDO1 mRNA
CTD
PMID:19244175
NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012
G
TAP1
transporter 1, ATP binding cassette subfamily B member
increases expression
EXP
Selenium results in increased expression of TAP1 mRNA
CTD
PMID:19244175
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TAPBP
TAP binding protein
increases expression
EXP
Selenium results in increased expression of TAPBP mRNA
CTD
PMID:19244175
NCBI chr 6:33,299,694...33,314,078
Ensembl chr 6:33,299,694...33,314,284
G
TARBP2
TARBP2 subunit of RISC loading complex
increases expression multiple interactions
EXP
Selenium results in increased expression of TARBP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA
CTD
PMID:19244175
NCBI chr12:53,500,923...53,506,431
Ensembl chr12:53,500,921...53,506,431
G
TAS2R14
taste 2 receptor member 14
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TAS2R14 mRNA
CTD
PMID:19244175
NCBI chr12:10,937,410...10,939,263
Ensembl chr12:10,937,408...11,171,573
G
TASOR
transcription activation suppressor
decreases expression
EXP
Selenium results in decreased expression of TASOR mRNA
CTD
PMID:19244175
NCBI chr 3:56,620,132...56,683,265
Ensembl chr 3:56,620,132...56,683,265
G
TAX1BP3
Tax1 binding protein 3
increases expression
EXP
Selenium results in increased expression of TAX1BP3 mRNA
CTD
PMID:19244175
NCBI chr17:3,662,895...3,668,578
Ensembl chr17:3,662,895...3,668,679
G
TBC1D30
TBC1 domain family member 30
decreases expression
EXP
Selenium results in decreased expression of TBC1D30 mRNA
CTD
PMID:19244175
NCBI chr12:64,759,484...64,881,033
Ensembl chr12:64,759,484...64,881,033
G
TBC1D8B
TBC1 domain family member 8B
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TBC1D8B mRNA Selenium results in decreased expression of TBC1D8B mRNA
CTD
PMID:19244175
NCBI chr X:106,802,673...106,876,150
Ensembl chr X:106,802,673...106,876,150
G
TBC1D9B
TBC1 domain family member 9B
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA Selenium results in increased expression of TBC1D9B mRNA
CTD
PMID:19244175
NCBI chr 5:179,862,071...179,907,897
Ensembl chr 5:179,862,066...179,907,897
G
TBCB
tubulin folding cofactor B
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TBCB mRNA Selenium results in increased expression of TBCB mRNA
CTD
PMID:19244175
NCBI chr19:36,114,967...36,125,941
Ensembl chr19:36,114,289...36,125,947
G
TBL1X
transducin beta like 1 X-linked
decreases expression
EXP
Selenium results in decreased expression of TBL1X mRNA
CTD
PMID:19244175
NCBI chr X:9,463,295...9,719,740
Ensembl chr X:9,463,320...9,741,037
G
TBL3
transducin beta like 3
increases expression
EXP
Selenium results in increased expression of TBL3 mRNA
CTD
PMID:19244175
NCBI chr16:1,972,053...1,982,929
Ensembl chr16:1,972,053...1,982,929
G
TBXAS1
thromboxane A synthase 1
multiple interactions
ISO
[Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of TBXAS1 mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in decreased expression of TBXAS1 protein
CTD
PMID:21669866
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TCAF1
TRPM8 channel associated factor 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TCAF1 mRNA Selenium results in decreased expression of TCAF1 mRNA
CTD
PMID:19244175
NCBI chr 7:143,851,375...143,902,176
Ensembl chr 7:143,851,375...143,902,198
G
TCEA2
transcription elongation factor A2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TCEA2 mRNA Selenium results in increased expression of TCEA2 mRNA
CTD
PMID:19244175
NCBI chr20:64,055,596...64,072,347
Ensembl chr20:64,049,836...64,072,347
G
TCERG1
transcription elongation regulator 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA Selenium results in decreased expression of TCERG1 mRNA
CTD
PMID:19244175
NCBI chr 5:146,447,330...146,511,961
Ensembl chr 5:146,447,311...146,511,961
G
TCF12
transcription factor 12
decreases expression
EXP
Selenium results in decreased expression of TCF12 mRNA
CTD
PMID:19244175
NCBI chr15:56,918,090...57,291,310
Ensembl chr15:56,918,623...57,299,281
G
TCF7L2
transcription factor 7 like 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA Selenium results in decreased expression of TCF7L2 mRNA
CTD
PMID:19244175
NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,247...113,167,678
G
TCP1
t-complex 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of TCP1 mRNA
CTD
PMID:11444866
NCBI chr 6:159,778,498...159,789,602
Ensembl chr 6:159,778,498...159,789,703
G
TCTN1
tectonic family member 1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TCTN1 mRNA Selenium results in decreased expression of TCTN1 mRNA
CTD
PMID:19244175
NCBI chr12:110,614,129...110,649,430
Ensembl chr12:110,614,027...110,663,431
G
TEAD3
TEA domain transcription factor 3
increases expression
EXP
Selenium results in increased expression of TEAD3 mRNA
CTD
PMID:19244175
NCBI chr 6:35,473,597...35,497,079
Ensembl chr 6:35,473,597...35,497,079
G
TECR
trans-2,3-enoyl-CoA reductase
increases expression
EXP
Selenium results in increased expression of TECR mRNA
CTD
PMID:19244175
NCBI chr19:14,527,726...14,565,980
Ensembl chr19:14,517,085...14,565,980
G
TERF1
telomeric repeat binding factor 1
decreases expression multiple interactions
EXP
Selenium results in decreased expression of TERF1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TERF1 mRNA
CTD
PMID:19244175
NCBI chr 8:73,008,864...73,048,123
Ensembl chr 8:73,008,856...73,048,123
G
TERT
telomerase reverse transcriptase
decreases activity multiple interactions decreases expression
EXP ISO
Selenium results in decreased activity of TERT protein [Benzene co-treated with Selenium] results in increased activity of TERT protein Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TERT mRNA] Selenium results in decreased expression of TERT mRNA
CTD
PMID:16600092 PMID:17948765 PMID:19080380
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TFAM
transcription factor A, mitochondrial
multiple interactions increases expression
ISO
NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]
CTD
PMID:17936198
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
G
TFB2M
transcription factor B2, mitochondrial
decreases expression
EXP
Selenium results in decreased expression of TFB2M mRNA
CTD
PMID:19244175
NCBI chr 1:246,540,561...246,566,261
Ensembl chr 1:246,540,561...246,566,261
G
TFEB
transcription factor EB
increases expression
EXP
Selenium results in increased expression of TFEB mRNA
CTD
PMID:19244175
NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259
G
TGFB1
transforming growth factor beta 1
multiple interactions increases expression
ISO
Selenium promotes the reaction [Drugs, Chinese Herbal inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]]; Selenium promotes the reaction [Drugs, Chinese Herbal inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]] Selenium inhibits the reaction [2-iodohexadecanal results in increased expression of TGFB1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in increased expression of TGFB1 mRNA] Selenium deficiency results in increased expression of TGFB1 mRNA
CTD
PMID:11260395 PMID:14991942 PMID:38013145
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFBR3
transforming growth factor beta receptor 3
decreases expression
EXP
Selenium results in decreased expression of TGFBR3 mRNA
CTD
PMID:19244175
NCBI chr 1:91,680,343...91,906,002
Ensembl chr 1:91,680,343...91,906,335
G
TGOLN2
trans-golgi network protein 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA
CTD
PMID:19244175
NCBI chr 2:85,318,027...85,327,989
Ensembl chr 2:85,318,027...85,328,251
G
TH
tyrosine hydroxylase
increases activity increases expression multiple interactions
ISO
Selenium deficiency results in increased activity of TH protein Selenium deficiency results in increased expression of TH mRNA [Selenium deficiency results in increased activity of TH protein] which results in increased chemical synthesis of Dopamine
CTD
PMID:11113527
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
THAP11
THAP domain containing 11
increases expression
EXP
Selenium results in increased expression of THAP11 mRNA
CTD
PMID:19244175
NCBI chr16:67,842,320...67,844,195
Ensembl chr16:67,842,320...67,844,195
G
THAP7
THAP domain containing 7
increases expression
EXP
Selenium results in increased expression of THAP7 mRNA
CTD
PMID:19244175
NCBI chr22:20,999,104...21,002,118
Ensembl chr22:20,999,104...21,002,196
G
THBD
thrombomodulin
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of THBD mRNA
CTD
PMID:19244175
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
THOC2
THO complex subunit 2
decreases expression multiple interactions
EXP
Selenium results in decreased expression of THOC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of THOC2 mRNA
CTD
PMID:19244175
NCBI chr X:123,600,569...123,733,052
Ensembl chr X:123,600,561...123,733,056
G
THRA
thyroid hormone receptor alpha
multiple interactions
ISO
Selenium inhibits the reaction [Iodine results in increased expression of THRA mRNA]
CTD
PMID:17555094
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
G
THRB
thyroid hormone receptor beta
multiple interactions
ISO
Selenium inhibits the reaction [Iodine results in increased expression of THRB mRNA]
CTD
PMID:17555094
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
G
THSD7A
thrombospondin type 1 domain containing 7A
decreases expression
EXP
Selenium results in decreased expression of THSD7A mRNA
CTD
PMID:19244175
NCBI chr 7:11,370,365...11,832,198
Ensembl chr 7:11,370,365...11,832,198
G
THUMPD1
THUMP domain containing 1
decreases expression
EXP
Selenium results in decreased expression of THUMPD1 mRNA
CTD
PMID:19244175
NCBI chr16:20,733,664...20,741,818
Ensembl chr16:20,702,816...20,742,084
G
THYN1
thymocyte nuclear protein 1
increases expression
EXP
Selenium results in increased expression of THYN1 mRNA
CTD
PMID:19244175
NCBI chr11:134,248,282...134,253,352
Ensembl chr11:134,248,279...134,253,370
G
TIA1
TIA1 cytotoxic granule associated RNA binding protein
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA Selenium results in decreased expression of TIA1 mRNA
CTD
PMID:19244175
NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,660
G
TIMM8A
translocase of inner mitochondrial membrane 8A
decreases expression
EXP
Selenium results in decreased expression of TIMM8A mRNA
CTD
PMID:19244175
NCBI chr X:101,345,661...101,348,742
Ensembl chr X:101,345,661...101,348,742
G
TIMM8B
translocase of inner mitochondrial membrane 8 homolog B
decreases expression
EXP
Selenium results in decreased expression of TIMM8B mRNA
CTD
PMID:19244175
NCBI chr11:112,084,800...112,086,756
Ensembl chr11:112,084,800...112,086,798
G
TIMM9
translocase of inner mitochondrial membrane 9
decreases expression
EXP
Selenium results in decreased expression of TIMM9 mRNA
CTD
PMID:19244175
NCBI chr14:58,408,494...58,427,531
Ensembl chr14:58,408,495...58,427,531
G
TIMP1
TIMP metallopeptidase inhibitor 1
decreases expression multiple interactions increases expression
EXP ISO
Selenium results in decreased expression of TIMP1 mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of TIMP1 protein] Selenium deficiency results in increased expression of TIMP1 mRNA
CTD
PMID:11444866 PMID:17390030 PMID:21144892
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TIMP2
TIMP metallopeptidase inhibitor 2
decreases expression multiple interactions
EXP
Selenium results in decreased expression of TIMP2 mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of TIMP2 protein]
CTD
PMID:17390030 PMID:21144892
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TIMP3
TIMP metallopeptidase inhibitor 3
increases expression decreases expression
EXP
Selenium results in increased expression of TIMP3 mRNA Selenium results in decreased expression of TIMP3 mRNA
CTD
PMID:17390030 PMID:19244175
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
G
TIMP4
TIMP metallopeptidase inhibitor 4
decreases expression
EXP
Selenium results in decreased expression of TIMP4 mRNA
CTD
PMID:17390030
NCBI chr 3:12,153,068...12,158,912
Ensembl chr 3:12,153,068...12,158,912
G
TJP1
tight junction protein 1
multiple interactions
EXP
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Selenium results in increased expression of and results in increased localization of TJP1 protein
CTD
PMID:16514648
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TKT
transketolase
increases expression
EXP
Selenium results in increased expression of TKT mRNA
CTD
PMID:19244175
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TLE2
TLE family member 2, transcriptional corepressor
increases expression
EXP
Selenium results in increased expression of TLE2 mRNA
CTD
PMID:19244175
NCBI chr19:2,997,644...3,047,635
Ensembl chr19:2,997,639...3,047,635
G
TLN1
talin 1
increases expression
EXP
Selenium results in increased expression of TLN1 mRNA
CTD
PMID:19244175
NCBI chr 9:35,696,948...35,732,195
Ensembl chr 9:35,696,948...35,732,195
G
TLR10
toll like receptor 10
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of TLR10 mRNA
CTD
PMID:21481475
NCBI chr 4:38,772,238...38,782,990
Ensembl chr 4:38,772,238...38,782,990
G
TM2D1
TM2 domain containing 1
decreases expression
EXP
Selenium results in decreased expression of TM2D1 mRNA
CTD
PMID:19244175
NCBI chr 1:61,681,046...61,725,141
Ensembl chr 1:61,681,046...61,725,423
G
TM9SF1
transmembrane 9 superfamily member 1
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TM9SF1 mRNA
CTD
PMID:19244175
NCBI chr14:24,189,149...24,195,441
Ensembl chr14:24,189,149...24,195,687
G
TM9SF4
transmembrane 9 superfamily member 4
increases expression
EXP
Selenium results in increased expression of TM9SF4 mRNA
CTD
PMID:19244175
NCBI chr20:32,109,714...32,167,256
Ensembl chr20:32,109,714...32,167,258
G
TMA7
translation machinery associated 7 homolog
decreases expression
EXP
Selenium results in decreased expression of TMA7 mRNA
CTD
PMID:19244175
NCBI chr 3:48,440,257...48,444,208
Ensembl chr 3:48,440,257...48,444,208
G
TMC5
transmembrane channel like 5
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TMC5 mRNA
CTD
PMID:19244175
NCBI chr16:19,410,539...19,499,113
Ensembl chr16:19,410,496...19,499,113
G
TMEM168
transmembrane protein 168
decreases expression
EXP
Selenium results in decreased expression of TMEM168 mRNA
CTD
PMID:19244175
NCBI chr 7:112,762,377...112,790,393
Ensembl chr 7:112,762,377...112,790,423
G
TMEM222
transmembrane protein 222
increases expression
EXP
Selenium results in increased expression of TMEM222 mRNA
CTD
PMID:19244175
NCBI chr 1:27,322,163...27,336,400
Ensembl chr 1:27,322,145...27,336,400
G
TMEM243
transmembrane protein 243
decreases expression
EXP
Selenium results in decreased expression of TMEM243 mRNA
CTD
PMID:19244175
NCBI chr 7:87,196,160...87,220,587
Ensembl chr 7:87,196,160...87,220,587
G
TMEM258
transmembrane protein 258
decreases expression
EXP
Selenium results in decreased expression of TMEM258 mRNA
CTD
PMID:19244175
NCBI chr11:61,788,949...61,792,599
Ensembl chr11:61,768,501...61,792,802
G
TMEM53
transmembrane protein 53
increases expression
EXP
Selenium results in increased expression of TMEM53 mRNA
CTD
PMID:19244175
NCBI chr 1:44,653,247...44,674,481
Ensembl chr 1:44,635,238...44,674,481
G
TMEM63A
transmembrane protein 63A
increases expression
EXP
Selenium results in increased expression of TMEM63A mRNA
CTD
PMID:19244175
NCBI chr 1:225,840,556...225,882,380
Ensembl chr 1:225,845,536...225,882,380
G
TMF1
TATA element modulatory factor 1
decreases expression
EXP
Selenium results in decreased expression of TMF1 mRNA
CTD
PMID:19244175
NCBI chr 3:69,019,827...69,052,333
Ensembl chr 3:69,019,827...69,052,339
G
TMPRSS2
transmembrane serine protease 2
increases expression
EXP
Selenium results in increased expression of TMPRSS2 mRNA
CTD
PMID:19244175
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
G
TMPRSS6
transmembrane serine protease 6
increases expression
EXP
Selenium results in increased expression of TMPRSS6 mRNA
CTD
PMID:19244175
NCBI chr22:37,065,436...37,110,536
Ensembl chr22:37,065,436...37,109,713
G
TMSB15A
thymosin beta 15A
decreases expression
EXP
Selenium results in decreased expression of TMSB15A mRNA
CTD
PMID:19244175
NCBI chr X:102,513,682...102,516,739
Ensembl chr X:102,513,682...102,516,739
G
TMSB15B
thymosin beta 15B
decreases expression
EXP
Selenium results in decreased expression of TMSB15B mRNA
CTD
PMID:19244175
NCBI chr X:103,919,155...103,974,426
Ensembl chr X:103,918,896...103,966,712 Ensembl chr X:103,918,896...103,966,712
G
TNF
tumor necrosis factor
multiple interactions increases expression
EXP ISO
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TNF mRNA; Selenium affects the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Selenium inhibits the reaction [Cadmium results in increased expression of and results in increased secretion of TNF protein]; Selenium inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Selenium promotes the reaction [T-2 Toxin results in increased expression of TNF protein] [Drugs, Chinese Herbal co-treated with Selenium] results in decreased expression of TNF mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of TNF mRNA [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of TNF protein] Selenium results in increased expression of TNF mRNA
CTD
PMID:10802230 PMID:15862027 PMID:17293063 PMID:18196609 PMID:21481475 PMID:21775527 PMID:24626144 PMID:26089086 PMID:29028684 More...
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP2
TNF alpha induced protein 2
increases expression
EXP
Selenium results in increased expression of TNFAIP2 mRNA
CTD
PMID:19244175
NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439
G
TNFAIP6
TNF alpha induced protein 6
increases expression
EXP
Selenium results in increased expression of TNFAIP6 mRNA
CTD
PMID:17293063
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TNFRSF10A
TNF receptor superfamily member 10a
multiple interactions
EXP
Selenium analog inhibits the reaction [Diazinon results in decreased expression of TNFRSF10A mRNA]
CTD
PMID:27920530
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
G
TNFRSF10B
TNF receptor superfamily member 10b
increases expression
EXP
Selenium results in increased expression of TNFRSF10B protein
CTD
PMID:12432279
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
G
TNFRSF10C
TNF receptor superfamily member 10c
increases expression
EXP
Selenium results in increased expression of TNFRSF10C mRNA
CTD
PMID:17293063
NCBI chr 8:23,102,921...23,117,445
Ensembl chr 8:23,102,921...23,117,445
G
TNFRSF12A
TNF receptor superfamily member 12A
increases expression
EXP
Selenium results in increased expression of TNFRSF12A mRNA
CTD
PMID:19244175
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF1A
TNF receptor superfamily member 1A
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TNFRSF1A mRNA; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]
CTD
PMID:21481475 PMID:27920530
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFSF10
TNF superfamily member 10
decreases expression
EXP
Selenium results in decreased expression of TNFSF10 mRNA
CTD
PMID:19244175
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TNK1
tyrosine kinase non receptor 1
increases expression
EXP
Selenium results in increased expression of TNK1 mRNA
CTD
PMID:19244175
NCBI chr17:7,380,047...7,389,742
Ensembl chr17:7,380,534...7,389,774
G
TNPO1
transportin 1
decreases expression
EXP
Selenium results in decreased expression of TNPO1 mRNA
CTD
PMID:19244175
NCBI chr 5:72,816,661...72,914,388
Ensembl chr 5:72,816,312...72,916,733
G
TNPO2
transportin 2
decreases expression
EXP
Selenium results in decreased expression of TNPO2 mRNA
CTD
PMID:19244175
NCBI chr19:12,699,201...12,723,932
Ensembl chr19:12,699,201...12,724,011
G
TNS2
tensin 2
increases expression
EXP
Selenium results in increased expression of TNS2 mRNA
CTD
PMID:19244175
NCBI chr12:53,046,991...53,064,379
Ensembl chr12:53,046,969...53,064,379
G
TOB2
transducer of ERBB2, 2
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TOB2 mRNA
CTD
PMID:19244175
NCBI chr22:41,433,494...41,446,801
Ensembl chr22:41,433,494...41,446,801
G
TOMM7
translocase of outer mitochondrial membrane 7
decreases expression
EXP
Selenium results in decreased expression of TOMM7 mRNA
CTD
PMID:19244175
NCBI chr 7:22,812,974...22,822,849
Ensembl chr 7:22,812,628...22,822,849
G
TOP1
DNA topoisomerase I
decreases expression multiple interactions
EXP
Selenium results in decreased expression of TOP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TOP1 mRNA
CTD
PMID:19244175
NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487
G
TOR1A
torsin family 1 member A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TOR1A mRNA
CTD
PMID:19244175
NCBI chr 9:129,812,942...129,824,136
Ensembl chr 9:129,812,942...129,824,244
G
TOR3A
torsin family 3 member A
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TOR3A mRNA
CTD
PMID:19244175
NCBI chr 1:179,082,070...179,095,996
Ensembl chr 1:179,082,070...179,098,023
G
TOX4
TOX high mobility group box family member 4
increases expression
EXP
Selenium results in increased expression of TOX4 mRNA
CTD
PMID:19244175
NCBI chr14:21,477,195...21,499,170
Ensembl chr14:21,476,597...21,499,175
G
TP53
tumor protein p53
multiple interactions decreases expression increases expression
EXP ISO
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA]; [Selenium co-treated with Vitamin E] results in increased expression of TP53 mRNA Selenium results in decreased expression of TP53 protein [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA]; Selenium inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein] Selenium results in increased expression of TP53 mRNA
CTD
PMID:16600092 PMID:17523932 PMID:19244175 PMID:21628957 PMID:27920530
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TPI1
triosephosphate isomerase 1
increases expression
EXP
Selenium results in increased expression of TPI1 mRNA
CTD
PMID:19244175
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
G
TPM2
tropomyosin 2
increases expression
EXP
Selenium results in increased expression of TPM2 mRNA
CTD
PMID:19244175
NCBI chr 9:35,681,993...35,690,056
Ensembl chr 9:35,681,992...35,690,056
G
TPP1
tripeptidyl peptidase 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TPP1 mRNA Selenium results in increased expression of TPP1 mRNA
CTD
PMID:19244175
NCBI chr11:6,612,768...6,619,422
Ensembl chr11:6,612,768...6,619,448
G
TPR
translocated promoter region, nuclear basket protein
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA Selenium results in decreased expression of TPR mRNA
CTD
PMID:19244175
NCBI chr 1:186,311,652...186,375,253
Ensembl chr 1:186,311,652...186,375,693
G
TRA2A
transformer 2 alpha homolog
decreases expression increases expression
EXP
Selenium results in decreased expression of TRA2A mRNA Selenium results in increased expression of TRA2A mRNA
CTD
PMID:17293063 PMID:19244175
NCBI chr 7:23,504,780...23,531,981
Ensembl chr 7:23,504,780...23,532,041
G
TRAF2
TNF receptor associated factor 2
multiple interactions
EXP
Selenium analog inhibits the reaction [Diazinon results in increased expression of TRAF2 mRNA]
CTD
PMID:27920530
NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607
G
TRAF4
TNF receptor associated factor 4
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TRAF4 mRNA Selenium results in increased expression of TRAF4 mRNA
CTD
PMID:19244175
NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956
G
TRAFD1
TRAF-type zinc finger domain containing 1
increases expression
EXP
Selenium results in increased expression of TRAFD1 mRNA
CTD
PMID:19244175
NCBI chr12:112,125,560...112,153,604
Ensembl chr12:112,125,538...112,153,604
G
TRAPPC14
trafficking protein particle complex subunit 14
increases expression
EXP
Selenium results in increased expression of TRAPPC14 mRNA
CTD
PMID:19244175
NCBI chr 7:100,154,423...100,158,723
Ensembl chr 7:100,154,420...100,158,723
G
TRAPPC2B
trafficking protein particle complex subunit 2B
decreases expression
EXP
Selenium results in decreased expression of TRAPPC2B mRNA
CTD
PMID:19244175
NCBI chr19:57,363,551...57,365,405
Ensembl chr19:57,363,551...57,365,405
G
TRAPPC8
trafficking protein particle complex subunit 8
decreases expression
EXP
Selenium results in decreased expression of TRAPPC8 mRNA
CTD
PMID:19244175
NCBI chr18:31,829,197...31,943,128
Ensembl chr18:31,829,197...31,953,136
G
TREM1
triggering receptor expressed on myeloid cells 1
multiple interactions
EXP
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of TREM1 mRNA
CTD
PMID:21481475
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TREX1
three prime repair exonuclease 1
increases expression
EXP
Selenium results in increased expression of TREX1 mRNA
CTD
PMID:19244175
NCBI chr 3:48,465,830...48,467,645
Ensembl chr 3:48,465,811...48,467,645
G
TRGC1
T cell receptor gamma constant 1
decreases expression
EXP
Selenium results in decreased expression of TRGC1 mRNA
CTD
PMID:19244175
NCBI chr 7:38,260,088...38,265,678
G
TRIB2
tribbles pseudokinase 2
increases expression
EXP
Selenium results in increased expression of TRIB2 mRNA
CTD
PMID:19244175
NCBI chr 2:12,716,936...12,742,734
Ensembl chr 2:12,716,910...12,742,734
G
TRIB3
tribbles pseudokinase 3
decreases expression
ISO
Selenium results in decreased expression of TRIB3 mRNA
CTD
PMID:28810182
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM24
tripartite motif containing 24
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TRIM24 mRNA Selenium results in decreased expression of TRIM24 mRNA
CTD
PMID:19244175
NCBI chr 7:138,460,259...138,589,996
Ensembl chr 7:138,460,259...138,589,996
G
TRIM27
tripartite motif containing 27
decreases expression
EXP
Selenium results in decreased expression of TRIM27 mRNA
CTD
PMID:19244175
NCBI chr 6:28,903,002...28,923,985
Ensembl chr 6:28,903,002...28,923,988
G
TRIM28
tripartite motif containing 28
increases expression
EXP
Selenium results in increased expression of TRIM28 mRNA
CTD
PMID:19244175
NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,544,064...58,550,722
G
TRIM29
tripartite motif containing 29
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TRIM29 mRNA Selenium results in increased expression of TRIM29 mRNA
CTD
PMID:19244175
NCBI chr11:120,111,286...120,138,113
Ensembl chr11:120,111,286...120,185,529
G
TRIM36
tripartite motif containing 36
decreases expression
EXP
Selenium results in decreased expression of TRIM36 mRNA
CTD
PMID:19244175
NCBI chr 5:115,124,772...115,180,294
Ensembl chr 5:115,124,762...115,180,546
G
TRIM38
tripartite motif containing 38
decreases expression
EXP
Selenium results in decreased expression of TRIM38 mRNA
CTD
PMID:19244175
NCBI chr 6:25,962,802...25,991,231
Ensembl chr 6:25,962,802...25,991,231
G
TRIM52
tripartite motif containing 52
decreases expression
EXP
Selenium results in decreased expression of TRIM52 mRNA
CTD
PMID:19244175
NCBI chr 5:181,249,062...181,261,143
Ensembl chr 5:181,254,077...181,261,150
G
TRIP6
thyroid hormone receptor interactor 6
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TRIP6 mRNA Selenium results in increased expression of TRIP6 mRNA
CTD
PMID:19244175
NCBI chr 7:100,867,387...100,873,454
Ensembl chr 7:100,867,387...100,873,454
G
TRIT1
tRNA isopentenyltransferase 1
decreases expression
EXP
Selenium results in decreased expression of TRIT1 mRNA
CTD
PMID:19244175
NCBI chr 1:39,838,110...39,883,511
Ensembl chr 1:39,838,110...39,883,511
G
TRMT11
tRNA methyltransferase 11 homolog
decreases expression
EXP
Selenium results in decreased expression of TRMT11 mRNA
CTD
PMID:19244175
NCBI chr 6:125,986,540...126,272,343
Ensembl chr 6:125,986,479...126,203,817
G
TRMT61B
tRNA methyltransferase 61B
decreases expression
EXP
Selenium results in decreased expression of TRMT61B mRNA
CTD
PMID:19244175
NCBI chr 2:28,849,821...28,870,309
Ensembl chr 2:28,849,821...28,870,309
G
TRO
trophinin
increases expression
EXP
Selenium results in increased expression of TRO mRNA
CTD
PMID:19244175
NCBI chr X:54,920,824...54,931,431
Ensembl chr X:54,920,462...54,931,431
G
TRPC4
transient receptor potential cation channel subfamily C member 4
decreases expression
EXP
Selenium results in decreased expression of TRPC4 mRNA
CTD
PMID:19244175
NCBI chr13:37,632,063...37,869,772
Ensembl chr13:37,632,063...37,869,802
G
TRRAP
transformation/transcription domain associated protein
increases expression
EXP
Selenium results in increased expression of TRRAP mRNA
CTD
PMID:19244175
NCBI chr 7:98,878,532...99,013,241
Ensembl chr 7:98,877,933...99,050,831
G
TSC2
TSC complex subunit 2
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TSC2 mRNA Selenium results in increased expression of TSC2 mRNA
CTD
PMID:19244175
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
G
TSPAN14
tetraspanin 14
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA Selenium results in increased expression of TSPAN14 mRNA
CTD
PMID:19244175
NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,265...80,533,124
G
TSR3
TSR3 ribosome maturation factor
increases expression
EXP
Selenium results in increased expression of TSR3 mRNA
CTD
PMID:19244175
NCBI chr16:1,349,240...1,351,878
Ensembl chr16:1,349,240...1,351,878
G
TSSC4
tumor suppressing subtransferable candidate 4
increases expression
EXP
Selenium results in increased expression of TSSC4 mRNA
CTD
PMID:19244175
NCBI chr11:2,400,750...2,403,876
Ensembl chr11:2,400,488...2,403,878
G
TTC17
tetratricopeptide repeat domain 17
decreases expression
EXP
Selenium results in decreased expression of TTC17 mRNA
CTD
PMID:19244175
NCBI chr11:43,358,920...43,494,931
Ensembl chr11:43,358,920...43,494,933
G
TTC3
tetratricopeptide repeat domain 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TTC3 mRNA Selenium results in decreased expression of TTC3 mRNA
CTD
PMID:19244175
NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112
G
TTC31
tetratricopeptide repeat domain 31
decreases expression multiple interactions
EXP
Selenium results in decreased expression of TTC31 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TTC31 mRNA
CTD
PMID:19244175
NCBI chr 2:74,483,081...74,494,559
Ensembl chr 2:74,483,073...74,494,559
G
TUBA1B
tubulin alpha 1b
increases expression
EXP
Selenium results in increased expression of TUBA1B mRNA
CTD
PMID:19244175
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
G
TUBA1C
tubulin alpha 1c
increases expression
EXP
Selenium results in increased expression of TUBA1C mRNA
CTD
PMID:19244175
NCBI chr12:49,227,926...49,274,600
Ensembl chr12:49,188,736...49,274,600
G
TUBA4A
tubulin alpha 4a
increases expression multiple interactions increases abundance
EXP
Selenium results in increased expression of TUBA4A mRNA TUBA4A mutant form results in increased abundance of [Selenium binds to SELENOP protein]; TUBA4A mutant form results in increased abundance of [Selenomethionine binds to Selenium] TUBA4A mutant form results in increased abundance of Selenium
CTD
PMID:19244175 PMID:28478440
NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902
G
TUBB
tubulin beta class I
increases expression
EXP
Selenium results in increased expression of TUBB mRNA
CTD
PMID:19244175
NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538
G
TUBB3
tubulin beta 3 class III
increases expression multiple interactions
EXP
Selenium results in increased expression of TUBB3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TUBB3 mRNA
CTD
PMID:19244175
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
G
TUG1
taurine up-regulated 1
decreases expression
EXP
Selenium results in decreased expression of TUG1 mRNA
CTD
PMID:19244175
NCBI chr22:30,969,265...30,979,395
Ensembl chr22:30,969,245...30,979,395
G
TULP3
TUB like protein 3
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TULP3 mRNA Selenium results in decreased expression of TULP3 mRNA
CTD
PMID:19244175
NCBI chr12:2,890,891...2,941,138
Ensembl chr12:2,877,223...2,941,138
G
TUT7
terminal uridylyl transferase 7
decreases expression
EXP
Selenium results in decreased expression of TUT7 mRNA
CTD
PMID:19244175
NCBI chr 9:86,287,733...86,354,410
Ensembl chr 9:86,287,733...86,354,454
G
TXLNGY
taxilin gamma Y-linked (pseudogene)
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of TXLNGY mRNA Selenium results in decreased expression of TXLNGY mRNA
CTD
PMID:19244175
NCBI chr Y:19,567,358...19,607,170
Ensembl chr Y:19,567,382...19,604,120 Ensembl chr Y:19,567,382...19,604,120
G
TXN
thioredoxin
increases expression affects expression
ISO
Selenium results in increased expression of TXN1 mRNA Selenium affects the expression of TXN1 mRNA
CTD
PMID:15792362 PMID:19351701
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
multiple interactions decreases expression affects activity increases activity increases expression
EXP ISO
[sulforaphane co-treated with Selenium] results in increased activity of TXNRD1 protein; Selenium promotes the reaction [erucin results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium promotes the reaction [iberin results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium promotes the reaction [Selenium results in increased expression of TXNRD1 protein]; Selenium promotes the reaction [sulforaphane results in increased expression of and results in increased activity of TXNRD1 protein]; Selenium results in increased expression of and results in increased activity of TXNRD1 protein Selenium inhibits the reaction [2-iodohexadecanal results in decreased expression of TXNRD1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of TXNRD1 mRNA] Selenium deficiency results in decreased expression of TXNRD1 mRNA Selenium affects the activity of TXNRD1 protein Selenium results in increased activity of TXNRD1 protein Selenium deficiency results in increased expression of TXNRD1 mRNA; Selenium results in increased expression of TXNRD1 mRNA Selenium deficiency results in decreased expression of TXNRD1 mRNA; Selenium deficiency results in decreased expression of TXNRD1 protein
CTD
PMID:12667700 PMID:12949356 PMID:15471857 PMID:15740016 PMID:15792362 PMID:16170372 PMID:17150329 PMID:19022953 PMID:19076066 PMID:19351701 PMID:38013145 More...
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TXNRD2
thioredoxin reductase 2
increases activity decreases expression increases expression
EXP ISO
Selenium results in increased activity of TXNRD2 protein Selenium deficiency results in decreased expression of TXNRD2 mRNA Selenium results in increased expression of TXNRD2 mRNA
CTD
PMID:15471857 PMID:15792362 PMID:17291446
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
G
TYMP
thymidine phosphorylase
increases expression
EXP
Selenium results in increased expression of TYMP mRNA
CTD
PMID:19244175
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
G
U2AF1
U2 small nuclear RNA auxiliary factor 1
increases expression
EXP
Selenium results in increased expression of U2AF1 mRNA
CTD
PMID:19244175
NCBI chr21:43,092,956...43,107,578
Ensembl chr21:43,092,956...43,107,570
G
UBA1
ubiquitin like modifier activating enzyme 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of UBA1 mRNA Selenium results in increased expression of UBA1 mRNA
CTD
PMID:19244175
NCBI chr X:47,190,847...47,215,128
Ensembl chr X:47,190,861...47,215,128
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
decreases expression
EXP
Selenium results in decreased expression of UBA52 mRNA
CTD
PMID:19244175
NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
G
UBA7
ubiquitin like modifier activating enzyme 7
increases expression
EXP
Selenium results in increased expression of UBA7 mRNA
CTD
PMID:19244175
NCBI chr 3:49,805,209...49,813,953
Ensembl chr 3:49,805,209...49,813,953
G
UBAP2
ubiquitin associated protein 2
decreases expression
EXP
Selenium results in decreased expression of UBAP2 mRNA
CTD
PMID:19244175
NCBI chr 9:33,921,693...34,049,199
Ensembl chr 9:33,921,693...34,049,388
G
UBAP2L
ubiquitin associated protein 2 like
increases expression
EXP
Selenium results in increased expression of UBAP2L mRNA
CTD
PMID:19244175
NCBI chr 1:154,220,172...154,271,510
Ensembl chr 1:154,220,179...154,271,510
G
UBE2L3
ubiquitin conjugating enzyme E2 L3
increases expression
EXP
Selenium results in increased expression of UBE2L3 mRNA
CTD
PMID:19244175
NCBI chr22:21,549,447...21,624,034
Ensembl chr22:21,549,447...21,624,034
G
UBE2V1
ubiquitin conjugating enzyme E2 V1
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA Selenium results in decreased expression of UBE2V1 mRNA
CTD
PMID:19244175
NCBI chr20:50,081,124...50,115,957
Ensembl chr20:50,081,124...50,115,959
G
UBE2Z
ubiquitin conjugating enzyme E2 Z
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of UBE2Z mRNA Selenium results in increased expression of UBE2Z mRNA
CTD
PMID:19244175
NCBI chr17:48,908,407...48,929,056
Ensembl chr17:48,908,407...48,929,056
G
UBE4B
ubiquitination factor E4B
increases expression
EXP
Selenium results in increased expression of UBE4B mRNA
CTD
PMID:19244175
NCBI chr 1:10,032,958...10,181,239
Ensembl chr 1:10,032,832...10,181,239
G
UBL3
ubiquitin like 3
decreases expression
EXP
Selenium results in decreased expression of UBL3 mRNA
CTD
PMID:19244175
NCBI chr13:29,764,371...29,850,617
Ensembl chr13:29,764,371...29,850,617
G
UBN1
ubinuclein 1
multiple interactions increases expression decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of UBN1 mRNA; [Selenium co-treated with Vitamin E] results in increased expression of UBN1 mRNA Selenium results in increased expression of UBN1 mRNA Selenium results in decreased expression of UBN1 mRNA
CTD
PMID:19244175
NCBI chr16:4,847,481...4,882,401
Ensembl chr16:4,846,665...4,882,401
G
UBXN1
UBX domain protein 1
increases expression
EXP
Selenium results in increased expression of UBXN1 mRNA
CTD
PMID:19244175
NCBI chr11:62,676,500...62,679,073
Ensembl chr11:62,676,498...62,679,117
G
UBXN4
UBX domain protein 4
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of UBXD2 mRNA Selenium results in decreased expression of UBXD2 mRNA
CTD
PMID:19244175
NCBI chr 2:135,741,855...135,785,056
Ensembl chr 2:135,741,734...135,785,056
G
UBXN6
UBX domain protein 6
increases expression
EXP
Selenium results in increased expression of UBXN6 mRNA
CTD
PMID:19244175
NCBI chr19:4,445,006...4,457,879
Ensembl chr19:4,444,999...4,457,794
G
UFD1
ubiquitin recognition factor in ER associated degradation 1
increases expression
EXP
Selenium results in increased expression of UFD1 mRNA
CTD
PMID:19244175
NCBI chr22:19,449,911...19,479,193
Ensembl chr22:19,449,911...19,479,202
G
UGCG
UDP-glucose ceramide glucosyltransferase
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA Selenium results in decreased expression of UGCG mRNA
CTD
PMID:19244175
NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases expression
ISO
Selenium deficiency results in increased expression of UGT2B1 mRNA
CTD
PMID:11444866
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
UNC5B
unc-5 netrin receptor B
increases expression
EXP
Selenium results in increased expression of UNC5B mRNA
CTD
PMID:19244175
NCBI chr10:71,212,570...71,302,864
Ensembl chr10:71,212,570...71,302,864
G
UPF3A
UPF3A regulator of nonsense mediated mRNA decay
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of UPF3A mRNA Selenium results in decreased expression of UPF3A mRNA
CTD
PMID:19244175
NCBI chr13:114,281,601...114,305,817
Ensembl chr13:114,281,601...114,305,817
G
UPF3B
UPF3B regulator of nonsense mediated mRNA decay
decreases expression
EXP
Selenium results in decreased expression of UPF3B mRNA
CTD
PMID:19244175
NCBI chr X:119,805,311...119,852,963
Ensembl chr X:119,834,022...119,852,998
G
UQCR10
ubiquinol-cytochrome c reductase, complex III subunit X
decreases expression
EXP
Selenium results in decreased expression of UQCR10 mRNA
CTD
PMID:19244175
NCBI chr22:29,767,369...29,770,413
Ensembl chr22:29,767,369...29,770,413
G
UQCRB
ubiquinol-cytochrome c reductase binding protein
decreases expression
EXP
Selenium results in decreased expression of UQCRB mRNA
CTD
PMID:19244175
NCBI chr 8:96,222,947...96,235,545
Ensembl chr 8:96,222,947...96,235,546
G
UQCRC1
ubiquinol-cytochrome c reductase core protein 1
increases expression
EXP
Selenium results in increased expression of UQCRC1 mRNA
CTD
PMID:19244175
NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
G
UQCRH
ubiquinol-cytochrome c reductase hinge protein
decreases expression
EXP
Selenium results in decreased expression of UQCRH mRNA
CTD
PMID:19244175
NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
G
UQCRQ
ubiquinol-cytochrome c reductase complex III subunit VII
decreases expression
EXP
Selenium results in decreased expression of UQCRQ mRNA
CTD
PMID:19244175
NCBI chr 5:132,866,642...132,868,847
Ensembl chr 5:132,866,630...132,868,847
G
USE1
unconventional SNARE in the ER 1
increases expression
EXP
Selenium results in increased expression of USE1 mRNA
CTD
PMID:19244175
NCBI chr19:17,215,357...17,219,829
Ensembl chr19:17,215,346...17,219,829
G
USF2
upstream transcription factor 2, c-fos interacting
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of USF2 mRNA Selenium results in increased expression of USF2 mRNA
CTD
PMID:19244175
NCBI chr19:35,268,962...35,279,821
Ensembl chr19:35,268,962...35,279,821
G
USP3
ubiquitin specific peptidase 3
decreases expression
EXP
Selenium results in decreased expression of USP3 mRNA
CTD
PMID:19244175
NCBI chr15:63,504,593...63,594,633
Ensembl chr15:63,504,511...63,594,640
G
USP33
ubiquitin specific peptidase 33
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA Selenium results in decreased expression of USP33 mRNA
CTD
PMID:19244175
NCBI chr 1:77,695,987...77,759,852
Ensembl chr 1:77,695,987...77,759,852
G
USP4
ubiquitin specific peptidase 4
decreases expression
EXP
Selenium results in decreased expression of USP4 mRNA
CTD
PMID:19244175
NCBI chr 3:49,277,144...49,340,053
Ensembl chr 3:49,277,144...49,340,712
G
USP47
ubiquitin specific peptidase 47
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of USP47 mRNA Selenium results in decreased expression of USP47 mRNA
CTD
PMID:19244175
NCBI chr11:11,841,972...11,961,887
Ensembl chr11:11,841,423...11,961,887
G
USP9X
ubiquitin specific peptidase 9 X-linked
decreases expression
EXP
Selenium results in decreased expression of USP9X mRNA
CTD
PMID:19244175
NCBI chr X:41,085,445...41,236,579
Ensembl chr X:41,085,445...41,236,579
G
USPL1
ubiquitin specific peptidase like 1
decreases expression
EXP
Selenium results in decreased expression of USPL1 mRNA
CTD
PMID:19244175
NCBI chr13:30,617,920...30,660,766
Ensembl chr13:30,617,693...30,660,770
G
UTP11
UTP11 small subunit processome component
decreases expression
EXP
Selenium results in decreased expression of UTP11 mRNA
CTD
PMID:19244175
NCBI chr 1:38,012,734...38,024,820
Ensembl chr 1:38,009,258...38,024,820
G
UTP25
UTP25 small subunit processome component
decreases expression
EXP
Selenium results in decreased expression of UTP25 mRNA
CTD
PMID:19244175
NCBI chr 1:209,827,972...209,857,565
Ensembl chr 1:209,827,972...209,857,565
G
VAMP8
vesicle associated membrane protein 8
increases expression
EXP
Selenium results in increased expression of VAMP8 mRNA
CTD
PMID:19244175
NCBI chr 2:85,577,586...85,582,031
Ensembl chr 2:85,561,562...85,582,031
G
VARS2
valyl-tRNA synthetase 2, mitochondrial
increases expression
EXP
Selenium results in increased expression of VARS2 mRNA
CTD
PMID:19244175
NCBI chr 6:30,914,238...30,926,459
Ensembl chr 6:30,914,205...30,926,459
G
VAT1
vesicle amine transport 1
increases expression
EXP
Selenium results in increased expression of VAT1 mRNA
CTD
PMID:19244175
NCBI chr17:43,014,607...43,022,385
Ensembl chr17:43,014,607...43,025,123
G
VCPKMT
valosin containing protein lysine methyltransferase
decreases expression
EXP
Selenium results in decreased expression of VCPKMT mRNA
CTD
PMID:19244175
NCBI chr14:50,102,716...50,116,572
Ensembl chr14:50,108,632...50,116,600
G
VGF
VGF nerve growth factor inducible
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA
CTD
PMID:19244175
NCBI chr 7:101,162,509...101,169,952
Ensembl chr 7:101,162,509...101,165,569
G
VILL
villin like
increases expression
EXP
Selenium results in increased expression of VILL mRNA
CTD
PMID:19244175
NCBI chr 3:37,987,978...38,007,185
Ensembl chr 3:37,988,059...38,007,188
G
VIM
vimentin
increases expression multiple interactions
EXP ISO
Selenium results in increased expression of VIM mRNA Selenium deficiency results in increased expression of VIM protein Selenium inhibits the reaction [Cisplatin results in increased expression of VIM protein]
CTD
PMID:16837816 PMID:17109141 PMID:19244175
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VIPR1
vasoactive intestinal peptide receptor 1
increases expression
EXP
Selenium results in increased expression of VIPR1 mRNA
CTD
PMID:19244175
NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573
G
VKORC1
vitamin K epoxide reductase complex subunit 1
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA Selenium results in increased expression of VKORC1 mRNA
CTD
PMID:19244175
NCBI chr16:31,090,854...31,094,797
Ensembl chr16:31,090,842...31,095,980
G
VPS28
VPS28 subunit of ESCRT-I
increases expression
EXP
Selenium results in increased expression of VPS28 mRNA
CTD
PMID:19244175
NCBI chr 8:144,423,617...144,428,548
Ensembl chr 8:144,423,601...144,428,563
G
VPS39
VPS39 subunit of HOPS complex
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA Selenium results in increased expression of VPS39 mRNA
CTD
PMID:19244175
NCBI chr15:42,158,701...42,208,304
Ensembl chr15:42,158,701...42,208,307
G
VPS4A
vacuolar protein sorting 4 homolog A
increases expression
EXP
Selenium results in increased expression of VPS4A mRNA
CTD
PMID:19244175
NCBI chr16:69,311,350...69,326,939
Ensembl chr16:69,311,350...69,326,939
G
VPS72
vacuolar protein sorting 72 homolog
increases expression
EXP
Selenium results in increased expression of TCFL1 mRNA
CTD
PMID:19244175
NCBI chr 1:151,176,304...151,190,197
Ensembl chr 1:151,176,304...151,195,321
G
WASF2
WASP family member 2
increases expression multiple interactions
EXP
Selenium results in increased expression of WASF2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA
CTD
PMID:19244175
NCBI chr 1:27,404,230...27,490,167
Ensembl chr 1:27,404,230...27,490,167
G
WASHC2C
WASH complex subunit 2C
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of WASHC2C mRNA
CTD
PMID:19244175
NCBI chr10:45,727,043...45,792,964
Ensembl chr10:45,727,200...45,792,964
G
WASHC3
WASH complex subunit 3
decreases expression
EXP
Selenium results in decreased expression of WASHC3 mRNA
CTD
PMID:19244175
NCBI chr12:102,012,840...102,062,124
Ensembl chr12:102,012,840...102,062,149
G
WBP2
WW domain binding protein 2
increases expression
EXP
Selenium results in increased expression of WBP2 mRNA
CTD
PMID:19244175
NCBI chr17:75,845,699...75,856,436
Ensembl chr17:75,845,699...75,856,507
G
WDR1
WD repeat domain 1
increases expression
EXP
Selenium results in increased expression of WDR1 mRNA
CTD
PMID:19244175
NCBI chr 4:10,074,339...10,116,799
Ensembl chr 4:10,068,089...10,116,972
G
WDR19
WD repeat domain 19
decreases expression multiple interactions
EXP
Selenium results in decreased expression of WDR19 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of WDR19 mRNA
CTD
PMID:19244175
NCBI chr 4:39,182,529...39,285,810
Ensembl chr 4:39,182,504...39,285,810
G
WDR45
WD repeat domain 45
increases expression
EXP
Selenium results in increased expression of WDR45 mRNA
CTD
PMID:19244175
NCBI chr X:49,074,442...49,101,178
Ensembl chr X:49,074,433...49,101,170
G
WDR5B
WD repeat domain 5B
decreases expression
EXP
Selenium results in decreased expression of WDR5B mRNA
CTD
PMID:19244175
NCBI chr 3:122,411,846...122,416,062
Ensembl chr 3:122,411,846...122,416,062
G
WDR6
WD repeat domain 6
increases expression
EXP
Selenium results in increased expression of WDR6 mRNA
CTD
PMID:19244175
NCBI chr 3:49,007,391...49,015,951
Ensembl chr 3:49,007,062...49,015,953
G
WFDC2
WAP four-disulfide core domain 2
increases expression
EXP
Selenium results in increased expression of WFDC2 mRNA
CTD
PMID:19244175
NCBI chr20:45,469,753...45,481,532
Ensembl chr20:45,469,753...45,481,532
G
WNT5B
Wnt family member 5B
increases expression
EXP
Selenium results in increased expression of WNT5B mRNA
CTD
PMID:19244175
NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212
G
WRAP53
WD repeat containing antisense to TP53
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of WRAP53 mRNA Selenium results in increased expression of WRAP53 mRNA
CTD
PMID:19244175
NCBI chr17:7,686,071...7,703,502
Ensembl chr17:7,686,071...7,703,502
G
WSB1
WD repeat and SOCS box containing 1
decreases expression
EXP
Selenium results in decreased expression of WSB1 mRNA
CTD
PMID:19244175
NCBI chr17:27,294,114...27,315,926
Ensembl chr17:27,294,076...27,315,926
G
WWP1
WW domain containing E3 ubiquitin protein ligase 1
decreases expression
EXP
Selenium results in decreased expression of WWP1 mRNA
CTD
PMID:19244175
NCBI chr 8:86,342,547...86,468,503
Ensembl chr 8:86,342,547...86,478,420
G
XPO6
exportin 6
decreases expression multiple interactions
EXP
Selenium results in decreased expression of XPO6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of XPO6 mRNA
CTD
PMID:19244175
NCBI chr16:28,097,976...28,211,965
Ensembl chr16:28,097,976...28,211,965
G
YBX3
Y-box binding protein 3
increases expression
EXP
Selenium results in increased expression of YBX3 mRNA
CTD
PMID:19244175
NCBI chr12:10,699,089...10,723,323
Ensembl chr12:10,699,089...10,723,323
G
YIPF3
Yip1 domain family member 3
increases expression
EXP
Selenium results in increased expression of YIPF3 mRNA
CTD
PMID:19244175
NCBI chr 6:43,511,832...43,516,926
Ensembl chr 6:43,511,832...43,516,985
G
YLPM1
YLP motif containing 1
decreases expression
EXP
Selenium results in decreased expression of YLPM1 mRNA
CTD
PMID:19244175
NCBI chr14:74,763,316...74,837,318
Ensembl chr14:74,763,316...74,859,435
G
YWHAE
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
decreases expression
EXP
Selenium results in decreased expression of YWHAE mRNA
CTD
PMID:19244175
NCBI chr17:1,344,275...1,400,222
Ensembl chr17:1,344,275...1,400,222
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in increased expression of YWHAZ mRNA
CTD
PMID:19244175
NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388
G
ZBTB11
zinc finger and BTB domain containing 11
decreases expression
EXP
Selenium results in decreased expression of ZBTB11 mRNA
CTD
PMID:19244175
NCBI chr 3:101,648,889...101,677,132
Ensembl chr 3:101,648,889...101,677,135
G
ZBTB44
zinc finger and BTB domain containing 44
decreases expression
EXP
Selenium results in decreased expression of ZBTB44 mRNA
CTD
PMID:19244175
NCBI chr11:130,226,677...130,314,917
Ensembl chr11:130,226,677...130,314,917
G
ZC2HC1A
zinc finger C2HC-type containing 1A
decreases expression
EXP
Selenium results in decreased expression of ZC2HC1A mRNA
CTD
PMID:19244175
NCBI chr 8:78,666,089...78,719,765
Ensembl chr 8:78,666,050...78,719,765
G
ZC3H15
zinc finger CCCH-type containing 15
decreases expression multiple interactions
EXP
Selenium results in decreased expression of ZC3H15 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZC3H15 mRNA
CTD
PMID:19244175
NCBI chr 2:186,486,260...186,509,361
Ensembl chr 2:186,486,253...186,509,361
G
ZC3HAV1
zinc finger CCCH-type containing, antiviral 1
decreases expression
EXP
Selenium results in decreased expression of ZC3HAV1 mRNA
CTD
PMID:19244175
NCBI chr 7:139,043,515...139,109,720
Ensembl chr 7:139,043,515...139,132,122
G
ZCCHC2
zinc finger CCHC-type containing 2
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZCCHC2 mRNA Selenium results in decreased expression of ZCCHC2 mRNA
CTD
PMID:19244175
NCBI chr18:62,523,025...62,586,729
Ensembl chr18:62,523,025...62,587,709
G
ZCCHC24
zinc finger CCHC-type containing 24
decreases expression
EXP
Selenium results in decreased expression of ZCCHC24 mRNA
CTD
PMID:19244175
NCBI chr10:79,382,325...79,445,624
Ensembl chr10:79,382,325...79,445,624
G
ZCCHC8
zinc finger CCHC-type containing 8
decreases expression
EXP
Selenium results in decreased expression of ZCCHC8 mRNA
CTD
PMID:19244175
NCBI chr12:122,471,600...122,500,932
Ensembl chr12:122,471,600...122,500,932
G
ZCWPW1
zinc finger CW-type and PWWP domain containing 1
increases expression multiple interactions
EXP
Selenium results in increased expression of ZCWPW1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA
CTD
PMID:19244175
NCBI chr 7:100,400,872...100,428,703
Ensembl chr 7:100,400,826...100,428,992
G
ZEB1
zinc finger E-box binding homeobox 1
decreases expression
EXP
Selenium results in decreased expression of ZEB1 mRNA
CTD
PMID:19244175
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
G
ZER1
zyg-11 related cell cycle regulator
increases expression
EXP
Selenium results in increased expression of ZER1 mRNA
CTD
PMID:19244175
NCBI chr 9:128,729,786...128,772,486
Ensembl chr 9:128,729,786...128,772,414
G
ZKSCAN1
zinc finger with KRAB and SCAN domains 1
decreases expression
EXP
Selenium results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:19244175
NCBI chr 7:100,015,596...100,045,374
Ensembl chr 7:100,015,572...100,041,689
G
ZMYM2
zinc finger MYM-type containing 2
decreases expression
EXP
Selenium results in decreased expression of ZMYM2 mRNA
CTD
PMID:19244175
NCBI chr13:19,863,840...20,089,115
Ensembl chr13:19,958,677...20,091,829
G
ZMYM4
zinc finger MYM-type containing 4
decreases expression
EXP
Selenium results in decreased expression of ZMYM4 mRNA
CTD
PMID:19244175
NCBI chr 1:35,268,709...35,422,058
Ensembl chr 1:35,268,709...35,422,058
G
ZNF12
zinc finger protein 12
decreases expression multiple interactions
EXP
Selenium results in decreased expression of ZNF12 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZNF12 mRNA
CTD
PMID:19244175
NCBI chr 7:6,688,433...6,706,947
Ensembl chr 7:6,688,433...6,706,947
G
ZNF131
zinc finger protein 131
decreases expression
EXP
Selenium results in decreased expression of ZNF131 mRNA
CTD
PMID:19244175
NCBI chr 5:43,120,914...43,176,324
Ensembl chr 5:43,065,176...43,192,021
G
ZNF148
zinc finger protein 148
decreases expression
EXP
Selenium results in decreased expression of ZNF148 mRNA
CTD
PMID:19244175
NCBI chr 3:125,225,669...125,375,354
Ensembl chr 3:125,225,669...125,375,325
G
ZNF180
zinc finger protein 180
decreases expression
EXP
Selenium results in decreased expression of ZNF180 mRNA
CTD
PMID:19244175
NCBI chr19:44,474,431...44,500,522
Ensembl chr19:44,474,428...44,500,524
G
ZNF195
zinc finger protein 195
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF195 mRNA Selenium results in decreased expression of ZNF195 mRNA
CTD
PMID:19244175
NCBI chr11:3,357,927...3,379,146
Ensembl chr11:3,339,261...3,379,222
G
ZNF211
zinc finger protein 211
decreases expression
EXP
Selenium results in decreased expression of ZNF211 mRNA
CTD
PMID:19244175
NCBI chr19:57,633,168...57,644,041
Ensembl chr19:57,630,395...57,644,041
G
ZNF212
zinc finger protein 212
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ZNF212 mRNA Selenium results in increased expression of ZNF212 mRNA
CTD
PMID:19244175
NCBI chr 7:149,239,651...149,255,606
Ensembl chr 7:149,239,651...149,255,606
G
ZNF219
zinc finger protein 219
increases expression multiple interactions
EXP
Selenium results in increased expression of ZNF219 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZNF219 mRNA
CTD
PMID:19244175
NCBI chr14:21,090,077...21,104,722
Ensembl chr14:21,090,077...21,104,722
G
ZNF26
zinc finger protein 26
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF26 mRNA Selenium results in decreased expression of ZNF26 mRNA
CTD
PMID:19244175
NCBI chr12:132,986,367...133,027,102
Ensembl chr12:132,986,365...133,032,952
G
ZNF264
zinc finger protein 264
decreases expression
EXP
Selenium results in decreased expression of ZNF264 mRNA
CTD
PMID:19244175
NCBI chr19:57,191,500...57,222,846
Ensembl chr19:57,191,500...57,222,846
G
ZNF274
zinc finger protein 274
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF274 mRNA Selenium results in decreased expression of ZNF274 mRNA
CTD
PMID:19244175
NCBI chr19:58,183,061...58,213,562
Ensembl chr19:58,183,029...58,213,562
G
ZNF324
zinc finger protein 324
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ZNF324 mRNA Selenium results in increased expression of ZNF324 mRNA
CTD
PMID:19244175
NCBI chr19:58,467,080...58,475,436
Ensembl chr19:58,467,056...58,475,436
G
ZNF337
zinc finger protein 337
decreases expression
EXP
Selenium results in decreased expression of ZNF337 mRNA
CTD
PMID:19244175
NCBI chr20:25,673,195...25,696,853
Ensembl chr20:25,673,195...25,696,853
G
ZNF358
zinc finger protein 358
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ZNF358 mRNA Selenium results in increased expression of ZNF358 mRNA
CTD
PMID:19244175
NCBI chr19:7,513,880...7,521,025
Ensembl chr19:7,515,292...7,521,025
G
ZNF492
zinc finger protein 492
decreases expression
EXP
Selenium results in decreased expression of ZNF492 mRNA
CTD
PMID:19244175
NCBI chr19:22,634,324...22,667,671
Ensembl chr19:22,634,324...22,667,671
G
ZNF500
zinc finger protein 500
increases expression
EXP
Selenium results in increased expression of ZNF500 mRNA
CTD
PMID:19244175
NCBI chr16:4,744,245...4,767,162
Ensembl chr16:4,748,239...4,767,624
G
ZNF552
zinc finger protein 552
decreases expression
EXP
Selenium results in decreased expression of ZNF552 mRNA
CTD
PMID:19244175
NCBI chr19:57,807,082...57,814,913
Ensembl chr19:57,803,841...57,814,913
G
ZNF573
zinc finger protein 573
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF573 mRNA Selenium results in decreased expression of ZNF573 mRNA
CTD
PMID:19244175
NCBI chr19:37,738,302...37,779,586
Ensembl chr19:37,735,833...37,817,300
G
ZNF580
zinc finger protein 580
multiple interactions increases expression
EXP
[Selenium co-treated with Vitamin E] results in increased expression of ZNF580 mRNA Selenium results in increased expression of ZNF580 mRNA
CTD
PMID:19244175
NCBI chr19:55,641,002...55,643,470
Ensembl chr19:55,635,016...55,643,470
G
ZNF586
zinc finger protein 586
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF586 mRNA Selenium results in decreased expression of ZNF586 mRNA
CTD
PMID:19244175
NCBI chr19:57,769,676...57,780,616
Ensembl chr19:57,769,655...57,819,939
G
ZNF692
zinc finger protein 692
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA
CTD
PMID:19244175
NCBI chr 1:248,850,008...248,859,085
Ensembl chr 1:248,850,006...248,859,144
G
ZNF768
zinc finger protein 768
increases expression
EXP
Selenium results in increased expression of ZNF768 mRNA
CTD
PMID:19244175
NCBI chr16:30,524,004...30,532,477
Ensembl chr16:30,524,004...30,526,821
G
ZNF839
zinc finger protein 839
multiple interactions
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA
CTD
PMID:19244175
NCBI chr14:102,317,506...102,342,367
Ensembl chr14:102,317,377...102,342,702
G
ZNF85
zinc finger protein 85
multiple interactions decreases expression
EXP
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF85 mRNA Selenium results in decreased expression of ZNF85 mRNA
CTD
PMID:19244175
NCBI chr19:20,923,251...20,950,697
Ensembl chr19:20,923,222...20,950,697
G
ZNF91
zinc finger protein 91
decreases expression
EXP
Selenium results in decreased expression of ZNF91 mRNA
CTD
PMID:17293063
NCBI chr19:23,305,004...23,395,471
Ensembl chr19:23,304,991...23,395,471
G
ZWINT
ZW10 interacting kinetochore protein
decreases expression
EXP
Selenium results in decreased expression of ZWINT mRNA
CTD
PMID:19244175
NCBI chr10:56,357,227...56,361,273
Ensembl chr10:56,357,227...56,361,273
G
ZYX
zyxin
increases expression multiple interactions
EXP
Selenium results in increased expression of ZYX mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZYX mRNA
CTD
PMID:19244175
NCBI chr 7:143,381,345...143,391,111
Ensembl chr 7:143,381,295...143,391,111
G
ZZEF1
zinc finger ZZ-type and EF-hand domain containing 1
increases expression multiple interactions
EXP
Selenium results in increased expression of ZZEF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA
CTD
PMID:19244175
NCBI chr17:4,004,445...4,143,030
Ensembl chr17:4,004,445...4,143,030
G
GPX2
glutathione peroxidase 2
decreases expression
ISO
Selenium decreases expression of Gpx2 mRNA in the jejunum
RGD
PMID:23271678
RGD:152998882
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX3
glutathione peroxidase 3
increases expression
EXP
selenium increases expression of GPX3 mRNA in colonic epithelium
RGD
PMID:23934683
RGD:151665784
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
ABCC2 protein affects the reaction [sodium selenide results in increased transport of arsenite]; sodium selenide inhibits the reaction [arsenite results in increased expression of ABCC2 protein]
CTD
PMID:34678219
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
multiple interactions
EXP
sodium selenide inhibits the reaction [arsenite results in increased expression of ABCC4 protein]
CTD
PMID:34678219
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]]; sodium selenide inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein]
CTD
PMID:17959236
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
TXN
thioredoxin
decreases expression multiple interactions
EXP
sodium selenide results in decreased expression of TXN protein sodium selenide inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]
CTD
PMID:17959236
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all